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Abstract
A disproportionate number of African American women are at increased risk for uterine
fibroid tumors (UF) compared to their Caucasian, Asian, and Hispanic counterparts.
Researchers have indicated that women diagnosed with UF can have a poorer healthrelated quality of life (HRQOL) when compared to women who do not have a diagnosis
of UF. The overall aim of this study was to explore the impact of UF symptoms on the
HRQOL of African American women. A quantitative, cross-sectional design was
employed utilizing the revised version of Wilson and Cleary’s model of HRQOL. A
sample was gathered of 80 participants who were African American women between age
30 and 45 years with a current diagnosis of UF. Linear and multiple hierarchical
regressions were performed to determine the relationship among UF symptom severity
and HRQOL based on 6 subscales of HRQOL (as measured by the UFS-QOL). There
was a statistically significant association between symptom severity, the 6 subscale
variables of HRQOL, and employment. No significant associations were observed with
age, family history (hx) of UF diagnosis, body mass index, general health perception,
overall quality of life, and symptom severity. The social change implication for this study
is to provide information that can direct health care providers in the development of
health maintenance programs that are sensitive to the needs of African American women
diagnosed with UF. In addition it will promote the need for public health professionals
and medical organizations to increase the availability of information related to UF
symptoms and the impact of UF symptoms on HRQOL among women.
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Chapter 1: Introduction
Introduction
Uterine leiomyomas or uterine fibroid (UF) tumors are reported to be one of the
most common forms of tumors for women in the United States (Davis et al., 2009; Flake,
Andersen, & Dixon, 2003) and identified as the fifth most commonly diagnosed
gynecological condition for women of reproductive age (Faerstein, Szklo, & Rosenshein,
2001; Office of Research on Women’s Health [ORWH], 2006). In addition, researchers
have identified UF as the leading indication for hysterectomies among African American
and Caucasian women in the United States (Flynn, Jamison, Datta, & Myers, 2006;
National Institutes of Health [NIH], 2006). Moorehead and Conrad (2001) found that the
rates of UF diagnoses among African American women were higher when compared with
women from all other racial backgrounds. As of 2011, African American women were
diagnosed up to three to nine times more often when compared to Caucasian women
(NIH, 2011). More specifically, African American women are identified as a “high risk”
population for developing UFs (Wise, Palmer, Stewart, & Rosenberg, 2005b). Not only
are African American women more likely to be diagnosed with UF compared to
Caucasian women, African American women are diagnosed with UF at earlier ages
(Davis et al., 2009; Wise et al., 2005b), have more tumors, and experience more
symptomatic tumors at the time of diagnosis (Davis et al., 2009; Hyuck et al., 2008;
Kjerulff, Lagenberg, & Sieden,1996). Current research findings reflect a disproportionate
number of African American women are diagnosed with and are treated for UF (Davis et
al., 2009; NIH, 2011; ORWH, 2006; Wise et al., 2005b). There is a disparity in the
number of African American women who are diagnosed with UF, the age at which
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African American women are diagnosed, and the symptoms that are experienced by
African American women when compared to their racial counterparts. Therefore, there
was a need for more investigation into how UFs are affecting African American women.
It is important to note that not all women diagnosed with UF experience
symptoms. The NIH (2006) stated many women do not know they have UF, implying the
prevalence of UF may be more than what has been reported in the past. Mauskopf, Flynn,
Thieda, Spalding, and Duchane (2005) reported that although a smaller percentage of
women in the United States are diagnosed with UF when compared to other
gynecological disorders, 35% to 50% of those women diagnosed seek treatment because
of the symptoms associated with UF. Women diagnosed with UF who experience
prominent symptoms often seek treatment because of the difficulty they encounter with
managing the symptoms effectively and the negative burden UF symptoms can have on
health-related quality of life (HRQOL).
HealthRelated Quality of Life
HRQOL is a multidimensional, dynamic concept that encompasses the physical,
social, and psychological aspects associated with a particular disease or treatment
(Ferrans, Zerwic, Wilbur, & Lawson, 2005; Williams, Jones, Mauskopf, Spalding, &
Duchane, 2006). The term HRQOL is often used interchangeably with the term quality of
life within research (Ferrans et al., 2005), suggesting that the two terms are synonymous.
Although quality of life is generally used to describe an individual’s sense of happiness
or satisfaction with life (Ferrans & Powers, 1992), HRQOL describes the effects of
health, illness, and treatment on overall quality of life or simply the impact of disease on
important areas of an individual’s life (Ferrans et al., 2005; Kimmel, 2000; Phillips,
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Davies, & White, 2001). In the past, researchers such as Lerner and Levine (1994)
implied that HRQOL refers to a group of health consequences that interfer with an
individual’s ability to complete usual daily activities. However, more recently researchers
have expanded their view of the concept to include the impact of health on the functional
status, psychological status, overall well-being, and social functioning of an individual
(Huget, Kaplan, & Feeny, 2008; Jakobsoon & Hallberg, 2006; Kaplan, 2003). For the
purpose of this study, HRQOL referred to the impact of UF symptoms on important areas
of an individual’s life, health, functional status, psychological, social functioning, and
overall well-being.
The impact of UF symptoms on the HRQOL of women suggests this chronic
condition can lead to a number of challenging social, physical, and emotional health
concerns. Compared with women who have similar gynecological disorders (chronic
pelvic pain, heavy bleeding, and urinary incontinence), women with UF experience a
poorer HRQOL—socially, physically, and emotionally (Spies et al., 2002; Williams et
al., 2006). More specifically, studies have indicated that problems related to:
1) limitations in social life,
2) anxiety related to inability to predict the onset of menses,
3) loss of ability to control breakthrough bleeding, leading to embarrassment,
4) loss of control in planning for future and social activities,
5) uncertainty about treatments options being able to preserve fertility,
6) feeling a loss of control in overall health, and
7) complaints of fatigue and feelings of depression,

4
were identified among women with UF as factors that impact HRQOL (Borah,
Nicholson, Bradley, & Stewart, 2013; Popovic et al., 2009; Spies et al., 2002; Spies et
al., 2004). Women diagnosed with a debilitating health condition like UF can have many
important areas of HRQOL and overall life affected.
The progression of UF symptoms is likely to increase throughout a woman’s
reproductive lifetime (Hartman et al., 2006). Borah et al. (2013) investigated the impact
of UF on the lives of a racially-mixed group of women age 29 to 59 years in the United
States. The researchers reported that 51% of the study participants, women who were
age 40 to 49 years, admitted that their UF “made them feel not in control of life” (p.
319.e3) as compared to only 11% of those women aged 50 to 59 years. Vines, Ta, and
Esserman (2010) suggested the presence and progression of symptomatic UF can lead to
an overall decline in HRQOL and general quality of life in women by “affecting work
and social activities because of pain and heavy bleeding; and leading to mental distress
related to the management of the disease symptoms” (p. 5). The symptoms associated
with UF can negatively influence the HRQOL of women diagnosed—socially,
physically, and emotionally—when compared to those women who do not have UF
(Spies et al., 2002; Williams et al., 2006). The overall physical and emotional wellbeing, health, social, and functional status of women with UF is impacted negatively.
Furthermore, it is evident that among African American women, the negative influence
of UF on their lives and health is increased because they have been shown to have a
greater risk for diagnosis and experience more problems associated with UF when
compared to their Caucasian and Asian counterparts. Therefore, exploring the symptoms
associated with UF and the impact of UF symptoms on HRQOL (functional status,
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psychosocial well-being, and overall general health) is important to those African
American women who have been diagnosed with this health issue.
Research on risk factors associated with UF and how they influence the health
and lives of women diagnosed have received more attention within the past 5 to 10 years.
However, according to Taran, Brown, and Stewart (2010), there has been limited
reporting of the participants’ race and ethnicity within the studies associated with UF.
The researchers found among the studies published from 2000 to 2006, approximately
75% of those studies did not report the participants’ race, and of those remaining studies
African American women only represented 15% of the sample population. The Black
Women’s Health Study (BWHS), one of the largest follow- up studies exclusively among
African American women ages 21 to 69 years conducted in the United States, released
several UF studies (Wise et al., 2004, 2005a, 2005b; Wise, Radin, Palmer, Kumanyika, &
Rosenberg, 2010). According to Taran et al. (2010), the BWHS studies were among the
few that clearly identified the race of their study participants exclusively as African
American. The studies from the BWHS researchers and Taran et al. (2010) suggests that
clear reporting of the participants’ race and ethnicity has an important role in UF
research. More importantly, the need to focus UF studies specifically among women in
the African American community will help the research community better understand
why the racial disparity exists among African American women who have been
diagnosed and treated for UF when compared to their counterparts.
This chapter provides an overall review of UF, symptoms associated with a UF
diagnosis, prevalence of UF among African American women, and the impact UF
symptoms have on HRQOL among African American women diagnosed with UF. In
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addition, the study’s theoretical framework along with a summary of the study’s research
questions, hypotheses, and overall research approach are included. Last, this chapter
provides a highlight of the study’s significance and social change implication.
Background of the Problem
What Are Fibroids?
UF tumors are diagnosed in women during routine yearly physical or radiological
examinations (Evans, 2008; Evans & Brunsell, 2007). The tumors described as lumps or
growths develop within the wall of the uterus (Evans & Brunsell, 2007). The location of
the UF tumors can vary within the uterus. Moorehead and Conrad (2001) reported that
the location of UF tumors occur inside the uterine wall (intramural), in the abdominal
cavity (subserosal), or in the uterine cavity (sub mucosal). The number of UF tumors
present in one uterus can range from one single UF tumor up to as many as 20 or more,
varying in size, with some being so small they are undetectable by means of a physical
exam (Moorehead & Conrad, 2001; Trivedi & Abreo, 2009). UF tumors primarily form
during the reproductive years of women and resolve with the onset of menopause (Evans
& Brunsell, 2007). Trivedi and Abreo (2009) reported that UF are usually benign and are
associated with a low mortality rate among women diagnosed in the United States.
Although researchers are still actively investigating the exact cause(s) for the increased
prevalence of UF diagnoses, increased symptoms, and growth rates among African
American women, diet, family history, weight gain, hormonal and estrogen levels are
some of the preliminary factors that have been associated (Evans & Brunsell, 2007;
Huyck et al., 2008; Schwartz et al., 2000; Wise et al., 2005a).
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Fibroids and Age
UFs are reported to be common among women of reproductive age in the United
States. The findings of several research studies reveal that the UFs and the symptoms
associated with UF impact more women during their reproductive years (Baird, Dunson,
Hill, Cousins, & Schectman, 2003; Davis et al., 2009; Wise et al., 2005b). Studies
performed by both Davis et al. (2009) and Wise et al. (2005) revealed that African
American women between the ages of 25 and 45 years have a statistically significant (p >
0.001) greater risk of diagnosis of UF when compared to Caucasian women. More
specifically, in a study completed by the National Institute of Environmental Health
Sciences, it was reported that by the age of 50 years, more than 80% of African American
women and about 70% of Caucasian women in the United States would be affected by
UF (Baird et al., 2003). Researchers have found that African American women have a
three-fold increased age-adjusted incidence rate and relative risk of fibroid tumor
diagnosis when compared to women from Caucasian, Hispanic, and Asian backgrounds
(Baird et al., 2003; Eltoukhi, Modi, Weston, Armstrong, & Stewart, 2013; Marshall et al.,
1997). The average age of diagnosis among African American women with UFs when
compared to their Caucasian counterparts was 5.3 years younger; African American
women usually received a diagnosis on average at 40.8 years of age versus a diagnosis at
45.1 years of age for Caucasian women (Huyck et al., 2008). Researchers have found that
African American women are diagnosed and treated for symptoms associated with UF
more often throughout their reproductive lifetime when compared to their counterparts
from other racial backgrounds (Hartman et al., 2006; NIH, 2011; Wise et al., 2005a,
2005b). The increased number of UF diagnoses among African American women of

8
reproductive age compared to the diagnosis of UF among their racial counterparts
suggests this chronic condition has become a public health concern (Eltoukhi et al.,
2013).
Prevalence and Uterine Fibroids
Prevalence rates of UF vary and are difficult to narrow depending upon the
population examined (U.S. Department of Health and Human Services [U.S. DHHS],
2011). Feinberg, Larsen, Catherino, Zhang, and Armstrong (2006) found that UF were
three times more prevalent among African American women (30.8%) when compared to
Caucasian women (10.7%) in their study. In the United States, prevalence rates for UF
are estimated primarily based on the annual rate of hysterectomies and myomectomies
performed. Researchers Flynn et al. (2006) reported that African American women are
more likely to require surgical treatment (myomectomy and hysterectomy) for treatment
of UF when compared to Caucasian women. Mauskopf et al. (2005) reported that, of the
600,000 hysterectomies performed in the United States on an annual basis, 33% to 40%
are related to treatment for UF among women diagnosed. In addition, reportedly at least
34,000 myomectomies are performed annually to remove UF among women diagnosed in
the United States (U.S. DHHS, 2011).
Several studies have listed UF as the principal single indicator for hysterectomies
among women (Flynn et al., 2006; Hartmann et al., 2006; U.S. DHHS, 2011). Keshavarz,
Hillis, Kieke, and Marchbanks (2002) investigated the trends of hysterectomies
performed on women in the United States from 1994 to 1999. Their findings
demonstrated a 17% increase in the rate of hysterectomies performed related to the
diagnosis of UF among women. More specifically, Keshavarz et al. (2002) found the rate

9
of hysterectomies for African American women with UF between the ages of 40–44
years was 16.8 per 1,000 women compared to a rate of 10.8 per 1,000 women for
Caucasian women in the same age group. According to Myers et al. (2002), the
cumulative risk of a hysterectomy due to UF for all women between the ages of 25–45
years is 7%. However, for African American women with UF in that same age category,
the risk of hysterectomy can be as high as 20% (Myers et al., 2002).
The healthcare cost associated with treatment of UF can be substantial for those
women who are diagnosed with this condition. The Agency for Healthcare Research and
Quality in their Fibroid Registry report noted that in the year 2000 alone, it was estimated
that, “253,000 hospital admissions (surgical and nonsurgical) with a principal diagnosis
of uterine fibroids” (U.S. DHHS, 2011, para. 3) resulted in hospital charges of more than
$2.6 billion (Flynn et al., 2006). Hartmann et al. (2006) found in their study that direct
costs (out of pocket expenses associated with in- patient hospitalizations, ER visits, outpatient procedures, and drug cost) and the indirect cost (work absenteeism and disability
claims) combined were at least 2.6 times higher for women with UF than for women
without UF. These researchers suggested that increased medical expenses are likely to be
incurred by African American women who are apt to experience more severe UF
symptoms when compared to Caucasian women. UF can have a negative financial impact
on African American women because of the frequency with which surgical interventions
are performed due to a UF diagnosis (Mauskopf et al., 2005; U.S. DHHS, 2011) along
with the increased use of health care resources for treatment of UF (Flynn et al., 2006;
Hartmann et al., 2006). Although there is a low mortality rate among African American
women diagnosed with UF (Trivedi & Abreo, 2009), the health distresses and financial
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and physical burdens of treatment that UF can have on the HRQOL of African American
women is far more relevant. There is a gap in the literature exploring the severity of UF
symptoms and the impact of UF symptoms on the HRQOL of African American women
age 30 to 45 years.
Theoretical Framework
A revised version of Wilson and Cleary’s 1995 model of HRQOL (Ferrans,
Zerwic, Wilbur, & Larson, 2005) guided this study (see Figure 1).

Figure 1. Revised Wilson and Cleary’s model of health-related quality of life.
From “Conceptual model of health-related quality of life” by C. Ferrans, J. Zerwic, J.
Wilbur, & J. Larson, 2005, Journal of Nursing Scholarship, 37(4), p,338. Reprinted with
permission.

The Wilson and Cleary model was designed in part to help delineate the
difference between the terms quality of life and HRQOL while drawing the focal point of
research to address the effects of health, illness, and treatment on the overall individual
(Ferrans et al., 2005). However, Ferrans et al. (2005) noted that the initial model still had
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some ambiguity associated with the HRQOL model determinants, and additional
clarification was needed. They suggested that researchers and practitioners needed a
causal model that would “clearly indicate the elements of HRQOL and their
determinants” (Ferrans et al., 2005, p. 336). The researchers revised the initial model to
add more clarification to the elements of HRQOL and clearly delineate how all of the
determinants of the model are influenced by characteristics of the individual and the
environment. The revised Wilson and Cleary model of HRQOL (Ferrans et al., 2005)
expands the original model to include other domains of life experiences, their influences
on health, and viewing the individual as a whole including the biological, psychological,
and social aspects of being. Subsequently, the researchers suggested in the revised model
that all areas in life affect health, and it is important to recognize how all of these factors
influence HRQOL (Ferrans et al., 2005).
Biological function as the first determinant of the model includes the
physiological processes that support life (Ferrans et al., 2005). According to Wilson and
Cleary (1995), biological function is a fundamental determinant of health status and the
model. The focal point of biological function is to examine the performance of cells and
organ systems and can often be measured through lab tests, physical assessment, and
medical diagnosis (Ferrans et al., 2005). The researchers believed that changes in an
individual’s biological function could influence all the subsequent determinants of the
model, including symptoms, functional status, general health perceptions, and overall
quality of life.
Symptoms, the next model determinant, is described as “a patient’s perception of
an abnormal physical, emotional, or cognitive state, which can be categorized as physical,

12
psychological, or psychophysical” (Ferrans et al., 2005, p. 339). According to Ferrans et
al. (2005), at least three common dimensions of symptoms are generally measured in
testing instruments: frequency, intensity, and distress. Although these are not the only
common dimensions that can be used to measure symptoms, it is important that
instruments used for investigating symptoms allow participants to rate or identify their
personal experiences with symptoms associated with their disease process. Symptoms are
an important feature to address when investigating HRQOL as they are unique to the
individual and may differ in persons who are experiencing the same disease process.
The next level of the revised Wilson and Cleary model is functional status, which
assesses the ability of an individual to perform tasks in several areas: physical, social, and
psychological (Ferrans et al., 2005; Wilson & Cleary, 1995). The need to measure
functional status as a separate variable is pertinent because researchers have indicated
that multiple elements of functionality can be assessed with this component (Ferrans et
al., 2005; Wilson & Cleary, 1995). Specifically, Ferrans et al. (2005) stated that
exploration of functional status helps to assess and explore how the capacity to perform
day-to-day activities, physical activity, and specific tasks has been impacted. More
importantly, the researchers identified functional status as the focus of how individuals
maximize the abilities and functions that remain and not necessarily the loss of function.
General health perceptions follow functional status as the next level of the model.
At least two characteristics are important to recognize when reviewing general health
perceptions:
1) They synthesize all of the components that come before it in the model.
2) They are subjective in nature. (Ferrans et al., 2005; Wilson & Cleary, 1995)
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General health perceptions are a separate component of the model that consists of more
than just combining the preceding concepts (Ferrans et al., 2005). Ferrans et al. suggested
this component is highly personal, and additional variables such as physiological
processes should be included when investigating this concept. According to Ferrans et al.,
people commonly contemplate several aspects of their health, lives, and the relevance of
each when considering their general health. Although general health perceptions are
described as being complex and individualized in nature, they are most often simply
measured on a Likert-type scale from poor to excellent using one single global question
(Ferrans et al., 2005).
All of the previous components of the model ultimately influence overall quality
of life, the last model component (Ferrans et al., 2005). Overall quality of life is
individualized and subjective, based on how happy or satisfied individuals may be with
their life in total (Ferrans et al., 2005; Wilson & Cleary, 1995). Overall quality of life is
based on the individuals’ perception of their own life satisfaction. This component can be
complex and multidimensional. According to Ferrans et al. (2005), overall quality of life
or life satisfaction may be dependent upon several factors including perception of
personal attributes (e.g., personal characteristics, demographic characteristics, optimism,
or pessimism) and their internal standards (e.g., personal values, expectation levels, and
personal needs). It is important to note that overall quality of life can be measured using
one single global question asking individuals to indicate how satisfied they are with life
in general measured on a Likert-type scale from poorly satisfied to highly satisfied or
with several questions that investigate satisfaction level in multiple aspects of a person’s
life (Ferrans et al., 2005)
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According to Ferrans et al. (2012), characteristics of the individual and
characteristics of the environment were included in Wilson and Cleary’s original model
but required more delineation and clarity. As a result, characteristics of the individual and
environment were clearly defined and conceptualized to help provide more clarity as to
how they influence the five components of the model (Bakas et al., 2012). Characteristics
of the individual in the revised model are described as those biological, demographic,
developmental, and psychological factors that influence health outcomes (Ferrans et al.,
2005). Biological factors are those characteristics (e.g., skin color, family history of
genetically linked disease, and body mass index) that may increase or decrease an
individual’s potential for developing a health condition or medical problem (Ferrans et
al., 2005). Demographic characteristics of the individual include gender, age, and
ethnicity and are generally nonmodifiable. Developmental characteristics of the
individual take into account the level at which a person is able to comprehend, institute,
change, or modify a behavior (Ferrans et al., 2005). The researchers indicated that
although this variable is not static, it also “cannot be changed or altered by interventions”
(Ferrans et al., 2005, p. 337). However, it is important to consider developmental
characteristics when deciding which types of health interventions will be successful with
certain populations of individuals (e.g., children versus adults; Ferrans et al., 2005).
Psychological factors, according to Ferrans et al. (2005), are dynamic, responsive to
intervention, modifiable, and include cognitive processes that change individual
perceptions, such as motivation and beliefs.
Characteristics of the environment are either physical or social factors that
influence health outcomes (Ferrans et al., 2005). Ferrans et al. described physical

15
characteristics of the environment as the unique aspects of various communal settings
that may influence health outcomes, such as an individual’s home, neighborhood, and
workplace. Social characteristics of the environment are defined as the influence of
significant others, such as marriage partners, friends, and cultural heritage on health
behavior and health practices (Ferrans et al., 2005).
The revised Wilson and Cleary model has been used to explore HRQOL among
an array of racial and ethnic populations with varied health conditions, such as heart
failure, HIV, and breast cancer (Henderson, Martino, Kitamura, Kim, & Erlen, 2012;
Heo, Moser, Riegel, Hall, & Christman, 2005; Sammarco & Konecny, 2010). For the
purposes of this study, the revised Wilson and Cleary model of HRQOL (Ferrans et al.,
2005) was used as a guide to obtain empirical evidence from an existing population of
African American women ages 30–45 years diagnosed with UF. The following
determinants of the revised Wilson and Cleary model of HRQOL were the focus of this
research: characteristics of the individual and environment, biological function,
symptoms, functional status, general health perception, and overall quality of life (see
Table 1; more details provided in Chapter 2). More specifically, I used the revised model
to focus the investigation on the following variables: age, family history of UF diagnosis,
employment, body mass index (BMI), symptom severity, concern, activities,
energy/mood, control, self-consciousness, sexual function, health perception, life
satisfaction (see Table 1), and HRQOL. These variables were examined among African
American women age 30 to 45 years with a diagnosis of UF.
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Table 1
Model Components and Related Study Variables

Model Components

Related Study Variables

Characteristics of the
Individual

Self -reported age in years

Family history of UF diagnosis
Characteristics of the
Environment
Employment

Biological Function

Body Mass Index

Symptoms

Symptom Severity

Functional Status

Concern, Activities, Energy/Mood, Control,
Self- Consciousness, and Sexual function.

General Health
Perception
Overall Quality of Life

How would you rate your current health on a
scale of 1 to 10 (with 1= poor and 10 =
excellent)?
How satisfied are you with your overall life
in general on a scale of 1 to 10 (with 1 =
poorly satisfied and 10 = very satisfied)

17
Although African American women aged 30 to 45 years diagnosed with UF may
be aware of some of the health, social, and physical barriers that occur with symptomatic
UF, they may have had limited opportunity to identify and articulate how UF symptoms
are affecting their HRQOL. I utilized participants’ demographic information along with
the Uterine Fibroid Symptom and Health Related Quality of Life (UFS-QOL) instrument
to explore UF symptom severity and the impact of UF symptoms on HRQOL among
African American women age 30 to 45 years who were diagnosed with UF.
Problem Statement
The negative impact UF symptoms can have on HRQOL, along with the
increased propensity for UF development among African American women, and the
burden of increased usage on healthcare systems for treatment of UF make this chronic
and progressive health condition a growing public health concern (NIH, 2011; ORWH,
2006). Data on HRQOL associated with UF show that women with UF have significantly
lower HRQOL scores when compared to those women without this condition (Pron et al.,
2003; Spies et al., 2002). Researchers have indicated that women diagnosed with UF are
not only impacted by their experience with the physical symptoms associated with UF,
but they also expressed feelings of hopelessness, emotional distress, concerns related to
body image, problems with sexual function, and relationships (Borah et al., 2013). The
progressive and chronic impact UF can have on HRQOL has lead several researchers to
suggest that further research in this area is needed (Cambridge & Sealy, 2012; Harding,
Coyne, Thompson, & Spies, 2008; Hartman et al., 2008; Lerner et al., 2008). Harding et
al. (2008) implied that more research that focuses on patient-reported outcomes about the
problems and issues associated with UF symptoms is important for the development of

18
patient-centered care options and to potentially improve patient outcomes. Williams et al.
(2006) also suggested that continued research that offers details and descriptions of the
specific areas in health and daily lives of women that are most affected by UF is
necessary. Exploring the impact of UF symptom severity on the HRQOL of African
American women provided a unique opportunity to gain a better understanding of the
personal impact of UF symptoms on overall health and HRQOL and support informed
decision making among African American women whose lives may be impacted
adversely by symptomatic UF.
African American women have a higher number of UF diagnoses that result in
increased need for surgical treatments (i.e., hysterectomy and myomectomy) because of
the symptoms associated with UF compared to Caucasian women (Davis et al., 2009;
NIH, 2011). More importantly, researchers have also suggested that the presence of
symptomatic UF can lead to an overall decline in job performance and impact African
American women negatively both socially and emotionally (Lerner et al., 2008; Vines,
Ta, & Esserman, 2010). Researchers associated with the BWHS have published studies
that have addressed risk factors associated with UF diagnosis (Wise et al., 2004, 2005a)
and environmental factors that may impact UF among African American women (Wise et
al., 2005b, 2010). Other researchers have investigated and compared risk factors,
environmental factors, or social factors associated with UF among African American
women and Caucasian women (Davis et al., 2009; Hartman et al., 2006; Lerner et al.,
2008; Mauskopf et al., 2005; Smith, Upton, Shuster, Klein, & Schwartz, 2004; Vines, Ta,
& Esserman, 2010). Borah et al. (2013) have investigated the impact of UF on the quality
of life among a racially diverse group of women age 29 to 59 years. Spies et al. (2002)
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and Spies et al. (2004) have investigated UF symptoms and factors that affect HRQOL
among white and black women in their studies. However, none have explored UF
symptom severity and the impact of UF symptoms on HRQOL among African American
women age 30 to 45 years. There is a gap in the literature regarding symptom severity
associated with UF and the impact of UF symptoms on HRQOL among African
American women aged 30 to 45 years.
Purpose of the Study
The purpose of this study was to explore the severity of symptoms associated with
UF and the impact of UF symptoms on HRQOL of African American women ages 30 to
45 diagnosed with UF. The study was designed to aid in determining the relationship of
specific factors that influence HRQOL among women who have been diagnosed with
UF. It was also designed to offer these women’s personalized perspective on how their
lives are being impacted by UF symptoms in order to assist investigators in their
continued efforts to monitor HRQOL and the impact of issues that influence HRQOL.
In this study, the revised Wilson and Cleary model of HRQOL was utilized as the
foundation to investigate the following factors: BMI, symptoms, functional status, overall
quality of life, general health perception, characteristics of the individual, and
characteristics of the environment among African American women age 30 to 45 years
with a diagnosis of UF. The revised Wilson and Cleary model of HRQOL was used in
this study to explore HRQOL among African American women who are diagnosed with
UF. More specifically the determinants of the revised Wilson and Cleary model, was
utilized to investigate seven distinct UF condition categories: symptom severity, concern,
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activities, energy/mood, control, self-conscious, and sexual function, based on the UFSQOL instrument.
Research Questions and Hypotheses
The following research questions and hypotheses were developed and were used
in order to explore the severity of UF symptoms and the impact of UF symptoms on
HRQOL.
The specific goal of the first six research questions was to examine the association
between symptom severity and the six HRQOL subscale variables (concern, activities,
energy/mood, control, self- consciousness, sexual function), as measured by the UFSQOL.
Research Question 1: What is the association between symptom severity, as
measured by the UFS-QOL instrument, and concern (a dimension of HRQOL) among
African American women ages 30 to 45 years diagnosed with UF?
H01: There will not be an association between symptom severity, as measured by
the UFS-QOL instrument, and concern (a dimension of HRQOL) among African
American women ages 30 to 45 years diagnosed with UF.
HA1: There will be an association between symptom severity, as measured by the
UFS- QOL instrument, and concern (a dimension of HRQOL) among African American
women age 30 to 45 years diagnosed with UF.
Data analysis: Linear regression analysis will be used to determine if there is a
relationship between symptom severity and concern.
Dependent variable: Concern (summed score of questions 9, 15, 22, 28, 32
on the survey).
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Independent variable: Symptom Severity (summed score of questions 1-8 on the
survey)
Research Question 2: What is the association between symptom severity, as
measured by the UFS-QOL instrument, and activities (a dimension of HRQOL) among
African American women ages 30 to 45 years diagnosed with UF?
H02: There will not be an association between symptom severity, as measured by
the UFS-QOL instrument, and activities (a dimension of HRQOL) among African
American women ages 30 to 45 years diagnosed with UF.
HA2: There will be an association between symptom severity, as measured by the
UFS- QOL instrument, and activities (a dimension of HRQOL) among African American
women age 30 to 45 years diagnosed with UF
Data analysis: Linear regression analysis will be used to determine if there is a
relationship between symptom severity and activities.
Dependent variable: Activities (summed score of questions 10, 11, 13, 19, 20, 27,
29 on the survey).
Independent variable: Symptom Severity (summed score of questions 1-8 on the
survey).
Research Question 3: What is the association between symptom severity, as
measured by the UFS-QOL instrument, and energy/mood (a dimension of HRQOL)
among African American women age 30 to 45 years diagnosed with UF?
H03: There will not be an association between symptom severity, as measured by
the UFS-QOL instrument, and energy/mood (a dimension of HRQOL) among African
American women age 30 to 45 years diagnosed with UF.
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HA3: There will be an association between symptom severity, as measured by the
UFS- QOL instrument, and activities (a dimension of HRQOL) among African American
women age 30 to 45 years diagnosed with UF
Data analysis: Linear regression analysis will be used to determine if there is a
relationship between symptom severity and energy/mood.
Dependent variable: Energy/mood (summed score of questions 12, 17, 23, 24, 25,
31, 35 on the survey).
Independent variable: Symptom Severity (summed score of questions 1-8 on the
survey).
Research Question 4: What is the association between symptom severity, as
measured by the UFS-QOL instrument, and control (a dimension of HRQOL) among
African American women age 30 to 45 years diagnosed with UF?
H04: There will not be an association between symptom severity, as measured by
the UFS-QOL instrument, and control (a dimension of HRQOL) among African
American women age 30 to 45 years diagnosed with UF.
HA4: There will be an association between symptom severity, as measured by the
UFS- QOL instrument, and control (a dimension of HRQOL) among African American
women age 30 to 45 years diagnosed with UF
Data analysis: Linear regression analysis will be used to determine if there is a
relationship between symptom severity and control.
Dependent variable: Control (summed score of questions 14, 16, 26, 30, 34 on the
survey).

23
Independent variable: Symptom Severity (summed score of questions 1-8 on the
survey)
Research Question 5: What is the association between symptom severity, as
measured by the UFS-QOL instrument, and self-consciousness (a dimension of HRQOL)
among African American women age 30 to 45 years diagnosed with UF?
H05: There will not be an association between symptom severity, as measured by
the UFS-QOL instrument, and self-consciousness (a dimension of HRQOL) among
African American women age 30 to 45 years diagnosed with UF.
HA5: There will be an association between symptom severity, as measured by the
UFS- QOL instrument, and self-consciousness (a dimension of HRQOL) among African
American women age 30 to 45 years diagnosed with UF
Data analysis: Linear regression analysis will be used to determine if there is a
relationship between symptom severity and self-consciousness.
Dependent variable: Self- Consciousness (summed score of questions 18, 21, 33
on the survey).
Independent variable: Symptom Severity (summed score of questions 1-8 on the
survey).
Research Question 6: What is the association between symptom severity, as
measured by the UFS-QOL instrument, and sexual function (a dimension of HRQOL)
among African American women age 30 to 45 years diagnosed with UF?
H06: There will not be an association between symptom severity, as measured by
the UFS-QOL instrument, and sexual function (a dimension of HRQOL) among African
American women age 30 to 45 years diagnosed with UF.

24
HA6: There will be an association between symptom severity, as measured by the
UFS- QOL instrument, and sexual function (a dimension of HRQOL) among African
American women age 30 to 45 years diagnosed with UF
Data analysis: Linear regression analysis will be used to determine if there is a
relationship between symptom severity and sexual function.
Dependent variable: Sexual Function (summed score of questions 36 and 37 on
the survey).
Independent variable: Symptom Severity (summed score of questions 1-8 on the
survey).
A.

The specific goal of Research Question 7 was to examine the associations

between symptom severity, body mass index (BMI), and overall HRQOL. The specific
goals of Research Questions 8 and 9 were to examine the associations between symptom
severity, body mass index (BMI), and overall HRQOL, controlling for three covariables
(age, family hx of UF, and employment).
Research Question 7: What is the association between symptom severity as
measured by the UFS-QOL instrument, BMI, and HRQOL total score as measured by the
UFS-QOL instrument among African American women ages 30 to 45 years diagnosed
with UF?
H07: There will not be an association between symptom severity as measured by
the UFS-QOL instrument, BMI, and HRQOL total score as measured by the UFS-QOL
instrument among African American women age 30 to 45 years diagnosed with UF.
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HA7: There will be an association between symptom severity as measured by the
UFS-QOL instrument, BMI, and HRQOL total score as measured by the UFS-QOL
instrument among African American women age 30 to 45 years diagnosed with UF.
Dependent variable: HRQOL score (sum of 6 subscale scores range 29 to 145)
Independent variable: Symptom Severity (summed score of questions 1-8 on the
survey) and BMI =Overall calculated value based on participants height and weight
(participant’s response to two questions on the DI form: question #2- What is your
height? and question #3-What is your weight?)
Research Question 8: When controlling for characteristics of the individual (age)
what is the association between symptom severity as measured by the UFS-QOL
instrument, BMI, and HRQOL total score as measured by the UFS-QOL instrument
among African American women age 30 to 45 years diagnosed with UF?
H08: When controlling for characteristics of the individual (age) there will not be
an association between symptom severity as measured by the UFS-QOL instrument,
BMI, and HRQOL total score as measured by the UFS-QOL instrument among African
American women age 30 to 45 years diagnosed with UF.
HA8: When controlling for characteristics of the individual(age) there will be an
association between symptom severity as measured by the UFS-QOL instrument, BMI,
and HRQOL total score as measured by the UFS-QOL instrument among African
American women age 30 to 45 years diagnosed with UF.
Dependent variable: HRQOL score (sum of 6 subscale scores range 29 to 145)
Independent variable: Symptom Severity (summed score of questions 1-8 on the
survey) and BMI =Overall calculated value based on participants height and weight
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(participant’s response to two questions on the DI form: question #2- What is your
height? and question #3-What is your weight?)
Covariant Characteristics of the Individual: Age (participant’s response to one
question about age #1 on the DI form).
Research Question 9: When controlling for characteristics of the environment
(family hx of UF diagnosis and employment) what is the association between symptom
severity as measured by the UFS- QOL instrument, BMI, and HRQOL total score as
measured by the UFS-QOL instrument among African American women age 30 to 45
years diagnosed with UF?
H09: When controlling for characteristics of the environment (family hx of UF
diagnosis and employment) there will not be an association between symptom severity as
measured by the UFS-QOL instrument, BMI and HRQOL total score as measured by the
UFS-QOL instrument among African American women age 30 to 45 years diagnosed
with UF.
HA9: When controlling for characteristics of the environment (family hx of UF
diagnosis and employment) there will be an association between symptom severity as
measured by the UFS-QOL instrument, BMI, and HRQOL total score as measured by the
UFS-QOL instrument among African American women age 30 to 45 years diagnosed
with UF.
Dependent variable: HRQOL score (sum of 6 subscale scores range 29 to 145)
Independent variable: Symptom Severity (summed score of questions 1-8 on the
survey) and BMI =Overall calculated value based on participants height and weight
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(participant’s response to two questions on the DI form: question #2- What is your
height? and question #3-What is your weight?)
Covariants Characteristics of the Environment:


Family History of UF diagnosis (participant’s response to one family history of
UF diagnosis question #5 on the DI form)



Employment (participant’s response to question # 4 on the DI form: Yes, No, I do
not know).
Data analysis (Research Questions 7, 8, 9): Hierarchical multiple regression

analysis will be used determine if there is a relationship between symptom severity, BMI,
and HRQOL, when controlling for three co- variables (age, family hx of UF, and
employment). The variables will be added to the model in three steps. In step one, the
control variables characteristics of the individual (age), and characteristics of the
environment (family history of UF diagnosis, and employment) and the dependent
variable HRQOL score will be added to the model. In step two, the variable symptom
severity and the dependent variable HRQOL score will be added to the model. In step
three, the variable BMI will be added to the model, and the dependent variable HRQOL
score.
B.

The specific goal of Research Question 10, was to examine the association

between symptoms severity, HRQOL total score, and general health perception. The
specific goals for Research Questions 11 and 12 was to examine the association between
symptom severity, HRQOL total score, and general health perception, controlling for
three co- variables (age, family history of uterine fibroids and employment history).
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Research Question 10: What is the association between symptom severity as
measured by the UFS-QOL instrument, HRQOL total score as measured by the UFSQOL instrument and general health perception among African American women age 30
to 45 years diagnosed with UF?
H010: There will not be an association between symptom severity as measured by
the UFS-QOL instrument, HRQOL total score as measured by the UFS-QOL instrument
and general health perception among African American women age 30 to 45 years
diagnosed with UF.
HA10: There will be an association between symptom severity as measured by the
UFS-QOL instrument, HRQOL total score as measured by the UFS-QOL instrument and
general health perception among African American women age 30 to 45 years diagnosed
with UF.
Dependent variable: General health perception (participants response to one
global question #7 on the DI form- “How would you rate your current health on a scale
from 1 to 10 (with 1= poor and 10 = excellent)?”).
Independent variable: HRQOL score (sum of 6 subscale scores range 29 to 145)
and Symptom Severity (summed score of questions 1-8 on the survey).
Research Question 11: When controlling for characteristics of the individual (age)
does symptom severity as measured by the UFS-QOL instrument, and HRQOL total
score as measured by the UFS-QOL instrument have an association with general health
perception among African American women age 30 to 45 years diagnosed with UF?
H011: When controlling for characteristics of the individual (age), symptom
severity as measured by the UFS-QOL instrument, and HRQOL total score as measured
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by the UFS-QOL instrument will not have an association with general health perception
among African American women age 30 to 45 years diagnosed with UF.
HA11: When controlling for characteristics of the individual (age), symptom
severity as measured by the UFS-QOL instrument, and HRQOL total score as measured
by the UFS-QOL instrument will have an association with general health perception
among African American women age 30 to 45 years diagnosed with UF.
Dependent variable: General health perception (participants response to one
global question #7 on the DI form- “How would you rate your current health on a scale
from 1 to 10 (with 1= poor and 10 = excellent)?”).
Independent variable: HRQOL score (sum of 6 subscale scores range 29 to 145)
and Symptom Severity (summed score of questions 1-8 on the survey).
Covariant Characteristics of the Individual: Age (participant’s response to one
question about age #1 on the DI form)
Research Question 12: When controlling for characteristics of the environment
(family hx of UF diagnosis and employment) does symptom severity as measured by the
UFS-QOL instrument, and HRQOL total score as measured by the UFS-QOL instrument
have an association with general health perception among African American women age
30 to 45 years diagnosed with UF?
H012: When controlling for characteristics of the environment (family hx of UF
diagnosis and employment), symptom severity as measured by the UFS-QOL instrument,
and HRQOL total score as measured by the UFS-QOL instrument will not have an
association with general health perception among African American women age 30 to 45
years diagnosed with UF.
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Sub HA12: When controlling for characteristics of the environment (family hx of
UF diagnosis and employment), symptom severity as measured by the UFS-QOL
instrument, and HRQOL total score as measured by the UFS-QOL instrument will have
an association with general health perception among African American women age 30 to
45 years diagnosed with UF.
Dependent variable: General health perception (participants response to one
global question #7 on the DI form- “How would you rate your current health on a scale
from 1 to 10 (with 1= poor and 10 = excellent)?”).
Independent variable: HRQOL score (sum of 6 subscale scores range 29 to 145)
and Symptom Severity (summed score of questions 1-8 on the survey).
Covariants Characteristics of the Environment:


Family History of UF diagnosis (participant’s response to one family history of
UF diagnosis question #5 on the DI form)



Employment (participant’s response to question # 4 on the DI form: Yes, No, I do
not know)
Data analysis (Research Questions 10, 11, 12): Hierarchical multiple regression

analysis will be used to determine if there is a relationship between symptom severity,
HRQOL and general health perception controlling for three co variables (age, family hx
of UF, and employment). The variables will be added to the model in three steps. In step
one, the control variables characteristics of the individual (age), and characteristics of the
environment (family history of UF diagnosis, and employment) and the dependent
variable general health perception will be added to the model. In step two, the variable
symptom severity and the dependent variable general health perception will be added to
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the model. In step three, the variable HRQOL will be added to the model, and the
dependent variable general health perception.
The specific goal of Research Question 13 was to examine the association
between symptom severity and overall quality of life.
Research Question 13: What is the association between symptom severity as
measured by the UFS-QOL instrument and overall quality of life among African
American women age 30 to 45 years diagnosed with UF?
H013: There will not be an association between symptom severity as measured by
the UFS-QOL instrument and overall quality of life among African American women age
30 to 45 years diagnosed with UF.
HA13: There will be an association between symptom severity as measured by the
UFS-QOL instrument and perception of overall quality of life among African American
women age 30 to 45 years diagnosed with UF.
Data analysis: Linear regression analysis will be used to determine if there is a
relationship between symptoms severity and overall quality of life among African
American women age 30 to 45 years diagnosed with UF.
Dependent variable: Overall quality of life (response to one global question #8 on
the DI form- ‘How satisfied are you with your overall life in general on a scale from 1 to
10 (with 1 = poorly satisfied and 10 = very satisfied)?”)
Independent variable: Symptom Severity (summed score of questions 1-8 on the
survey).
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Nature of the Study
In this study, the severity and impact of UF symptoms on HRQOL of African
American women age 30 and 45 years diagnosed with UF was explored. The exploratory,
nonexperimental, quantitative research method was chosen for this study. This method
was suitable for this study because none of the independent variables (symptom severity,
BMI, HRQOL, age, and family history of UF diagnosis) were able to be ethically
manipulated.
The aim of the study was to investigate the perspective of African American
women’s experiences with UF symptoms and their impact on HRQOL utilizing the
Wilson and Cleary revised model of HRQOL. I investigated seven UF condition- specific
categories: symptom severity, concern, activities, energy/mood, control, selfconsciousness, and sexual function, based on the UFS-QOL survey. A more detailed
presentation of the methodological process for this study is presented in Chapter 3.
The sampling frame for this study included African American women who are
affiliated with two graduate chapters of Delta Sigma Theta Sorority, Inc.—MariettaRoswell Alumnae (MRACDST) located in Cobb County and Stone Mountain Lithonia
Alumnae (SMLACDST) located in DeKalb County. Additionally, women who are
affiliated with Run Girl Run (RGR), a running group for African American women in
Atlanta, received an invitation to participate in the study. The combined membership of
SMLACDST, MRACDST, and RGR totals approximately 1,600 women. Based on a
G*Power analysis of Faul, Erdfelder, Buchner, and Lang (2009), an anticipated sample
size of 92 study participants was required. The invitation for participation was sent to the
organizations’ leadership teams via e-mail to distribute to the members and affiliates of
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their organizations. African American women who have a current diagnosis of UF, are
between the ages of 30 and 45 years, have never received treatment in the form of a
myomectomy, hysterectomy ,or uterine artery embolization, and are members or affiliates
of the identified organizations were asked to participate in the study.
Operational Definitions of Terms
The following terms are defined as they are used in this study.
African American women: Any women of African heritage (African American,
descendants of Africans); throughout this research the terms African American and
Blacks are interchangeable and mutually inclusive.
Hysterectomy: Invasive surgical procedure that removes the uterus leaving
women with the inability to get pregnant/conceive (Evans & Brunsell, 2007).
Myomectomy: Invasive surgical procedure to remove/excise uterine fibroids
tumors from the uterus that leaves the uterus intact for conception (Evans & Brunsell,
2007).
Uterine artery embolization: Procedure designed to cut the blood supply to UF
tumors, causing them to shrink (Wolanske & Gordon, 2004).
Assumptions, Limitations, and Delimitations
Two assumptions provided the basis for this research. In this study, it was
assumed that HRQOL exists as a multidimensional construct, and that abstract and
unobservable constructs, such as symptom severity and health perception among African
American women age 30 to 45 years with a diagnosis of UF, can be quantified and tested
by the UFS-QOL survey instrument. In this study, it was also assumed that African
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American women age 30 to 45 years with a diagnosis of UF will accurately and honestly
answer questions that measure the concepts of interest in this study.
The inclusion of only African American women between the ages of 30 and 45
years limits the findings from being generalized to the entire African American female
population, or to other racial or ethnic groups. Another limitation of the study is that
biological function as a study construct was self-reported by study participants as I had
no access to participants’ personal medical healthcare records. The revised theoretical
model characteristics of the individual are comprised of four focus areas: psychological,
development, biological, and demographic. Biological characteristics of the individual
such as diet (D’Aloisio, Baird, DeRoo, & Sandler, 2010; Radan, Palmer, Rosenberg,
Kumanyika, & Wise, 2010; Villarosa, 2003), obesity (Flake, Anderson, & Dixon, 2006;
Parazzi et al., 2004; Trivedi & Abreo, 2009), and estrogen level (Dixon et al., 2006;
Flake et al., 2006) are reported to have an association with UF. However, access to
participants’ medical records was unavailable to me as the researcher and was required in
order to ascertain information related to a diagnosis associated with these biological
characteristics of the individual. In addition, inquiries into the participants’ dietary habits
were outside of the focus area of the study and the study survey instrument.
Developmental characteristics of the individual focus on the individuals’ intellectual
capacity to change or modify behavior, while psychological characteristics of the
individual center on the different types of motivation for starting and maintaining certain
behaviors (Ferrans et al., 2005). To date, no developmental studies investigating an
individual’s intellectual capacity for behavior change related to UF have been published,
and psychological factors associated with the need for and ability to sustain behavior
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change related to UF was outside the scope of this research. Therefore, as a study
delimitation, characteristics of the invidual only included the following biological and
demographic factors: family history of UF, sex, age, and race. Also the developmental
factors of the characteritics of the indvidual (participants intellectual capacity to
participate in the study) was delimited to and addressed as a part of the eligibility criteria
for participation in this study (see Chapter 3).
An additional limitation of the study was that questionnaires that are selfreporting present difficulties in accuracy of response and recall. Participants may also
experience some level of discomfort with providing information about medical history in
the questionnaires. The last limitation of this study was that the researcher used a
convenience sample in which participants were recruited because they were accessible to
the researcher based on their affiliation with RGR, MRACDST, and SMLACDST.
UFs affect many women, but there is a higher prevalence among African
American women of child- bearing age compared with women of other races (Davis et
al., 2009; Wise et al., 2005b). A delimitation of this study was that the participants were
only African American women who had a current diagnosis of UF, and age 30 to 45
years. Another delimitation of this study was to focus on women who had not received
medical treatment in the form of a hysterectomy, myomectomy, or UFE for the
alleviation of UF tumors or the symptoms associated with UF. The aforementioned study
delimitation was important to note because the questions on the UFS-QOL instrument are
UF-condition specific and based upon participants having the presence of UFs at the time
of completion of the survey (Coyne et al., 2012).
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Significance of Study
The symptoms associated with UF can be debilitating for women. Women who
have been diagnosed with UF face a myriad of issues related to how to effectively
address the UF symptoms, minimize financial burden, and limit interruption in their
lifestyle. According to Davis et al. (2009), African American women diagnosed with UF
typically have more than one UF tumor, a variety of symptoms, and more prominent
health problems related to the diagnosis. As the role of African American women
continues to evolve in the work force, community, and in the home, the troubles of
lengthy recovery times and extended leaves from work associated with the symptoms or
medical treatment of UF no longer appear to be a functionally or financially conducive
option. The ability of African American women to continue leading active and
meaningful lives while addressing the problems associated with UF and UF symptoms
depends on the impact of this chronic condition to their HRQOL. In this study, data
obtained from participants’ demographic history along with the UFS-QOL instrument
were used to explore UF symptom severity and the impact of UF symptoms on HRQOL
among African American women age 30 to 45 years who are diagnosed with UF. The
following variables based on the revised Wilson and Cleary model of HRQOL were used
to guide this research: age, family history of UF diagnosis, employment, BMI, symptom
severity, concern, control, activities, self-consciousness, sexual function, energy/mood,
general health perception, and overall quality of life, with more details provided in
Chapter 3.
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Social Change
Research suggests problematic UF has had a negative impact on various areas of
HRQOL and lead to increased distress on health and life of African American women
who are diagnosed with this condition (Cabness, 2010; Cambridge & Sealy, 2012; Lerner
et al., 2008; Popovic et al., 2009; Spies et al., 2002). Specifically, researchers have found
a number of UF symptoms have been associated with poorer job performance, high levels
of stress, increased need for surgical intervention, and limited social interaction among
African American women diagnosed with UF (Lerner et al., 2008; Mauskopf et al., 2005;
Smith et al., 2004; Spies et al., 2002, 2004; Vines, Ta, & Esserman, 2010). The social
change implication of exploring personal health factors associated with UF and their
specific impact on HRQOL is key in supporting health care providers in the development
of health maintenance programs that can aid African American women with
implementing improved symptom management and potentially enhancing HRQOL. The
availability of information related to UF symptoms and impact of UF symptoms on
HRQOL may help decrease adverse outcomes associated with UF and positively support
the continued well-being of African American women diagnosed.
Summary
UFs are a medical condition with widespread symptoms that occur among women
of all races. The Office of Research on Women’s Health (2006) indicated that 20–25% of
all women in the United States of reproductive age have symptomatic UF. However,
African American women are likely to be diagnosed up to three times more when
compared to their Euro American, Asian, and Hispanic counterparts (Moorehead &
Conrad, 2001; NIH, 2011). Researchers have identified that UF symptoms and the
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problems associated with UF symptoms can affect the HRQOL among women
diagnosed. The impact of UF symptoms on the HRQOL of African American women
ages 30 to 45 years diagnosed with UF requires further attention. This study investigated
the experiences among African American women diagnosed with UF ages 30 to 45 years
regarding symptom severity associated with UF and impact of UF symptoms on HRQOL.
This study explored these variables using the revised Wilson and Cleary model of
HRQOL as a theoretical guide.
Chapter 1 offered an overview of UF and its impact on the HRQOL of women.
Chapter 1 also provided the basis for the importance of the research with an overview of
current research. Literature relevant to the purpose of the research is presented in Chapter
2. In Chapter 3, I discuss the selected methodology in this study, including sampling
procedures, research procedures, and sample characteristics. Details on the reliability and
validity of the instruments used in the study are also discussed in Chapter 3. In Chapter 4,
the results of the research study and the analysis used in this study are outlined. In
Chapter 5, I will communicate the summary, possible implications, conclusion and
recommendation(s) for further research.
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Chapter 2: Review of Literature
Introduction
This chapter includes a review and analysis of relevant literature that pertain to
African American women and UF. The methodologies implemented in previous research
studies and those utilized in this dissertation are also reviewed. The review begins with
correlates that have been associated with UF risk factors and HRQOL, UF treatment, and
financial implications, then moves to the revised Wilson and Cleary model of HRQOL
that guided the study, and narrows with measures that have been used to investigate
HRQOL among women with UF. The social change construct and its relevance to the
impact of UF on HRQOL among African American women are also reviewed. Because
the prevalence of UF is high among African American women and their HRQOL is being
impacted, further investigation into the burden and impact of UF symptoms is warranted.
The following literature review will support these variables as well as summarize
previous and current research findings. This chapter will also identify topic areas that
require further investigation and review in future research.
I identified information for use in this literature review by searching for peerreviewed journal articles, scholarly books, electronic dissertations, and published
manuscripts dated from 1988–2015. I sought to identify only relevant studies and sources
for this research project, regardless of date. The seminal literature sources utilized for this
research project relate to information specific to the participating sorority-community
service organization (Giddings, 1988), the theoretical framework (Ferrans & Powers,
1992; Leidy, 1994; Lerner & Levine, 1994; Wilson & Cleary, 1995), and UF (Kjerulff,
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Lagenberg, & Sieden, 1996; Marshall et al., 1997), as these factors are central variables
in this research project. The primary search engines utilized were EBSCO databases of
Academic Search Premier, CINAHL PLUS, MEDLINE, SociIndex, PsychINFO, and
PsycArticles. An array of key search terms (African American, Black, women, uterine
fibroids, uterine leiomyomata, health related quality of life, quality of life, symptoms,
hysterectomy, myomectomy, hospital, treatment, risk factors, impact of uterine fibroids)
were used to narrow and focus the search for relevant research literature.
Women, Uterine Fibroid Risk Factors, Symptoms,
and Health-Related Quality of Life
The etiological factors associated with a diagnosis of UF continue to be
investigated. It has been difficult for researchers to narrow the cause to any one specific
factor. Researchers have identified the following as having an increased risk for diagnosis
of UF: dietary practices (D’ Aloisio, Baird, DeRoo, & Sandler, 2010; Radan, et al., 2010;
Villarosa, 2003), hormone and estrogen levels (Dixon et al., 2006; Flake, Anderson, &
Dixon, 2006), and obesity or weight gain (Faerstein, Szklo, & Rosenshein, 2001; Parazzi
et al., 2004; Trivedi & Abreo, 2009; Wise et al., 2005a). Approximately 60% of African
Americans reportedly do not engage in the recommended amount of exercise (Centers for
Disease Control and Prevention [CDC], 2007). Many African Americans report dietary
practices that are high in fat and lacking in fruit, vegetables, and whole grains (Felton,
Boyd, Bartoces, & Tavakoli, 2002). It is important to note that obesity, weight gain, and
dietary practices have consistently been noted as risk factors among African American
women with a diagnosis of UF.
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Modifiable Uterine Fibroid Risk Factors
Diet. Dietary practices may influence the risks associated with a diagnosis of UF
(D’ Aloisio et al., 2010; Radin et al., 2010; Trivedo & Abreo, 2009). Radin et al. (2010)
found that foods that raise an individual’s blood glucose concentration have been
associated with an overall risk of development of UF among younger women. Trivedi
and Abreo (2009) also reported that women who had vegetarian or primarily fish-eating
diets were three times less likely to have UF when measured against women who were
primarily red-meat eaters. The study findings of D’ Aloisio et al. (2010) suggest that soy
based food products may increase the risk of fibroid development among women due to
the high concentrations of estrogenic isoflavones. In a study of dietary practices of Black
women, Wise et al. (2010) reported that eating foods high in fat content and lower in
dairy products were inversely associated with UF risk among Black women who were
symptomatic.
Estrogen/hormones. The exact role and influence of hormonal and estrogen
levels in the development of UF continues to be explored. However, some researchers
have found that hormonal and estrogen levels in women have an influence on the
development of UF tumors (Evans, 2008; Radin et al., 2010; Wise et al., 2005a).
According to Flake et al. (2003), dietary practices can also have an impact on the
stimulation of estrogen metabolism in premenopausal women. The researchers indicated
that diets that are high in fiber and low in fat may be a contributing factor in reducing
serum estrogen. Baird et al. (2006) found that Black women who exercised at least 4
hours per week had lower circulating sex hormones (estrogen), and insulin levels were
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found to have a slower onset of UF development. It is important to note that the problems
associated with UF development tend to decline with the onset of menopause in Black
and White women suggesting that the growth of UF tumors are sensitive to the sex
hormones estrogen and progesterone (Stewart, 2001).
Obesity or weight gain. Not only has obesity been shown to have an association
with increased risk for diagnosis of UF, but weight gain has also been reported to have an
association. Flake et al. (2003) reported an association between an elevated BMI or
obesity and the presence of UF particularly among women in the United States.
According to Van Voorhis (2009), weight gain among African American women was
associated with the existence of UF. In a retrospective study conducted by Trivedi and
Abreo (2009), 2,540 cases of UF diagnosis over a 14-year period among women ages 23–
51 years were reviewed for pre-disposing factors associated with UF occurrence among
women. The researchers found an 18% increase in the incidence rate of UF occurrence
for every 10-kg rise in weight among women in their study population. The researchers
suggest that an association exists between UF diagnosis and higher BMI. According to
Wise et al. (2005a), weight gain had a positive risk association with UF among parous
African American women only in the Black Women’s Health Study. The researchers also
found premenopausal African American women with a BMI between 20.0–22.4
demonstrated an association with increased risk of UF when compared to those with a
BMI less than 20.0.
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Nonmodifiable Uterine Fibroid Risk Factors
Age. Studies demonstrate that African American women are more likely to
develop UF at an earlier age, have more than one UF tumor, have UF tumors that are
larger, and experience more severe symptoms compared to women of other races (Evans
& Brunsell, 2007; Flake et al., 2003; Huyck et al., 2008; Kjerulff, Lagenberg, & Sieden,
1996). Study findings by Peddada et al. (2008) indicated the rate at which UF tumors
grow are similar for both African American and Caucasian women under the age 35;
however, as women get older, the growth rate declines for Caucasian women, but
increases for African American women. Davis et al. (2009) conducted a 4-year study
between 2001 and 2004 investigating UF growth, symptoms, and clinical outcomes
among African American and Caucasian women ranging in age from 20 to 54 years. The
researchers found that African American women in the following age categories had the
highest percentage of UF diagnosis: 30–34 years, 29%; 35–39 years, 22%; and 40–44
years, 29%. In addition, they found that 80% of African American women versus 69% of
Caucasian women in the study population with UF were between the ages of 30 and 44
years. The Black Women’s Health Study (Wise et al., 2005b) also reported a peak age of
diagnosis for UF among African American women to be 40 to 45 years.
Race. Davis et al. (2009) also found that 90% of the women in their study, both
African American and Caucasian, reported having more than one UF tumor and
approximately 33% had more than 10 UF tumors. However, the researchers also found,
despite the increased number of UF tumors reported by both African American and
Caucasian women, the African American women in their study population still had a
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statistically significant (p = 0.004) higher number of diagnoses of UF in comparison to
the Caucasian women (Davis et al., 2009). Research indicates African American women
are at greater risk for development of UF when compared to Caucasian and Asian women
(Davis et al., 2009; Moorehead & Conrad, 2001; ORWH, 2006). Hyuck et al. (2008)
found that the Black participants in their study population reported increased symptoms
of menstrual pain and fewer days between menstrual cycles when compared to the White
participants.
Family history. Studies specifically examining the relationship between family
history of UF and UF development are limited; however, some researchers have found a
correlation between the two factors. Schwartz et al. (2000) found that participants in their
study population who had a mother or sister with a diagnosis of UF were 33.2% more
likely to have UF when compared to the control group who did not have relatives with
UF. Peddada et al. (2008) reported study findings that women in their study population
with an identical twin sister were observed to have a risk for earlier onset of UF
development when compared to women who did not have an identical twin. Studies
among African American women with UF have also found that family history of UF has
some correlation to UF development and symptom severity. Hyuck et al. (2008) reported
African American women with a family history of UF diagnosis expressed increased
severity of UF symptoms when compared to Caucasian women.
Uterine Fibroids Symptoms and Health Related Quality of Life
The symptoms associated with UF can lead to negative health consequences for
diagnosed women. In addition, UF tumors cause an array of burdensome health problems
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which can negatively impact HRQOL including excessive menstrual bleeding, painful
cramping, frequent urination, lower back pain, spot bleeding in between periods, and
painful sexual intercourse (Evans, 2008; Fennessy, Kong, Tampany, & Swan, 2011;
Villarosa, 2003). Exploration into the views of African American women diagnosed with
UF on how UF symptoms are impacting their health and HRQOL was conducted by
Cabness (2010) who found that 60% of the women in her study admitted that symptoms
associated with UF was a factor involved in their thought process prior to selection of
medical intervention. The researcher suggested that the perception of symptom severity
caused by UF among African American women with UF plays a fundamental role in
determining the type of medical treatment they will select.
Some of the more problematic physical symptoms associated with the presence of
UF have led to miscarriages and even resulted in the loss of the uterus for some women
(Moorehead & Conrad, 2001; Williams et al., 2006). The aforementioned is of significant
import because a diagnosis of UF can make the ability to have children difficult if not
impossible and potentially cause a negative effect on HRQOL for some women in their
reproductive years. The NIH (2011) indicated that African American women were less
successful in positive reproductive treatment outcomes and more likely to have UF when
compared to their Caucasian counterparts among the category of women who were
pursuing treatment for reproductive health problems. Researchers have demonstrated that
UF can negatively affect the reproductive health of African American women
(Moorehead & Conrad, 2001; NIH, 2011; Williams et al., 2006) and that there is a need
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to further understand the unique experiences that occur among African American women
diagnosed with UF who are of reproductive age.
Symptoms. The symptoms associated with UF can have a direct bearing on the
functional ability, emotional state, work performance outcomes, and self-perception of
health in women diagnosed (Cote, Jacobs, & Cumming, 2003; Downes et al., 2010;
Lerner et al., 2008; Spies et al., 2002). Lerner et al. (2008) found among women with UF,
reports of more difficulty managing physical and interpersonal job tasks, increased atwork productivity loss, increased fatigue, and difficulty concentrating were consistently
higher among African American women compared to Caucasian women in their study
population. Using data from a multicenter clinical trial in Ontario, researchers Pron et al.
(2003) found of the 85% of the women with UF who were working in their study
population, almost half had work absences related to symptoms associated with uterine
fibroids. Downes et al. (2010) conducted an analysis of 1,756 women in five European
(France, Germany, Italy, Spain, and United Kingdom) countries diagnosed with or
experiencing UF related symptoms. Their study findings demonstrated a loss in work
productivity by 36% and a 37.9% decrease was noted in the general activity level for
women with UF compared to women without UF in their study population.
Problems with bloating, pain, feeling of fullness and heaviness in the abdomen,
bleeding that may interfere with sexual function and cause uncontrolled soaking of
clothing, bleeding that inhibits some social and physical activities are common among
women with UF (Spies et al., 2004). Moreover, researchers have demonstrated that some
of the aforementioned problems interfere with and limit the important roles women are
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able to play in their family, community, and workplace (Cambridge & Seally, 2012;
Lerner et al., 2008; Spies et al., 2004). Researchers indicated UF are the most common
benign tumors in women of child bearing age, and many women commonly experience
physical problems with abnormal and excessive bleeding, urinary and bowel problems,
and severe pelvic pain, along with other impediments such as limited physical and social
activity, and fatigue (Kjerulff et al., 1996; Walker & Stewart, 2005). Spies et al. (2002)
also reviewed several reoccurring themes among women related to UF symptoms. The
authors found that physical symptoms such as pelvic pressure, back and pelvic pain,
fatigue, and break through bleeding often were identified as problematic issues among
women with UF. Multiple researchers have found increased fatigue, depressive
symptoms, difficulty concentrating, and feelings of anxiety are commonly reported
concerns among African American women with UF (Cabness, 2010; Lerner et al., 2008;
Popovic et al., 2009). Symptoms such as breakthrough and untimely bleeding, pelvic
pain, cramping, and frequent urination have been identified as a concern among African
American women with UF and supported by research as having a negative impact on
HRQOL.
Health related quality of life. When reviewing UF and symptoms associated
with UF development, the varied ways in which HRQOL is affected is important. Evans
(2008) found that many women strive to understand “safer and more natural approaches”
(p. 31) to UF development and symptom prevention, in order to minimize the impact of
UF on HRQOL. Fennessy et al. (2011) suggested that HRQOL factors such as motivation
for later childbearing and shorter recovery time may be reasons why women are
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increasingly seeking “minimally invasive” (p. 786) treatment options for UF. Side effects
associated with UF (bleeding, pain, and bulkiness) along with women’s desire to avoid
surgical interventions that may negate their ability to remain childbearing are some of the
factors identified by Evans (2008). Indeed, concerns related to invasive treatment options,
reproductive health outcomes, and symptom management, among others, can shape
perceptions of how HRQOL is being affected by UF and support reasons why African
American women desire to become more knowledgeable about UF influencing factors.
Vines, Ta, and Esserman (2010) reported that African American women with
elevated levels of stress had a modest association with the presence of UF when
compared with Caucasian women in their study population. Feelings of increased anxiety
related to insecurity and shame of breakthrough bleeding prevented African American
women with UF from attending social events were reported in one study (Cabness, 2010).
More specifically, Lerner et al. (2008) found feelings of depression (fatigue and difficulty
concentrating) were consistently higher among African American women with UF
compared to African American women without UF among their study population. The
emotional burden of high stress levels and increased anxiety found to be associated with
the presence of symptomatic UF among African American women can potentially have a
negative influence their HRQOL.
Zimmerman et al. (2012) found among women with UF in their study population, that
work performance, sexual function, family, and relationships, were some of the important
life dynamics that were negatively impacted by problems associated with UF. Spies et al.
(2002) found other life dynamics such as concern over inability to control bleeding,
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concern or fear of soiling clothes, and decreased level of energy to participate in activities
were frequently identified as quality of life issues among women. The researchers also
found that of the six HRQOL variables (concern, activities, energy/mood, control, selfconscious, sexual function) associated with UF, Black and White women identified,
concern (soiling cloth, soiling bed linens, inability to predict onset of periods), and
control (ability to participate in social activities, productivity, overall health) as two of
the highest problem areas.
Aiding African American women’s understanding of the problems associated with
UF symptoms can influence decisions related to health treatment options and symptom
management. Ankem (2007) investigated the information seeking behavior among 28
women aged 20 to 58 years diagnosed with symptomatic UF. The demographic
breakdown of the study population was 81.6 % African American, 12.3% Caucasian, and
the remaining 6.1% were of other ethnicity or racial backgrounds. The researcher noted
among the women in his study population, “almost all expressed a great need for
information on diagnosis, treatment and self-care” (Ankem, 2007, p. 167) related to UF.
Their research findings demonstrate that African American women are seeking to gain
more insight into options for care and treatment of symptomatic UF.
African American women with UF are interested in preserving their ability to
remain child bearing. Research suggests that African American women with UF are
actively seeking out information related to UF symptoms and ways they can minimize
those symptoms from impacting their lives (Ankem, 2007). Therefore, more investigation
that focuses specifically on patient-reported problems and issues associated with UF
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symptoms may support health professionals and African American women alike in
gaining more insight into some of the problems faced by women diagnosed with this
condition. Studies conducted that have investigated the impact of UF on HRQOL of
women with UF (Davis et al., 2009; Lerner et al., 2008; Popovic et al., 2009; Spies et al.,
2004) have compared pre and post UF treatment symptom severity and manifestation of
UF symptoms only as the measure of HRQOL. To date none has explored the impact of
UF symptoms on the HRQOL of African American women aged 30 to 45 years.
Uterine Fibroid Treatment and Financial Implications
The increased number of UF diagnoses and expanded utilization of health care
resources for treatment of UF suggests this chronic condition is becoming an increased
health concern. Problematic UF symptoms often lead African American women to seek
the advice of health care practitioners and potentially pursue medical intervention. The
myomectomy, Uterine artery embolization (UAE) or hysterectomy, are the most common
medical procedures used to treat UF. Evans and Brunsell (2007) reported findings
indicating 30% of the hysterectomies performed are associated with the “presence of
uterine fibroid tumors” (p. 1506). Myers et al. (2002) found the cumulative risk of a
hysterectomy due to uterine fibroids for all women between the ages of 25-45 years is
7%. However, for African American women in that same age group with UF the risk
goes up to as high as 20%.
Uterine Fibroid Treatments
Hysterectomy is a treatment method used to impede women from having a
reoccurrence of UF growth by removing the uterus. However, because the uterus is
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removed during this procedure women are then prevented from being able to conceive
children. Increased health concerns related to the symptoms (bleeding, reproductive
difficulties, pain) associated with UF and the increased number of UF tumors cause
African American women to be more likely to receive hysterectomies compared to
Caucasian women (Faerstein et al., 2001; Viswanathan et al., 2007). Myers et al. (2002)
reported the rate at which hysterectomies are required due to health problems associated
with UF is up to 20% among African American women compared to 7% among
Caucasian women. The Agency for Healthcare Research and Quality sponsored a study
conducted by Viswanathan et al. (2007) which found that 50% of African American
women, compared with 30% of Caucasian women were likely to require hysterectomies
because of complications related to UF. Researchers have found the number and size of
UF tumors are increased among African American women who receive hysterectomies
compared to Caucasian women (Kjerulff, Lagenberg, & Sieden, 1996; Moorman,
Leppert, Myers, & Wang, 2013). Subsequently, it is likely that African American women
who are treated surgically for UF are at increased risk for post-surgical complications
such as infections and bleeding (Eltoukhi et al., 2013). It is important to note that in spite
of some of the potential complications associated with the hysterectomy procedure, there
are additional surgical procedures available to women who want to treat UF that can
preserve their ability to conceive.
The myomectomy procedure is just as surgically invasive as the hysterectomy.
The most significant difference between the hysterectomy and myomectomy procedures
is that the latter removes the UF tumors and leaves the uterus intact for women who may
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want the option of getting pregnant (Evans & Brunsell, 2007; Van Voorhis, 2009).
Although the UF tumors are surgically removed with the myomectomy procedure, there
is a strong possibility that the UF tumors can return (Van Voorhis, 2009). While the
myomectomy supports the ability of women to conceive children, the surgical procedure
is associated with increased medical cost and greater risk of morbidity (U.S. DHSS,
2011). Myers et al. (2002) reported that approximately 37,000 myomectomies are
performed on an annual basis in the United States. This number remains comparable to
more recent statistics, which indicate that as of 2011 at least 34,000 are performed
annually in the United States. (U.S. DHSS, 2011). Reducing the burden of treatment and
providing women with UF the options that support improved health is imperative towards
positively impacting HRQOL.
In recent years, research has focused on alternative treatments for UF that are not
as costly as the hysterectomy or myomectomy procedure. The procedure known as the
UAE reportedly offers similar relief in symptoms and supports improved HRQOL. UAE
is the latest method of treatment used to address UF and the symptoms that are associated
with diagnosis. It was not until the late 1980s that UAE demonstrated a positive response
in causing UF to shrink and in its effectiveness for controlling the symptoms associated
with the presence of UF in women (Wolanske & Gordon, 2004). The UAE procedure is
different from the hysterectomy and the myomectomy in that it does not require being
operated on under general anesthesia. In this procedure, the blood supply to UF is cut off,
which causes them to shrink (Beard, 2006; Miller, 2005). Although UAE has been
demonstrated to be an effective option for UF treatment that allows women to keep their
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uterus intact and offer shorter recovery times, it is unclear if women will be able to
successfully conceive and carry a fetus to term after having the procedure (Van Voorhis,
2009).
The emotional and physical burden experienced by women diagnosed with UF
who have to seek out medical interventions, further suggest that the presence and
treatment of UF can cause disruption in health and quality of life. According to Dixon et
al. (2006), more research in the area that focuses on improved symptom management and
enhanced quality of life is necessary in order to help support continued efforts in the
development of less invasive treatment strategies and to decrease the negative effect of
UF on African American women’s reproductive health. Subsequently, in order to assist
African American women in better understanding how to best approach UF treatment,
prevention, and improve HRQOL, it is important that the public health community
continue to review and research the impact of UF on HRQOL for African American
women with this condition.
Financial Implications
The myomectomy, UAE, and hysterectomy, are the most common medical
procedures used to treat UF and the symptoms associated with UF (Kershavarz et al.,
2002; NIH, 2011; Pron et al., 2003; U.S. DHHS, 2011). The high number of surgical
interventions performed due to symptoms associated with UF along with the use of health
care resources for treatment of UF suggests that UF have a clear financial impact on
those women diagnosed. The out of pocket care expenditures associated with UF
treatment are estimated to be approximately $4,624 annually for each woman (Hartmann
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et al., 2006); this suggests that an economic burden exists for women with UF in the
United States. The expenses related to drugs used to treat UF, managing the symptoms
associated with UF (bleeding and pelvic pain), and work loss due to UF symptoms
present an undue financial burden for these women (Cote, Jacobs, & Cumming, 2002;
Mauskopf et al., 2005). According to the ORWH (2006), the medical costs associated
with treatment and management of symptoms of UF are unduly borne by African
American women due to their increased likelihood to be diagnosed with UF.
Theoretical Model
There are a number of HRQOL models that have been used to investigate the
interrelationship of concepts related to illness, health, communities, and individuals.
However, over the past 10 years, three have emerged as the most commonly used models
of HRQOL that offer a clear, more concise, and less ambiguous framework to guide
research specific to HRQOL (Bakas et al., 2012). The three HRQOL models identified
by researchers Bakas et al. (2012) are the Wilson and Cleary model of HRQOL, the
World Health Organization International Classification of Functioning Disability and
Health (WHO ICF), and the Revised Wilson and Cleary model of HRQOL. All three
models were found to be useful in exploring the causal and reciprocal relationship
between multiple variables to allow researchers and practitioners to “make sense of real
world application” (Bakas et al., 2012, p. 4), and brought structure to HRQOL research.
However, researchers noted that there are some limitations to the WHO-ICF model. The
WHO-ICF model is restricted in its ability to discriminate between conditions that are
non-health related, is more applicable for classification and mapping of disease
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processes, and is not unique to HRQOL research (Bakas et al., 2012; World Health
Organization [WHO], 2007). The symptoms associated with UF have the potential to
affect the physical health, functional ability, and emotional health of the women
diagnosed. Therefore, it is important to have a model that will encompass and explain
multiple aspects of how UF symptoms can impact HRQOL.
Original Wilson and Cleary Model of HRQOL
The original model developed by Wilson and Cleary is rooted in a disease-based
framework or model of health-related quality of life (Wilson & Cleary, 1995) to allow
researchers and healthcare providers the ability to focus on the social, psychological, and
physical impact of disease on the total being. By integrating two different views of
health, the biomedical and the social science, Wilson and Cleary (1995) were able to
focus on understanding relationships between fundamental components of life and health,
exploring the overall well-being, and functioning of individuals. As a result, the authors
proposed that the model would focus on five main determinants: biological function,
symptoms, functional status, general health perceptions and overall quality of life
(Wilson & Cleary, 1995).
In this model, connecting associations between five patient outcome
measurements (biological function, symptoms, functional status, general health
perceptions and quality of life) were identified. It is important to note that three of the
limitations of the original model were that it lacked clarity in identifying causal
relationships between the model determinants, it was ambiguous in defining the critical
elements of HRQOL and it contained numerous arrows that were marked with examples
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(Ferrans et al., 2005). Researchers indicated it was difficult to manage and clearly
identify relationships between the components of the model because of the examples
indicated on the arrows (Ferrans et al., 2005).
The Revised Wilson and Cleary Model of HRQOL
The revised Wilson and Cleary model of HRQOL takes into consideration not
only the original five patient dimensions (biological function, symptoms, functional
status, general health perceptions, and overall quality of life), but also the impact of
characteristics of the individual and environment on these dimensions (Ferrans et al.,
2005). In order to help clarify the impact and streamline the causal relationship between
all of the model determinants, one of the key changes made in the revised model was to
address the labels and arrows within the original model. For instance, in the revised
model, example labels on the arrows were omitted to help streamline causal associations
between components (Ferrans et. al, 2005). In addition, directional arrows from
characteristics of the individual and characteristics of the environment were included to
demonstrate that biological function is influenced by these two elements (Ferrans et al.,
2005). Furthermore, the researchers of the revised model highlighted that the arrows in
the revised model indicate the “dominant causal associations” (Ferrans et al., 2005, p.
338) between the model components and the path of the arrows can demonstrate
reciprocal relationships in the model, but they are not necessarily demonstrated in the
figure.
One of the premises for the revised Wilson and Clearly model of HRQOL is that
different people with the same condition may experience that condition in different ways
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based upon their perception of the condition and outside influencing factors. This concept
is important because an array of health problems and personal concerns have been
identified among women diagnosed with UF. Some of these issues include increased
healthcare costs (Cote, Jacobs, & Cummings, 2003; Hartman et al., 2006), functional
limitations and decreased work performance (Downes et al., 2010; Lerner et al., 2008),
and constant feelings of fatigue, depression and anxiety (Brolmann & Hurine, 2008;
Popovic et al., 2009; Spies et al., 2002). Subsequently, in order to gain greater clarity and
understanding of some of the factors that influence the HRQOL of women who have
been diagnosed with UF, it is important to further investigate this condition utilizing the
revised Wilson and Cleary model of HRQOL. The constructs of the revised Wilson and
Cleary model of HRQOL will be useful in this study because their use will provide a
broader approach to explore HRQOL among African American women who are
diagnosed with UF. More specifically, the revised model will be used as the foundation to
investigate BMI, symptom severity, functional status, quality of life, general health
perceptions, characteristics of the individual (age), and characteristics of the environment
(family hx of UF diagnosis and employment) among African American women age 30 to
45 years with a diagnosis of UF.
Model Constructs
Characteristics of the individual. According to Ferrans et al. (2005),
characteristics of the individual are identified as factors that influence health outcomes.
These factors are categorized as demographic, biological, psychological, and
developmental (Ferrans et al., 2005). While the demographic, biological and
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developmental characteristics of the individual are usually not modifiable, they do
provide researchers with relevant information to help determine how and which
populations should be targeted for health interventions.
Demographic factors such as age and race have been linked to increased
diagnoses of UF among African American women (Davis et al., 2009; NIH, 2011; Wise
et al., 2005b). In addition, biological factors such as family history of UF does play a role
in risk for UF diagnosis (Evans & Brunsell, 2007; Schwartz et al., 2000) and increased
symptomology (Hyuck et al., 2008) among African American women. Therefore, the
association between age and family history of UF diagnosis will be included as
characteristics of the individual and will serve as the focus of this research.
Developmental characteristics of the individual take into account the level at
which a person is able to comprehend, institute, change or modify a behavior (Ferrans et
al., 2005). This variable is not static and is non-modifiable but must be considered when
considering what population can and should be targeted for interventions designed to
change or modify behavior (Ferrans et al., 2005). Studies investigating an individual’s
intellectual capacity for behavior change based on UF symptoms that are unrelated to
medical treatment have yet to be published. While the focus of this study is not to seek to
change or modify participants’ behavior, participants’ intellectual capacity and ability to
articulate how their lives are affected by UF is important. Therefore, developmental
characteristics of the individual for participants in this study will be addressed utilizing
the study eligibility criteria by requiring participants to be able to read and understand
English on at least a 12th grade level. Research specifically related to psychological
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characteristics of the individual on the ability of individuals to sustain behavior change
related to UF symptoms is unavailable. It is important to note that the ability to sustain
behavior change related to UF symptoms and HRQOL is outside the scope of this
research; therefore, psychological characteristics of the individual will not be included as
a variable in this study.
Characteristics of the environment. Characteristics of the environment are
either social or physical (Ferrans et al., 2005). According to Ferrans et al. (2005),
individuals’ cultural heritage plays an important role in how they are affected by their
social environment. Research suggests that social factors such as a culture of “suffering
in silence” (Cambridge & Sealy, 2012, p. 21), is widespread among African American
women diagnosed with UF. Research has identified that “suffering in silence”
(Cambridge & Sealy, 2012, p. 21) is also common practice among women who
experience significant problems with UF. Giving voice to women diagnosed with UF is
important in helping to raise public awareness about some of the health problems
associated with UF and support the need for further research related to the exact cause of
this condition among women, particularly African American women.
The influence of significant others, such as marriage partners, family, friends and
other social support systems are also included but not limited to the social characteristics
of the environment (Ferrans et al., 2005). Published research relevant to the potential
relationship or association between social characteristics of the environment such as
participants’ marital status, family and friend support systems, and other social support
networks and UF is unavailable and outside the scope of this research. Therefore, the
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influence of marital status, friends and other social support systems will be excluded as a
variable in this study.
Research indicates that physical factors of the environment such as work and job
performance can influence HRQOL (Ferrans et al., 2005). Studies have shown that
decreased work productivity and work loss are pertinent concerns identified by women
diagnosed with UF and are supported by research as having a negative impact on
HRQOL (Downes et al., 2010; Lerner et al., 2008; Pron et al., 2003). Cote, Jacobs, and
Cummings (2002) estimated that costs associated with work loss from symptoms
associated with UF are around $1,692 annually per woman. Identifying some of the
unique experiences that occur among women diagnosed with UF particularly African
American women will help focus attention on the specific concerns of African American
women who are challenged physically, socially, and emotionally by this chronic
condition. Therefore, the impact of UF on employment or the need to take time off work
will be included as the characteristic of the environment variable in this study.
Biological function. Biological function is one of the determinants of health
status and includes the physiological processes that support life (Ferrans et al., 2005;
Wilson & Cleary, 1995). Biological functions focus on the performance of cells, organ
systems, and are often measured utilizing lab tests, physical assessments, and medical
diagnoses (Ferrans et al., 2005; Wilson & Cleary, 1995). Furthermore, alterations in
biological function can affect all other factors of quality of life such as symptoms,
functional status and general health perceptions (Ferrans et al., 2005; Wilson & Cleary,
1995). For example, researchers have found that, among African American women,
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estrogen level and elevated BMI may increase their risk for developing UF (Faerstein,
Szklo, & Rosenshein, 2001; Flake, Andersen, & Dixon, 2003). Feelings of anxiety,
depression, and problems with fatigue are some common physical factors identified
among African American women with UF. Multiple researchers have found increased
fatigue, depressive symptoms, difficulty concentrating, and feelings of anxiety are
commonly reported concerns among African American women with UF (Cabness, 2010;
Lerner et al., 2008; Popovic et al., 2009). For the purpose of this study, biological
function will focus on participants BMI. The BMI will be calculated using the CDC
Adult BMI Calculator tool (CDC, 2013). The participants will self- report their individual
height and weight using the demographic survey form. Participants’ self- reported height
and weight will then be loaded into the Adult BMI Calculator tool (CDC, 2013) and their
corresponding BMI range (underweight, normal, overweight, and obese) will be obtained.
Estrogen levels as a biological function will be excluded as I will not have access to
participant’s medical records in order to ascertain this information.
Symptoms. According to Figure 1, biological function moves to symptoms, the
second major determinant of the revised model. According to Wilson and Cleary (1995),
a symptom may encompass the individual’s perception of any abnormal physical,
emotional or psychological conditions. Progressive conditions such as symptomatic UF
generally result in symptoms such as excessive and unpredictable menstrual bleeding,
pain, abdominal bloating, and frequent urination, which can be distressful for women
(Evans, 2008; Fennessy et al., 2011; Villarosa, 2003). Zimmerman, Bernuit, Gerlinger,
Schaefers, and Geppert (2012) reported complaints of pain symptoms, heavy bleeding,
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sexual-dysfunction, negative impact on relationships, and work performance were
common among the women with UF who participated in their international study. UF
symptoms are often individualized and can manifest differently in each individual.
According to Ferrans et al. (2005), it is important to understand the relationship between
the physical and emotional symptoms an individual may experience in order to recognize
how they affect health related quality of life. UF symptom severity will be investigated as
the symptom component of the theoretical model for this study. Exploring how African
American women diagnosed with UF evaluate and interpret the severity of UF symptoms
and the relationship between those UF symptoms and HRQOL, is essential in gaining a
better understanding of some of the barriers that impede positive HRQOL.
Functional status. The third factor of the revised Wilson and Cleary model is
functional status in which the ability of an individual to perform certain tasks is assessed
(Ferrans et al., 2005). This multidimensional concept characterizes an individual’s ability
to perform activities of daily living, fulfilling usual roles, and maintain health and wellbeing (Bennett, Steward, Kayser-Jones, & Glasser, 2002; Leidy, 1994). Four domains of
functioning that are often measured are physical, social, role, and psychological (Wilson
& Cleary, 1995). Ferrans et al. (2005) in their revised model focused on the effects of a
health condition on functional status and its impact on daily life. Some of the functional
limitations expressed by women with UF include but are not limited to: difficulty
concentrating, depressive symptoms, decreased work performance, and impaired sexual
function (Cabness, 2010; Lerner et al., 2008; Popovic et al., 2009; Zimmerman et al.,
2012). Multiple researchers have found several functional areas of daily life that have
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been impacted among women who are diagnosed with UF. Subsequently, for the purpose
of this study functional status will be investigated in six areas that are often impacted in
the lives of women with UF based on the UFS-QOL survey instrument (Spies et al.,
2002): concern, activities, energy/mood, control, self-consciousness, and sexual function.
General health perceptions. General health perceptions are described as the
individuals’ overall evaluation of the various aspects of their health, in addition to others
that may not be depicted by the model (Wilson & Cleary, 1995), and is the next level of
the revised Wilson and Cleary model. General health perceptions are subjective in nature
and allow for the individual to:
1) summarize all of the aforementioned concepts
2) place value on the importance of each variable
3) generate a summation of individual health.
Ferrans et al. (2005), suggests that general health perceptions can be measured with one
global rating of health, indicating an overall health rating on a Likert-type scale of poor to
excellent. Cambridge and Sealy (2012) stated, “…while UF are not as life threatening as
HIV and cancer, they do affect one’s well-being…” (p. 28). In this study, I will utilize
one global question based on Ferrans et al. (2005). This question will ask participants to
rate their current health on a scale of 1 to 10 to examine general health perceptions. It is
important to evaluate how African American women diagnosed with UF characterize and
view their overall health.
Overall quality of life. All of the aforementioned components of the revised
Wilson and Cleary model (Ferrans et al., 2005) have an effect on the last component,
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overall quality of life as a dimension of the total HRQOL model. According to Ferrans et
al. (2005), overall quality of life is rooted in a person’s sense of well-being that stems
from satisfaction or dissatisfaction with the areas of life that are important to him or her.
Indeed, African American women with symptomatic UF are often challenged with
constant pain, embarrassment, and in some cases limited support systems (Cambridge &
Sealy, 2012) which can negatively affect their life and sense of well-being. It is important
to note that the preceding components of the model allow overall quality of life to be
subjective for each person and allows for individualized perception of illness impact.
Various researchers have described how UF symptoms have affected the quality of lives
for women diagnosed in a number of ways. Popovic et al. (2009) reported issues such as
limitations in social life, loss of control, fatigue, and depression were identified concerns
among the women with UF in their study population. In addition, other concerns such as
increased risk for infertility, fatigue, depression, and decreased urinary function because
of UF development and the symptoms associated with UF have been reported among
women diagnosed with UF (Brolmann & Hurine, 2008; Moorehead & Conrad, 2001;
Parazzini et al., 2004; Popovic et al., 2009). Due to the subjective and individualized
reports of acuity associated with UF symptoms among women diagnosed it is important
to understand how their personal views of the impact of UF symptoms is shaped by
various physical, psychological and social attributes of the disease process as suggested
by Ferrans et al. (2005). Based on Ferrans et al., (2005), I will include one question
asking participants to rate how satisfied they are with their overall life to serve as the
overall quality of life measure for this study.
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Theoretical Model and Other Research Studies
Researchers Heo et al. (2005) used the revised Wilson and Cleary model to
investigate the impact of heart failure diagnosis on HRQOL among their study
participants. The purpose of their study was to measure the ability of the revised Wilson
and Cleary model of HRQOL to identify variables that influence HRQOL among patients
with a heart failure diagnosis. It is important to note that the specific racial makeup of its
sample population was not identified, but does specify that the sample population was
only elderly women. The researchers found the revised Wilson and Cleary model of
HRQOL was useful in predicting an association with health perception and symptom
status on HRQOL. However, the model was not able to demonstrate a significant
association among functional status, biological/physiological and overall quality of life
among participants in their sample population (Heo et al., 2005). Based on the findings of
the researchers’ some correlation between general health perception and symptoms was
noted using the revised Wilson and Cleary model; however, the model was limited in
being able to adequately delineate all of the HRQOL factors associated with persons who
have complex heart conditions.
The revised Wilson and Cleary model of HRQOL was used by Saban et al. (2007)
to investigate patients’ perspectives and experiences of factors that impacted HRQOL
among individuals who were undergoing elective lumbar spinal surgery. Their study
population was composed of participants between 21 and 84 years with a mean age of
53.4 years. Over half of their study population (52.6 %) was female and 89.5% were
White, 8.9% were Black with the remaining percentage classified as American Indian.
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The study findings demonstrated that the revised Wilson and Cleary model of HRQOL
was useful in investigating the specific HRQOL factors associated with persons
undergoing this surgical procedure. The model identified that fatigue, as a biological
determinant along with other variables remained an issue for the subjects postoperatively.
Conversely, symptom status, functional status and overall general mood were reportedly
improved post operatively among the study participants. According to the researchers,
two of the major limitations to the study were the small sample size and the lack of a
control comparison group (Saban et al., 2007). This suggests that the revised Wilson and
Cleary model of HRQOL may be an appropriate model to capture the individuals’
perspectives on how their health and life is affected by a progressive medical condition
like UF prior to treatment.
Research suggests that individuals with a positive HIV diagnosis are living longer
and are likely to experience more co- morbid complications such as liver disease because
of the antiretroviral medications taken to treat some of the symptoms associated with the
HIV infection (Henderson et al., 2012). Utilizing the revised Wilson and Cleary model of
HRQOL to investigate if persons living with HIV and liver disease had a poorer HRQOL
compared to persons living with only HIV was the focus of the study by Henderson et al.
(2012). For the comparison and control groups in the study, men represented 67.5 % and
72.7% respectively of the study population. In addition, it is important to note that
anywhere from 45% to a little over 50% of the study populations for both groups were
classified as non-White. The study findings demonstrated that the revised model of
HRQOL was able to identify race as a strong predictive co-variate linked to symptom
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status, functional status, and overall general health perceptions. The model also aided
researchers in determining if symptom status had a direct and significant impact on the
functional status and overall perception of quality of life among their study participants.
This information is vital because the revised model was used successfully in determining
the impact of symptoms on HRQOL of persons with a progressive and chronic condition
like HIV. Subsequently, the revised model of HRQOL could possibly be used to help
explore how UF symptoms are impacting the lives of women who are diagnosed with this
medical condition.
Measures Used for Assessing Health Related
Quality of Life and Uterine Fibroids
Historically, the availability of tools aimed at investigating women’s perceptions
of the severity of symptoms associated with UF and evaluating the impact on quality of
life or HRQOL has been minimal. There have been at least three clinical models in recent
years designed to assess HRQOL measures in women diagnosed with UF according to
Williams et al. (2006). The three most prominently used instruments identified by
Williams et al. (2006) are:
1) Short Form 36 (SF-36)
2) EuroQol now referred to as the EQ-5D
3) The Uterine Fibroid Symptom and Health Related Quality of Life (UFSQOL).
According to Williams et al. (2006), the SF-36 and EQ-5D instruments/questionnaires
were not developed specifically to address HRQOL perceptions in women with UF, but
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were found useful in being able to assess disease specific measures. Although the SF-36
and EQ-5D tools in addition to some others were adequate in reviewing symptomology
associated with UF, they still lacked the capacity to explore the impact of UF and UF
symptoms on HRQOL, from the patients’ perspective (Spies et al., 2002).
Created by Spies et al. (2002), the UFS-QOL was designed to investigate the
impact of UF on HRQOL. This clinical survey instrument was developed specifically to
address questions regarding the individuals’ personal experiences and feelings as they
pertain to the impact of UF on HRQOL (Spies et al., 2002). The UFS-QOL is used to
obtain information on the severity of UF symptoms and six subscales of HRQOL:
concern, activities, energy or mood, control, self-consciousness, and sexual function
(Harding et al., 2008; Spies et al., 2002). The subscales aide researchers by:
1) Providing greater insight into the specific health distresses related to UF
identified by women diagnosed with the condition.
2) Reviewing the impact of identified indicators on HRQOL, and
3) Narrowing the focus on common health and personal concerns related to UF
diagnosis.
The UFS-QOL questionnaire has been used in a number of studies related to UF
research and HRQOL. Lerner et al. (2008) utilized the UFS-QOL instrument to evaluate
women’s perception of the impact of UF on their work performance. Smith, Upton,
Shuster, Klein, and Schartz (2004) successfully utilized the UFS-QOL to investigate
patient satisfaction on quality of life and HRQOL among women before and after the
UAE procedure. Spies et al. (2002) the authors of the instrument as well as, Coyne et al.
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(2012) have successfully utilized the UFS- QOL among Black and White participants and
identified it as a reliable and valid instrument to measure symptoms and HRQOL in
women with UF. The UFS-QOL is condition specific and designed specifically to
investigate the unique experiences among women who are diagnosed with UF (Spies et
al., 2002). The UFS-QOL instrument provides opportunities for the individual to
articulate their feelings and experiences with UF symptoms and identify the ways UF is
specifically impacting their lives. Therefore, the UFS-QOL is considered the most
appropriate tool to utilize for this study when attempting to explore the impact of UF
symptoms and HRQOL factors associated with uterine fibroids among African American
women.
Summary
Uterine fibroid research continues to demonstrate that African American women
are at a greater risk for diagnosis of UF, when compared to their Caucasian and Asian
counterparts. Moreover, investigation among African American women with UF and UF
symptoms impact on HRQOL is imperative. There are varying factors being investigated
as the primary cause of UF development among African American women; however,
research in the area of UF development and prevention has focused primarily on medical
treatment. A significant portion of the research has centered on identifying the most
efficacious medical treatment options for removal of UF that would decrease the
extended time of recovery and still allow women of childbearing age the option to keep
their uterus intact supporting improved quality of life. However, despite increased rates
of UF diagnoses among African American women, there is limited research on the impact
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of UF symptom severity on HRQOL among African American women age 30 to 45 years
utilizing the revised Wilson and Cleary model of HRQOL. Therefore, exploration into
UF symptom severity and the impact of UF symptoms on HRQOL among African
American women age 30 to 45 years diagnosed with UF necessitates further
investigation.
In Chapter 3, I describe the methodology used in the study. The study
methodology was designed to explore the impact of UF symptoms on HRQOL among
African American women and identify HRQOL indicators associated with UF. The
research design, sampling of the population, instrumentation, disclaimer about the
protection of participants’ rights, and data analysis were reviewed.
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Chapter 3: Methodology
Introduction
In this chapter, the study design that was used for this study, in addition to
rationale for why this study design and approach were selected, was addressed. This
included general information regarding the targeted population of interest; sampling and
data collection protocols; survey instrument used to retrieve data; validity and reliability.
This section also included data regarding the eligibility criteria for participating in this
study. Descriptions of the instrument that was used for data collection, the data collection
process, and the data analysis are also included. In addition, this chapter is comprised of
information related to the protection of human subjects and maintaining confidentiality
within this study.
Research Design
The purpose of this study was to explore UF symptom severity and the impact of
UF symptom on HRQOL among 30 to 45 years old African American women diagnosed
with UF. The exploratory non- experimental quantitative research method was chosen
because it provided an in- depth perspective of African American women’s experiences
with UF and their impact on HRQOL. The primary objective of the study was to obtain
evidence from an existing population of African American women ages 30 to 45
diagnosed with UF regarding the symptoms associated with UF and the impact of UF
symptoms on their HRQOL. This was an exploratory non- experimental quantitative
study design utilizing a survey instrument. The type of design was selected specifically
for this study due to the decreased expense and increased efficiency for expedient data
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collection. The survey was cross- sectional and data was collected electronically. A
correlational design was used in this study. According to Polit and Beck (2008), a
correlational design allows the researcher to examine interrelationships and associations
among dependent variables and the independent variables that cannot be manipulated.
This approach was suitable for this study because none of the independent variables
(symptom severity, personal medical history, HRQOL, BMI, age, employment, and
family hx of UF diagnosis) were able to be logistically or ethically manipulated. The
cross- sectional design included a sample of African American women with a current
diagnosis of UF, between 30 and 45 years old who were able to read and understand
English. Participants of the study electronically self-administered the UFS-QOL
developed by Spies et al. (2002).
Target Population
In this study, I specifically focused on 30 to 45 year old African American women
who were currently diagnosed with UF and affiliated with Run Girl Run (RGR) or with
the graduate chapter sorority, Delta Sigma Theta Sorority (DST), Inc. (community
service organization) based in Cobb and DeKalb Counties in Georgia. The DST graduate
chapters were selected because one of the foci of the national and local organization is on
the physical and mental health for its members, the communities which they serve, and
racial makeup of the members is primarily African American (Giddings, 1988). The
emphasis on physical and mental health is a mandate from the organization on a national
level and has been in place for well over 60 years (Giddings, 1988). The members of
Marietta Roswell Alumnae (MRACDST) and Stone Mountain Alumnae (SMLACDST)
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chapters are comprised of African American women, who were residents of Cobb, North
Fulton, South Fulton, and DeKalb Counties in the state of Georgia. The RGR
organization was selected because one of the foci of the organization is to promote
improved health and a healthy lifestyle among African American women by
incorporating physical fitness into their lives (personal communication, Jones, N., July 1,
2013).
There are nine graduate DST chapters located throughout Metro Atlanta and its
surrounding counties. The membership base of the local DST graduate chapters varies
ranging from approximately 200 to 900 members. The approximately 530 women of the
MRACDST (personal communication, Pattman, P., September 8, 2012) and
approximately 854 women of the SMLACDST chapters (personal communication,
Johnson, T., April 8, 2013) are African American, are early twenties and older, are a
mixture of married and single women; are all college educated, and are all primarily
working professionals. The combined membership of the SMLACDST and MRACDST
chapters totals approximately 1,384 women, which classify the chapters as two of the
larger graduate chapters of DST located throughout Metro Atlanta and its surrounding
counties. Information pertaining to the demographic breakdown of the SMLACDST
membership base is unavailable. However, communication with the chapter’s past
president revealed that, of the approximate 854 African American women affiliated with
their chapter, it is estimated that women between the ages of 30 to 45 years reportedly
represent approximately 50% of the SMLACDST membership base (personal
communication, Johnson, T., April 8, 2013). According to MRACDST, 73% of the
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chapters’ membership are between the ages of 25 and 48 years (Marietta Roswell
Alumnae Chapter, Delta Sigma Theta Sorority, Inc. [MRACDST], 2011). More
importantly, 60% of the members who responded to the chapter’s survey conducted in
2009-2010, noted that they had “issues with uterine fibroids” (MRACDST, 2011, para. 2)
when asked to identify if they had any health concerns. RGR is an organization of
approximately 200 women who are primarily of African American and between the age
of 30 and 50 years (personal communication, Jones, N., July 1, 2013).
Approximately 1,600 African American women in total were accessible for this
research project based on their affiliation with at least one of the three organizations.
Prevalence rates for UF in the United States are estimated primarily based on the annual
rate of hysterectomies and myomectomies performed (DHHS, 2011), which make it
difficult to narrow the exact number of women that are currently diagnosed with UF. The
ORWH (2006) indicated that 20-25% of all women in the United States of reproductive
age have UF. However, the NIH (2011) reported that African American women were
diagnosed with UF between three and nine times more often when compared to
Caucasian women. Therefore, it was reasonable to estimate that at least 30% to 33% of
all African American women or at least one in three African American women have a
current diagnosis of UF. Therefore, it was justifiable to expect that at least 30% or 528
women of the 1600 women in the target population size will have a current UF diagnosis.
Representatives for all three participating organizations reported approximately 50% to
70% of their membership base are between the ages of 30 and 45 years, which is the age
requirement for this study. I estimated approximately 40% or 212 women of the expected
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target population size of 528 would be ineligible to participate in the project due to their
age. Therefore, justification for an estimated target population size of 316 women (who
met the age criteria of 30 to 45 years and had a current diagnosis of UF) to be eligible to
participate in the study project was appropriate.
Sample Size. The primary model was examined using linear and hierarchical
multiple regressions. The appropriate a priori sample size for this study was determined
using G*Power analysis Faul et al. (2009). A total of 92 subjects has 80% power to detect
a medium effect size f2 equal to 0.15 with 5 predictor variables at a significance of 0.05.
The effect size is estimated from the findings of Ward and Heidrich (2009) who indicated
that a medium effect size was adequate to examine group differences in beliefs, coping,
and perceived stigma among African American ages 25-85 years, utilizing an
exploratory, cross-section survey design. The model tested whether the independent
variables (UF symptom severity, BMI, HRQOL, age, and family hx of UF diagnosis)
predict the dependent/criterion variables (concern, activities, energy/mood, control, selfconscious, sexual function, general health perception, and overall quality of life).
Eligibility Criteria
In order to participate in this study, the inclusion criteria were:
1) African American women aged 30 to 45 years,
2)

current diagnosis of UF,

3)

able to give informed consent,

4)

the ability to read and understand English at a 12th grade level,

5)

have access to internet and able to answer electronic survey, and
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6)

no surgical interventions for UF.

The exclusion criteria for this study were those African American women who were:
1) Over the age of 45 or younger than 30,
2) who have been treated for UF with the following surgical procedures
(Hysterectomy, Myomectomy, and UFE),
3) who do not have a current diagnosis of UF,
4) unable to read and understand English at a 12th grade level,
5) no access to the internet and unable to answer electronic survey.
The average age of diagnosis among Black women with UF when compared to their
White counterparts was 5.3 years younger, 40.8 years of age for Black women versus
45.1 years of age for White women (Huyck et al., 2008). More recently, Davis et al.
(2009) reported that Black women in the following age categories had the highest
percentage of UF diagnosis: 30-34 years 29%; 35-39 years 22% and 40-44 years 29%
when compared to white women in their study population. Because UF tumors are
generally noted to form during the reproductive years of women and resolve with the
onset of menopause (Evans & Brunsell, 2007), for the purpose of this study, women
ages 30 to 45 only were included.
Instruments
The Uterine Fibroid Symptom and Health Related Quality of Life (UFS-QOL)
designed by Spies et al. (2002) to explore perception of symptom severity and the impact
of UF symptoms on HRQOL was used for this study. Consent was obtained from
Carolyn Strain, Director of the Society of Interventional Radiology (SIR) Foundation to
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utilize the instrument for this study (Appendix F). This clinical survey instrument was
developed specifically to address questions related to the impact of UF symptoms on
HRQOL matters among women diagnosed with UF (Spies et al., 2002). The UFS-QOL
seeks to obtain information related to UF symptom severity and HRQOL along six
subscales of categories from women who are diagnosed: concern, activities,
energy/mood, control, self-consciousness, and sexual function (Harding et al., 2008;
Spies et al., 2002). The 37- item survey instrument was used to assess the severity of
symptoms among African American women with UF and impact UF symptoms on
HRQOL. The UFS- QOL survey questionnaire is based on a 5- point Likert scale, in
order to ensure consistency in the participant responses.
The survey is divided into two sections: symptom severity and HRQOL. The first
eight questions of the survey are the symptom severity section of the survey. These
questions use a 5- point Likert-type scale ranging from 1 (not at all) to 5 (a very great
deal) for this project. The data obtained from this scale are at the ordinal level. The
participants received points based upon their response as indicated: 1 point for not at all,
2 points for a little bit, 3 points for somewhat, 4 points for a great deal and 5 points for a
very great deal. This section has eight questions total; therefore, scores for this section
ranged from 8 to 40 (with scores closer to 40 reflecting greater perceived symptom
severity) (Spies et al., 2002). According to Spies et al. (2002) the developers of the UFSQOL instrument, section one of the survey was successful in discriminating between
levels of symptom severity among women diagnosed with UF, supporting its ability and
usefulness to investigate UF symptom severity from an individual perspective.

80
Researchers Harding et al. (2008) also found the UFS-QOL instrument was useful in
investigating severity of UF symptoms among women diagnosed with UF.
Section 2 of the survey evaluates the impact of factors associated with HRQOL
and consists of 27 questions. This section is broken down into six subsections: concern
(Questions 9, 15, 22, 28, 32), activities (Questions 10, 11, 13, 19, 20, 27, 29),
energy/mood (Questions 12, 17, 23, 24, 25, 31, 35), control (Questions 14, 16, 26, 30,
34), self-conscious (Questions, 18, 21, 33), and sexual function (Questions 36 and 37).
The subscales are used to assess feelings and experiences regarding the impact of uterine
fibroids symptoms on various areas of each participant’s life. These questions use a 5
point Likert scale ranging from 1 (none of the time) to 5 (all of the time) for this project.
The data obtained from this scale are at the ordinal level. The participants received points
based upon their response as indicated: 1 point for none of the time, 2 points for a little
bit of the time, 3 points for some of the time, 4 points for most of the time and 5 points
for all of the time.
The HRQOL total score is the sum of the item values from each of the six
subscales. The subscale for concern has a total of 5 questions; therefore scores for this
section ranged from 5 to 25. The subscale for activities has a total of 7 questions;
therefore scores for this section ranged from 7 to 35. The subscale for energy/mood has a
total of 7 questions; therefore scores for this section ranged from 7 to 35. The subscale
for control has a total of 5 questions; therefore scores for this section ranged from 5 to 25.
The subscale for self-conscious has a total of 3 questions, therefore scores for this section
ranged from 3 to 15. The subscale for sexual function has a total of 2 questions; therefore
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scores for this section ranged from 2 to 10. Therefore, the combined raw scores from
each subscale represented the total score for HRQOL section and ranged from 29 to 145
(with scores closer to 145 reflecting greater impact on health related quality of life). The
UFS-QOL has established reliability and validity with a subscale Cronbach’s alpha range
from 0.83 to 0.95 with the overall health related quality of life score alpha =0.97 and testretest interclass reliabilities correlation coefficients of 0.76 to 0.93 (Spies et al., 2002).
The Screening information (SI) form (see appendix B) consisted of questions that
were used for screening purposes for this project. The SI form had four screening
questions to ensure that only women who meet the inclusion criteria were allowed to take
the survey. The Demographic Information (DI) form (see appendix C), had a total of
eight questions. The first six questions were used to obtain information about each
participant’s employment or time missed from work, height, weight, family history of
diagnosis of UF, and age. The next two questions were designed to measure general
health perceptions and overall quality of life. The question to measure general health
perceptions was: “How would you rate your current health on a scale from 1 to 10 with
1= poor and 10 = excellent?” as suggested by Ferrans et al. (2005). The last question on
the DI form, measured overall quality of life, was: “How satisfied are you with your
overall life in general on a scale from 1 to 10 with 1 = poorly satisfied and 10 = very
satisfied?” as indicated by Ferrans et al. (2005).
Protection of Human Subjects
In this study, I worked diligently to keep information confidential by adhering to the
Health Insurance Portability and Accountability Act (HIPAA) guidelines and maintaining
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participants’ anonymity with description and survey data. Institutional review board
(IRB) approval from Walden University was obtained prior to conducting research in
order to ensure that participants’ rights and safety are met and maintained in accordance
with the University’s identified standards. Participants in this study were assured of the
confidentiality involved in this research process. Demographic information collected was
not to be divulged in relation to participation in this study. There were no personal
identifiers listed on the survey tool. The survey databases were secured in a locked file
cabinet area in the researcher’s home for complete confidentiality. This research study
was voluntary and all participants had the right to refuse to participate in the study at any
time. Participants were asked to review a consent form prior to beginning the study. Upon
review of the consent form participants were made aware that by accessing the survey
link they would be providing their consent to participate in the study project.
Subsequently, I did not collect paper consent forms from the study participants. However,
participants were able to print and save a personal copy of the consent form for future
reference, if so desired.
Data Collection Procedures
A convenience sampling method was utilized from the women who volunteered to be
a part of the study because subjects were accessible through the identified organizations.
The processes involved in the research study was as follows: following IRB approval to
conduct research, the leadership teams of RGR, MRACDST, and SMLACDST were
contacted via email to request dissemination of the survey link to their members and
affiliates.
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Participants were recruited from members of MRACDST, SMLACDST and
women affiliated with RGR. A contact person from each of the leadership teams of
MRACDST, SMLACDST, and RGR was identified. The identified contact person(s) for
each organization placed an informational announcement in the organizations’ weekly
announcement bulletins to explain the study and seek participants. The announcement
introduced me to the members of both DST chapters and women of RGR. The
announcement also highlighted information about the study and the criteria for
participation, which required participants to be African American women, aged 30 to 45,
with a current diagnosis of UF, able to give informed consent, able to read and
understand English, no history of surgical treatment for UF, have access to the internet,
and able to answer an electronic survey. Potential participants were asked to go online by
accessing the identified web link to an established web based system (Survey Monkey) to
review the consent form, SI form, DI form, and the survey. An electronic version of the
Walden University consent (see Appendix A) form was used in the database for
participants to review and with a detailed statement that the participant have informally
consented to be in the study by completing the SI form and all subsequent survey forms
thereafter. Study participants were prompted to review the consent form prior to
participation in the study in order to ensure that all participants understood that
participation in the study was voluntary. More importantly, it also indicated that they are
not required to participate in the study because of their membership or affiliation with the
participating organizations. Participants were made aware that they had the right to
discontinue the study at any time. No identification markers were used. Contact
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information for the researcher was made available electronically to the participants upon
entry into the web based survey to provide an opportunity for participants to address any
questions related to the survey content.
Upon entry to the web based survey link, participants were prompted to review a
set of instructions outlining procedures for completing the SI Form, DI form, and UFSQOL survey electronically in order to maintain a standardized method of survey
completion. The set of instructions made participants aware that all information obtained
in the SI form, DI form, and UFS-QOL survey was confidential and those forms
instructed them not to include self-identifying information. Because the topic of this
study required some information of a private nature, it was extremely important to
maintain participant comfort and confidentiality while minimizing the potential for
participant embarrassment and reluctance to participate. Participants were prompted
initially to complete the SI form in order to ensure they meet all of the inclusion criteria
for participation in the study. Those study participants who did not meet the inclusion
criteria after completion of the SI form were instructed to stop and were not allowed to
proceed with completion of the DI form or UFS-QOL survey instrument.
After completion of the SI form, those participants who did meet the study
inclusion criteria were prompted to move forward with completion of the DI form and the
UFS-QOL 37- item survey instrument as best they can. All study participants were
instructed to answer questions based upon their current level of understanding and
familiarity of the subject content. Once participants complete the DI form and UFS-QOL
survey they were prompted to submit the completed form and survey electronically.
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Participants were provided with the number and name of a local mental health resource to
follow up should they become distressed after completion of the survey and desire to seek
professional assistance; however, this was not an expected reaction.
I selected an established web based system (Survey Monkey) to aide in
transferring the testing instruments, screening information and demographic form on line.
Emails were sent to MRACDST, SMLACDST, and RGR with a request for them to
distribute directly to their members and affiliates the survey information. The survey
information included the identified survey web link which asked individuals to complete
the survey electronically in order to maximize access to all potential participants.
Utilizing the electronic data collection method afforded this researcher the opportunity to
administer the survey to multiple parties, offered the ease of being able to take the survey
at a time that is convenient for the participants, supported participants’ confidentiality,
and was cost effective. I believe that the electronic survey method was the most
advantageous for this study project. Moreover, because the topic of this study was of a
private nature, it was extremely important for me to maintain participant comfort and
confidentiality while minimizing the potential for participant embarrassment and
reluctance to participate. Therefore, the electronic survey process was selected because of
the need to limit participant bias, maximize access to the entire participant pool, and
administration of one survey questionnaire was potentially more effective for the
participants.
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Data Analysis
Initially, the data were checked and verified with the electronic data files to ensure
accuracy for data entry. The data were then examined for data inaccuracies such as
abnormal data entry (e.g. survey response > 5) and missing survey response values. After
review and verification of the data using an excel spreadsheet, survey entries that were
noted to contain inadequate and missing data were systematically excluded from the data
analysis.
There were two phases to data analysis, descriptive and inferential. In the first
phase of the analyses, descriptive statistics were used to determine means and the
standard deviation to describe the continuous variable (age). Frequency and percent was
used to describe the responses to the survey items. For the second phase of the analyses,
regression was used to answer the research questions and determine if there was a
relationship between the identified variables (BMI, symptoms, functional status, general
health perception, and HRQOL). Statistics software, SPSS version 20.0 for Windows was
used for all statistical analysis (IBM SPSS Inc., 2011). A p value less than 0.05 was
considered significant.
Assumptions for Linear Regression
1. The relationship between the dependent variable (DV) and independent variable
(IV) is linear. This assumption was tested by examining the scatter plot. If the plot
of the data points falls in a line or at least oval or oblong shape the assumption of
a linear relationship was supported.
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2. Homoscedasticity (the errors have the same variance; Leech, Barrett, & Morgan,
2005). This assumption was tested by examining the plots of the standardized
residuals against the predicted values. If the plots are approximately rectangle
around the middle y = 0 line, the assumption of homoscedasticity was supported.
3. The errors are independent of each other: Durbin-Watson Statistic was used to test
this assumption. The value of the Durbin-Watson statistic ranges from 0 to 4
(Leech, Barrett, & Morgan, 2005). As a general rule of thumb, the residuals are
not correlated if the Durbin-Watson statistic is approximately 2 (an acceptable
range is 1.50 - 2.50; Leech, Barrett, & Morgan, 2005). If the Durbin-Watson
statistic falls in this range, the assumption that the errors are independent was
supported.
4. The errors or residual are normally distributed residuals: This assumption was
tested using the Shapiro-Wilk test of studentized residuals. If the p-value of the
Shapiro-Wilk statistics was greater than .05 the assumption that the errors are
normally distributed was supported (Leech, Barrett, & Morgan, 2005).
Assumptions for Multiple Regressions
The assumptions for linear regression also apply to multiple regressions and will
be tested as indicated above.
Of most concern with multiple regressions is multicollinearity. This is not an
assumption as such, but is of concern when conducting multiple regression analyses.
High inter-correlation among the IVs can result in multicollinearity. Multicollinearity
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results in unstable equation coefficients. The following steps were followed to check for
multicollinearity:
1. Correlation matrix was calculated and constructed in order to examine the
correlations of the IVs to the DV and the inter-correlations among the IVs. An
outcome of high correlations between the DV and each IV and low intercorrelations among the IVs indicates that multicollinearity does not exist.
2. Examine the Tolerance: A Tolerance close to 0 indicates multicollinearity. The
cut-off used was 0. If the Tolerance was more than 0.1, multicollinearity among
the IVs does not exist.
The following research questions and hypotheses were developed and used in
order to explore the severity of UF symptoms and the impact of UF symptoms on
HRQOL (see Table 2):
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Table 2
Research Questions, Study Variables, and Data Analysis
RESEARCH
QUESTIONS

STUDY VARIABLES

DATA ANALYSIS

RQ 1: What is the
association between
symptom severity, as
measured by the UFSQOL instrument, and
concern (a dimension of
HRQOL) among African
American women ages
30 to 45 years diagnosed
with UF?

Dependent: Concern (summed score
of questions 9, 15, 22, 28, 32 on the
survey);

Linear Regression

RQ 2: What is the
association between
symptom severity, as
measured by the UFSQOL instrument, and
activities (a dimension of
HRQOL) among African
American women ages
30 to 45 years diagnosed
with UF?

Dependent: Activities (summed
score of questions 10, 11, 13, 19, 20,
27, 29 on the survey);

Independent : Symptom Severity
(summed score of questions 1-8 on
the survey)

Linear Regression

Independent: Symptom Severity
(summed score of questions 1-8 on
the survey)

Table 2 Continues
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RQ 3: What is the
association between
symptom severity, as
measured by the UFSQOL instrument, and
energy/mood (a
dimension of HRQOL)
among African American
women ages 30 to 45
years diagnosed with
UF?

Dependent: Energy/mood (summed
score of questions 12, 17, 23, 24, 25,
31, 35 on the survey);

RQ 4: What is the
association between
symptom severity, as
measured by the UFSQOL instrument, and
control (a dimension of
HRQOL) among African
American women ages
30 to 45 years diagnosed
with UF?

Dependent: Control (summed scores
of questions 14, 16, 26, 30, 34 on the
survey);

RQ 5: What is the
association between
symptom severity, as
measured by the UFSQOL instrument, and
self-consciousness (a
dimension of HRQOL)
among African American
women ages 30 to 45
years diagnosed with
UF?

Dependent: Self-consciousness
(summed score of 18, 21, 23 on the
survey);

Linear Regression

Independent: Symptom Severity
(summed score of questions 1-8 on
the survey)

Linear Regression

Independent: Symptom Severity
(summed score of questions 1-8 on
the survey)

Linear Regression

Independent: Symptom Severity
(summed score of questions 1-8 on
the survey)

Table 2 Continues
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RQ 6: What is the
association between
symptom severity, as
measured by the UFSQOL instrument, and
sexual function (a
dimension of HRQOL)
among African American
women ages 30 to 45
years diagnosed with
UF?

Dependent: Sexual function
(summed scores of questions 36 and
37 on the survey);

RQ 7: What is the
association between
symptom severity as
measured by the UFSQOL instrument, BMI,
and HRQOL total score
as measured by the UFSQOL instrument among
African American
women ages 30 to 45
years diagnosed with
UF?

Dependent Variable: HRQOL score
(sum score of 6 subscale scores
range from 29 to 145);

RQ8: When controlling
for characteristics of the
individual (age) what is
the association between
symptom severity as
measured by the UFSQOL instrument, BMI,
and HRQOL total score
as measured by the UFSQOL instrument among
African American
women ages 30 to 45
years diagnosed with
UF?

Linear Regression

Independent: Symptom Severity
(summed score of questions 1-8 on
the survey)

Independent: Symptom Severity
(summed score of questions 1-8 on
the survey) and BMI – overall
calculated value based on
participants height and weight
(participants response to two
questions on DI form: question #2What is your height? and question
#3- What is your weight?)
Dependent Variable: HRQOL score
(sum score of 6 subscale scores
range from 29 to 145);

Hierarchical multiple
Regression

Hierarchical multiple
Regression

Independent: Symptom Severity
(summed score of questions 1-8 on
the survey) and BMI – overall
calculated value based on
participants height and weight
(participants response to two
questions on DI form: question #2What is your height? and question
#3- What is your weight?)
Co-variant-Characteristics of the
Individual:
Age (participant’s response to one
question about age #1 on the DI
form)

Table 2 Continues
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RQ9: When controlling
for characteristics of the
environment (family hx
of UF diagnosis and
employment) what is the
association between
symptom severity as
measured by the UFSQOL instrument, BMI,
and HRQOL total score
as measured by the UFSQOL instrument among
African American
women ages 30 to 45
years diagnosed with
UF?

Dependent Variable: HRQOL score
(sum score of 6 subscale scores
range from 29 to 145);

Hierarchical multiple
Regression

Independent: Symptom Severity
(summed score of questions 1-8 on
the survey) and BMI – overall
calculated value based on
participants height and weight
(participants response to two
questions on DI form: question #2What is your height? and question
#3- What is your weight?)

Co-variants-Characteristics of the
Environment:
A) Family History of UF diagnosis
(participant’s response to one family
history of UF diagnosis question #5
on the DI form).
B) Employment (participant’s
response to question # 4 on the DI
form: Yes, No, I do not know).
RQ 10: What is the
association between
symptom severity as
measured by the UFSQOL instrument,
HRQOL total score as
measured by the UFSQOL instrument and
general health perception
among African American
women age 30 to 45
years diagnosed with
UF?

Dependent Variable: General health
perceptions (participants response to
one global question #7 on the DI
form- “How would you rate your
current health on a scale from 1 to
10 (with 1 = poor and 10 =
excellent)

Hierarchical multiple
Regression

Independent: HRQOL score (sum
score of 6 subscale scores range
from 29 to 145) and Symptom
Severity (summed score of questions
1-8 on the survey).

Table 2 Continues
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RQ11: When controlling
for characteristics of the
individual (age) what is
the association between
symptom severity as
measured by the UFSQOL instrument,
HRQOL total score as
measured by the UFSQOL instrument and
general health perception
among African American
women age 30 to 45
years diagnosed with
UF?

Dependent = General health
perceptions (participants response to
one global question #7 on the DI
form- “How would you rate your
current health on a scale from 1 to
10 (with 1= poor and 10 =
excellent)?”).

Hierarchical multiple
Regression

Independent = HRQOL score (sum
of 6 subscale scores range 29 to 145)
and Symptom Severity (summed
score of questions 1-8 on the
survey).
Co-variant-Characteristics of the
Individual:

Age (participant’s response to one
question about age #1 on the DI
form).
RQ 12: When controlling Dependent = General health
for characteristics of the perceptions (participants response to
environment (family hx
one global question #7 on the DI
of UF diagnosis and
form- “How would you rate your
employment) what is the current health on a scale from 1 to
association between
10 (with 1= poor and 10 =
symptom severity as
excellent)?”).
measured by the UFSQOL instrument,
Independent = HRQOL score (sum
HRQOL total score as
of 6 subscale scores range 29 to 145)
measured by the UFSand Symptom Severity (summed
QOL instrument and
score of questions 1-8 on the
general health perception survey).
among African American Co-variants-Characteristics of the
women age 30 to 45
Environment:
years diagnosed with
A) Family History of UF diagnosis
UF?
(participant’s response to one family

Hierarchical multiple
Regression

history of UF diagnosis question #5
on the DI form).
B) Employment (participant’s
response to question # 4 on the DI
form: Yes, No, I do not know).

Table 2 Continues
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RQ 13: What is the
association between
symptom severity as
measured by the UFSQOL instrument and
overall quality of life
among African American
women age 30 to 45
years diagnosed with
UF?

Dependent = Overall quality of life
(response to one global question #8
on the DI form- ‘How satisfied are
you with your overall life in general
on a scale from 1 to 10 (with 1 =
poorly satisfied and 10 = very
satisfied)?”)
Independent = Symptom Severity
(summed score of questions 1-8 on
the survey).

Linear Regression

Summary
Throughout this chapter, broad information regarding the design of the study was
presented. An inclusive description that detailed the target population, protection of
human subjects and information pertaining to the instrument that was used to analyze
data is addressed. In addition, the data analysis plan was presented. The data analysis
plan addressed and examined components of the thirteen hypotheses and explored the
research questions. Chapter 4 presents the data analysis, interpretation of data and
provide a summarization of the overall results of the study. Chapter 5 will communicate
the summary, possible implications, conclusion and recommendation(s) for further
research.
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Chapter 4: Results
Introduction
The purpose of the current chapter is to present the results from the statistical
analyses performed to address the research questions from this study. A description of the
final sample size is followed by descriptive statistics for the demographic and
environmental variables from this study. In addition, the HRQOL variables, methods
used to examine each of the questions, and the results of the tests derived from the linear
and multiple regression analyses from this study is described. The chapter ends with a
summary of the key findings from this study.
Sample
All three of the participating organizations (MRAC DST, SMLAC DST, and
RGR) received a recruitment letter via email. In the email, the organizations were asked
to send out the survey link in their weekly correspondence to their members and
affiliates. After four months of data collection a total of 103 survey entries were received.
The data were initially checked to ensure that the entries met the study inclusion criteria
based on responses to the screening questions and were checked for accuracy in data
responses. Four screening questions were used to ensure that only women who met the
inclusion criteria were allowed to complete the survey. Based on the survey screening
questions, all 103 participants identified their race as African American. Of those 103
respondents, 3 indicated they had not been informed they had a diagnosis of uterine
fibroids by a medical professional and they were excluded from the study. Two
respondents indicated they were outside of the age requirements for the study, 53 years
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and 47 years, both were excluded from the study. Sixteen respondents replied ‘yes’ that
they had received treatment for their uterine fibroids and those 16 were not included in
the study. A total of 21 survey entries were excluded because they did not meet the study
inclusion criteria based on their responses to the 4 screening questions. In addition, 2
survey entries were excluded for incomplete data responses. In total, 23 survey entries
were excluded from this study, leaving a total of 80 respondents who were included in the
study.
Ninety-two participants were estimated to have 80% power to detect a medium
effect f2 equal to 0.15 with 5 predictor variables at a significance of 0.05. It is important
to note the estimated sample size of 92 was initially based on the target population size of
1,600 women (the total number of women available from all three participating
organizations). In chapter 3 however, it was noted that of those 1,600, only
approximately 316 women would be eligible to participate in the study project based on
their age and diagnosis of UF. After the data were collected and reviewed for accuracy it
was evident that the obtained study sample of n= 80 was less than the estimated sample
size. Therefore, it was determined that a post hoc power analysis was needed. A post hoc
power analysis using G*Power (Faul et al., 2009) was used to calculate the post hoc
power for the hierarchical regression to ensure that the obtained study sample size of 80
would be able to adequately power the study. Post hoc analysis demonstrated with an n =
80, medium effect f2 equal to 0.15, and alpha = 0.05, the post hoc power was .87 or 87%.
Therefore, the obtained sample size (n = 80) was enough to adequately power the study
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because it reflects the true power for the study based on the sample obtained from the
actual target population size.
Descriptive Statistics
The data were checked and verified using the electronic data file to ensure
accuracy for data entry. The data were examined using frequencies for data inaccuracies
such as abnormal data entry (e.g., survey response >5) and there were none. After review
and verification of the data using the Excel spreadsheet, 23 survey entries were
systematically excluded from the data analysis because they failed to meet the study
inclusion criteria prior to the final sample size being established.
Descriptive statistics for the demographic physical characteristics of the
participants are shown in Table 3. The participants had a mean age of 39.2 years with a
mean height of 64.1 inches (5 feet 4 inches). The Body Mass Index (BMI) mean for the
participants of this study was 30.8. Of the total number of participants in the study 20%
reported a weight class which placed them in the category of being overweight with a
calculated BMI range of 25 to 29.9. Another 46.25% of the participants fell into the obese
category with a calculated BMI range of 30.0 or higher. It is important to note that
according to the CDC (2013), a normal BMI range is 18.5 to 24.9.
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Table 3
Physical Characteristics of the Participants
N

Minimum

Maximum

Mean

Std. Dev.

Age

80

30

45

39.2

3.8

Height (in)

80

52

73

64.1

2.8

Weight (lbs)

80

107

298

180.1

40.0

BMI

80

19

51

30.8

7.0

Descriptive statistics for the demographic environmental characteristics of the
participants are shown in Table 4. Participants were asked if they had missed work as a
direct result of symptoms associated with uterine fibroids. Over one third of the
participants indicated they had missed work due to uterine fibroid symptoms. Only
participants that indicated they had a diagnosis of UF were asked to identify which family
member(s) (mother, aunt, sister, grandmother) if any that also had a UF diagnosis.
Participants were allowed to select multiple relatives or choose the option “I don’t
know”, if they were unaware if one of the relatives listed had a UF diagnosis (see Table
4).
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Table 4
Environmental Characteristics of the Participants
a. Missed work as direct result of uterine fibroid symptoms
Missed
Frequency
Percent
work?
Yes

29

36.2

No

45

56.3

Don't know

4

5.0

Missing

2

2.5

Total

80

100.0

b. Immediate relative was diagnosed with uterine fibroidsa
Relative
Frequency
Percent
Responses for total sample
Any relative (yes)

55

68.7

Any relative (no)

14

17.5

Any relative (missing, DK)

11

13.8

Total

80

100.0

Responses for 55 women who indicated do they have a relative
who was diagnosed with uterine fibroidsb
Mother

40

50.0

Aunt

26

32.5

Table 4 Continues

100
Grandmother

12

15.0

Sister

15

18.7

None

25

31.3

a.
b.

Respondents could have had more than one relative who had fibroids
percent of total sample of 80 respondents

Symptom Severity and HRQOL Scale Descriptives
The purpose of the UFS-QOL is to obtain information related to UF symptom
severity and HRQOL along six subscales of categories from women who are diagnosed:
concern, activities, energy/mood, control, self-consciousness, and sexual function
(Harding et al., 2008; Spies et al., 2002). The 37- item survey instrument was used to
assess the severity of symptoms among African American women with UF and the
impact of UF symptoms on HRQOL. The UFS- QOL survey questionnaire is based on a
5- point Likert-type scale. The survey is divided into two sections: symptom severity and
HRQOL.
Symptom severity. The first set of questions of the survey is the symptom
severity section. The range for the average response was from 8 to 40 with a mean of
24.4 (SD 7.7, see Table 5). The midpoint total score was 24 for the symptom severity
scale descriptive. The mean midpoint total score for symptom severity in this study was
statistically significant and it fell to the right of the midpoint score. A midpoint total score
of 24. 4 for symptom severity suggested that, on average, the respondents felt somewhat
distressed by the severity of symptoms associated with their uterine fibroids.
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Table 5
Scores and Scale Descriptives for UFS-QOL Questionnaire
Scale

N

Symptomsa
Concernb
Self consciousnessb
Energy/moodb
Sexual functionb
Activitiesb
Controlb
HRQOL totalb

Minimum Maximum

Mean

Std. Dev

80

8.0

40.0

24.4

7.7

80

3.0

25.0

14.6

7.1

80

3.0

15.0

7.8

3.4

80

6.0

29.0

17.9

6.9

80

2.0

10.0

5.1

2.4

80

6.0

34.0

17.4

8.3

80

4.0

21.0

11.5

4.8

80

29.0

129.0

74.2

29.3

scale – 1=not at all, 2=a little bit, 3= somewhat, 4=a great deal, 5=a very great deal
scale - 1=none of the time, 2=a little of the time, 3=some of the time, 4=most of the
time, 5=all of the time
a

b

HRQOL. Section 2 of the survey evaluated the impact of factors associated with
HRQOL and consisted of 27 questions. This section included questions that were
categorized into one of six subsections: concern, activities, energy/mood, control, selfconscious, and sexual function. The combined raw scores from each subscale represented
the total score for HRQOL section and ranged from 29 to 145 (with scores closer to 145
reflecting greater negative impact on health related quality of life, see Table 5). The six
HRQOL scales have a different number of items and thus different possible scores. The
response for each subscale variable are highlighted in Table 5.
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Concern. There were 5 questions related to concern on the UFS-QOL survey
instrument. Topics addressed under this variable consisted of problems related to soiling
clothing and undergarments, soiling bed linens, unpredictability of onset of menses, and
the inconvenience of having to carry additional feminine hygiene products (Spies et al.,
2002). The calculated midpoint total score for the subscale variable concern was 15. In
this study the participants mean midpoint total score for concern was 14.6 (SD 7.1, see
Table 5). The total score for concern was statistically significant in this study based on
linear regression analysis; however, it did fall slightly to the left of the midpoint score.
Nevertheless, the summed score for concern in this study implied that, the respondents on
average did have concern some of the time regarding the severity of UF symptoms they
experienced.
Self-consciousness. There were 3 questions related to self-consciousness on the
UFS-QOL survey instrument. Topics addressed under this variable consisted of problems
related to weight gain, physical appearance, and clothing size (Spies et al., 2002). The
calculated midpoint total score for the subscale variable self-consciousness was 9. In this
study the participants mean midpoint total score for concern was 7.8(SD 3.4, see Table
5). Even though the total score for self-consciousness fell to the left of the midpoint score
it was statistically significant in this study based on linear regression analysis. These
study findings indicate that between a little to some of the time on average the
respondents felt self-conscious regarding the severity of UF symptoms they experienced.
Energy/mood. There were 7 questions related to energy/mood on the UFS-QOL
survey instrument. Matters addressed under this variable consisted of problems related to
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feelings of being tired, drowsy, sleepy, sad, hopeless or discouraged, irritable, and feeling
weak (drained, Spies et al., 2002). The calculated midpoint total score for the subscale
variable energy/mood was 21. In this study the participants mean midpoint total score for
energy/mood was 17.9 (SD 6.9, see Table 5). Even though the total score for
energy/mood fell to the left of the midpoint score, based on linear regression analysis it
was found to be statistically significant in this study. These study findings suggest
between a little to some of the time on average the respondents felt their energy/mood
was adversely impacted by the severity of UF symptoms they experienced.
Sexual function. The average response ranged from one to five with a mean
response of 2.5. There were 2 questions related to sexual function on the UFS-QOL
survey instrument. Topics addressed under this variable were avoidance of sexual activity
and diminished sexual desire (Spies et al., 2002). The calculated midpoint total score for
the subscale variable sexual function was 6. In this study the participants’ mean midpoint
total score for sexual function was 5.1 (SD 2.4, see Table 5). Even though the total score
for sexual function fell to the left of the midpoint score it was statistically significant in
this study based on linear regression analysis. These study findings indicate between a
little to some of the time the respondents on average felt their sexual function was
diminished and avoided sexual relations as a result of the severity of UF symptoms they
experienced.
Activities. There were7 questions related to activities on the UFS-QOL survey
instrument. Questions under this variable addressed a number of activities that related to
traveling, exercise, social activities, usual daily activities and the planning of those
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activities (Spies et al., 2002). The calculated midpoint total score for the subscale
variable activities was 21. In this study the participants mean midpoint total score for
energy/mood was 17.4 (SD 8.3, see Table 5). The subscale variable activities was found
to be statistically significant using linear regression analysis, even though it fell to the left
of the midpoint total score. In this study, the findings indicated that, between a little to
some of the time the respondents on average felt their ability to carry out activities such
as those listed previously was limited by the severity of UF symptoms they experienced.
Control. There were 5 questions related to control on the UFS-QOL survey
instrument. This variable addressed feelings related to the lack of control a person may
feel over their personal health, life, and how untimely symptoms could alter plans for
social engagements, travel or physical activity (Spies et al., 2002). The calculated
midpoint total score for the subscale variable control was 15. In this study the participants
mean midpoint total score for energy/mood was 11.5 (SD 4.8, see Table 5). Using linear
regression analysis Control was found to be statistically significant in this study with a
midpoint total score of 11.5. In this study, the findings indicated that, between a little to
some of the time the respondents on average felt their control to plan and predict their
activities and life events was limited by the severity of UF symptoms they experienced.
Total HRQOL. There were no questions related directly to the total HRQOL of
the participants on the UFS-QOL survey instrument. The total HRQOL score is a sum of
the 6 subscale scores. The calculated midpoint total HRQOL score was 87. In this study
the participants mean midpoint total HRQOL score was 74.2 (SD 29.3, see Table 5) and
it fell to the left of the midpoint score. The mean midpoint total HRQOL score of 74.2,
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though less than the calculated midpoint score was statistically significant in this study.
The total HRQOL summed scored in this study indicates that between a little to some of
the time the respondents felt their total HRQOL was adversely impacted by the severity
of UF symptoms they experienced.
Test of Statistical Assumptions
Prior to conducting regression analyses to address the research questions and test
the hypotheses, the assumptions for all of the research questions in this study were tested.
The assumptions of linear regression were tested to assess the relationship between the
dependent variables (DV) and the independent variable (IV) in research questions 1-6 and
13. The assumptions of hierarchical multiple regressions were tested to assess the
relationship between the DV and IVs in research questions 7-12. The four assumptions
for the regression analyses that were addressed were linearity, homoscedasticity,
independence of errors, and normality.
To test for normality of the scale scores, skewness was examined. According to
Leech (2005), if the skewness is between -1 and +1, the distribution is approximately
normal. In this study all the scale score had skewness between -1 and +1, indicating the
distributions are approximately normal (see Table 6). Therefore, recoding for entry into
the model was not required for the linear and multiple regressions analyses.
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Table 6
Skewness for Scale Scores on Health Related Quality of Life Questionnaire (HRQOL)

a

Scale

N

Skewnessa

Symptoms

80

-.041

Concern

80

.054

Self-consciousness

80

.061

Energy/mood

80

-.079

Sexual function

80

.341

Activities

80

.342

Control

80

.329

HRQOL total

80

.010

skewness between -1 and +1 indicates distribution is approximately normal.

Linear Regression Assumptions Research Questions 1-6 and 13
Linearity. The assumption of linearity was assessed by examining scatter plots.
The correlations of symptom severity (IV) and the HRQOL subscales (DV) are displayed
in Table 6. This method was used to identify if the association between symptoms
severity (IV) and the 6 HRQOL subscale variables (DVs) were statistically significant.
Statistical significance were identified when the p- value for the association between
variables was < 0.05. Bivariate correlations showed a strong positive correlation between
symptom severity and all 6 of the HRQOL subscale variables (see Table 7). All of the
correlations of the IV to the DVs are significant indicating that symptom severity has a
linear relationship with all of the HRQOL sub scale variables. Therefore the question of
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if there was an association between the IV and DV was supported in research questions
1-6.
Table 7
Correlations of HRQOL Scales with Symptom Severity

Scale

Severity

Concern

.576**

Activities

.581**

Energy mood
Control

.614**

Self-conscious
Sexual

.505**

.590**
.443**

**p < .01, n =80

For research question 13, the correlation of symptom severity (IV) and the overall
quality of life (DV) is displayed in Table 8 (r = .627). The correlation of the IV to the DV
is not significant indicating that the IV (symptom severity) does not have a linear
relationship or association with the DV (overall quality of life). Therefore the assumption
of an association between symptom severity and overall quality of life in research
question 13 was not supported.
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Table 8
Correlations of Overall Quality of Life with Symptom Severity
SymptomSeverity
Overall quality of life

.627**

**p < .01, n= 80

Homoscedasticity. The assumption of homoscedasticity (the errors have the same
variance) was tested by examining the plots of the standardized residuals against the
predicted values. The plots of the standardized residuals against the predicted values in
research questions 1- 6 were constructed (see Appendix F, Figures 1 - 6). If the plots are
approximately rectangle around the middle y = 0 line, the assumption of
homoscedasticity is supported. The plots in Appendix F, Figures 1-6 were approximately
rectangular around the middle y = 0. Therefore the assumption of homoscedasticity of
variance is supported in research questions 1-6.
Appendix I, Figure 13 displays the plot of the standardized residuals against the
predicted values for research question 13. If the plots are approximately rectangle around
the middle y = 0 line, the assumption of homoscedasticity is supported. The plot in
Appendix 1, Figure 13 was approximately rectangular around the middle y = 0. Therefore
the assumption of homoscedasticity of variance is supported in research question 13.
Independence of errors. The assumption of independence of error was assessed
with Durbin- Watson statistic. The Durban -Watson statistic was used to test for
independence in research questions 1-6. The acceptable range for the Durban-Watson
statistic is between 1.50 and 2.50 (Leech, Barrett, & Morgan, 2005). The Durban-Watson
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statistics for all of the hypotheses tests were within this range. Therefore the assumption
that the errors are independent was supported in research questions 1-6 (see Table 9).
Table 9
Summary of Assumptions Support for Research Question 1 - Research Question 6, &
Research Question 13
RQ

Relationa

Homoscedasticityb

Residuals Independentc

Residuals Normald

1

Yes

Yes

2.03

.98 (.201)

2

Yes

Yes

1.83

.98 (.247)

3

Yes

Yes

1.71

.94 (.001)

4

Yes

Yes

1.70

.97 (.031)

5

Yes

Yes

2.00

.99 (.895)

6

Yes

Yes

2.15

.99 (.937)

13

Yes

Yes

1.78

.93(.000)

a

refer to correlation matrix in Table 7 & 8; n= 80
refer to the scatterplots in Appendix F & I, Figures 1 – 6, 13
c
Durban-Watson statistic - an acceptable range is 1.50 - 2.50
d
Shapiro-Wilk statistic - .ss(.ppp) .ss = Shapiro-Wilk statistic, .ppp = probability, .ppp>
.05 supports the hypothesis
b

The Durban -Watson statistic was also used to test for independence in research
question 13. The acceptable range for the Durban-Watson statistic is between 1.50 and
2.50 (Leech, Barrett, & Morgan, 2005). The Durban-Watson statistic for RQ13 was
within this range (Durban-Watson = 1.78). Therefore the assumption that the errors are
independent was supported in research question 13 (see Table 9).
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Errors of normality. The assumption of normality was assessed by using the
Shapiro-Wilk test of studentized residuals for research questions 1-6. The Shapiro-Wilk
statistic was used to test for normality of the residuals. If the p is greater than .05 the
assumption that the distribution for the residuals is normal is supported. For four of the
six hypotheses p > .05 (RQ 1, 2, 5, 6) indicating the residual distributions were normal.
For these four tests the assumption of normality of the residuals was supported. For RQ 3
and RQ 4 p <.05 indicating the residual distributions were not normal. For these two tests
the assumption of normality of the residuals was not supported. When
… some procedures can provide very reliable results even
when an assumption is not fully met. In such cases a
condition may offer a rule of thumb that indicates whether
or not we can safely override the assumption and apply the
procedure anyway. (Bock, 2014, Distinguish Between
Assumptions and Conditions, ¶ 3).
If the histogram is approximately unimodal and symmetric the condition that the
distribution is nearly normal is supported (Bock, 2014). As the assumption of normality
is not supported by Shapiro-Wilk, an examination of the histograms for RQ 3 and RQ 4
was carried out to see if the histograms were approximately unimodal and symmetric (see
Figures 2 – 3). Both distributions are unimodal and approximately symmetric. Therefore
the condition of normality is supported in research questions 3-4.
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Figure 2. Histogram of RQ3 standardized residuals.

Figure 3. Histogram of RQ4 standardized residuals.

The Shapiro-Wilk statistic was also used to test for normality of the residuals in
research question 13. If the p is greater than .05 the assumption that the distribution for
the residuals is normal is supported. For RQ13 p < .05 indicating the residual
distributions was not supported. As the assumption of normality was not supported by
Shapiro-Wilk, an examination of the histogram for RQ 13 was carried out to see if the
histogram was approximately unimodal and symmetric (see Figure 4). The distributions
was unimodal and approximately symmetric. Therefore the condition of normality is
supported in research question 13.
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Figure 4. Histogram of RQ13 standardized residuals.

Multiple Regression Assumptions Research Questions 7-9
The assumptions for linear regression also apply to multiple regressions and were
tested as indicated previously. The assumptions of multiple regressions were tested to
assess the ability of the model to see if there was a relationship between symptom
severity, BMI, and HRQOL, along with three covariates (age, family history of uterine
fibroids, and employment) in research questions 7-9. The four assumptions of multiple
regressions that were addressed were linearity, homoscedasticity, independence of errors,
and normality.
Linearity. The assumption of linearity was assessed by examining scatter plots. The
relationship between the DV and IV is linear. The correlations of the HRQOL total score
(DV) with the IV (symptom severity, BMI) and covariates (age, relative, missed work)
are displayed in Table 10. This approach was also used to identify if the association
between symptoms severity, BMI, HRQOL total score and the three covariates were
statistically significant. Statistical significance was identified when the p- value for the
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association between variables was < 0.05. Bivariate correlations showed a positive
correlation between symptom severity, BMI, and employment history with the HRQOL
total score (see Table 10). All the correlations of the IVs to the DV are significant
indicating that the IVs (symptom severity and BMI) have a linear relationship with the
DV (HRQOL total score). Therefore, the assumption of an association between the IVs
and DV was supported. However, for the covariates only employment history had a
significant correlation with the HRQOL total score.
Table 10
Correlations of HRQOL Total Score with Symptom Severity, BMI, and Demographics
Variable
HRQOL Total
a

Severity of Symptoms

a

BMI

a

.627**
.218*

Age

.109

b

Employment History

b

Family History

.392**
-.056

* p < .05 **p < .01
a
n = 80, b n = 77

Homoscedasticity. The assumption of homoscedasticity (the errors have the same
variance) was tested by examining the plots of the standardized residuals against the
predicted values. The plots of the standardized residuals against the predicted values were
constructed (see Appendix G, Figures 7 - 9). If the plots are approximately rectangle
around the middle, y = 0 line, the assumption of homoscedasticity is supported. The plots
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in Appendix G, Figures 7-9 were approximately rectangular around the middle y = 0.
Therefore the assumption of homoscedasticity of variance is supported.
Independence of errors. The assumption of independence of error was assessed
using the Durbin- Watson statistic. The Durban -Watson statistic was used to test for
independence. The acceptable range for the Durban-Watson statistic is between 1.50 and
2.50 (Leech, Barrett, & Morgan, 2005). The Durban-Watson statistics for all of the
hypotheses tests were within this range. Therefore the assumption that the errors are
independent was supported (see Table 11).
Table 11
Summary of Assumptions Support for Research Question 7 - Research Question 9
RQ
Relationa
Homoscedasticityb Residuals Independentc Residuals Normald
7e

yes

Yes

1.76

.936 (.001)

8e

Yes

Yes

1.76

.934 (.000)

9f

Yes

Yes

1.81

.942 (002)

a

refer to correlations in Table 12,
refer to the scatterplots in Appendix G, Figures 7 - 9
c
Durban-Watson statistic - an acceptable range is 1.50 - 2.50
d
Shapiro-Wilk statistic - .sss(.ppp) .sss = Shapiro-Wilk statistic, .ppp = probability or pvalue, a p-value > .05 indicates the residuals are distributed normally
e
RQ 7-8 n = 80
f
RQ 9 n = 77
b

Errors of Normality. The assumption of normality was assessed by using the
Shapiro-Wilk test of studentized residuals. The Shapiro-Wilk statistic was used to test for
normality of the residuals. If the p is greater than .05 the assumption that the distribution
for the residuals is normal is supported. For all three hypotheses p < .05 indicating the
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residual distributions were not normal. For these tests the assumption of normality of the
residuals was not supported. If the histogram is approximately unimodal and symmetric
the condition that the distribution is nearly normal is supported (Bock, 2014). As the
assumption of normality was not supported by Shapiro-Wilk, an examination of the
histograms for the residuals was carried out to see if the histograms were approximately
unimodal and symmetric (see Figures 5 – 7). All three of the distributions are unimodal
and approximately symmetric. Therefore the condition of normality is supported in
research questions 7-9.

Figure 5. Histogram of RQ7 standardized residuals.
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Figure 6. Histogram of RQ8 standardized residuals.

Figure 7. Histogram of RQ9 standardized residuals.

Of most concern with multiple regressions is multicollinearity. This is not an
assumption as such, but is of concern when conducting multiple regression analyses.
High inter-correlation among the IVs can result in multicollinearity. Multicollinearity
results in unstable equation coefficients. Therefore, correlation matrix and tolerance were
used to examine for multicollinearity.
Correlation Matrix. The correlation matrix was constructed in order to examine
the correlations of the IVs to the DV and the inter-correlations among the IVs (see Table
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12). An outcome of high correlations between the DV and each IV and low intercorrelations among the IVs indicates that multicollinearity does not exist. The correlation
of the DV (total HRQOL score) and the IVs (symptom severity and BMI) were
significant. The correlation between the IVs (symptom severity and BMI) was not
significant. The inter-correlations among the IVs and the covariates were all insignificant
except between severity of symptoms and employment history, and between age and
family history. The correlations were small; therefore, the tolerance results were
examined as a test for multicollinearity.
Table 12
Intercorrelations of HRQOL Total Score and the IVs
Variable
1
2
3
1. HRQOL Totala
2. Severity Symptomsa
3. BMIa
4. Agea

.627**

4

5

6

.218*

.109

.392**

-.056

.144

.019

.283*

-.039

-.028

.128

.016

.061

-.251*

5. Employment Historyb

-.171

6. Family Historyb
* p < .05
a
n =80
b
n = 77

**p < .01

Tolerance. In Table 13, the calculations for the Tolerance are listed. A Tolerance
close to 0 indicates multicollinearity. The cut-off used was 0. If the Tolerance is more
than 0.1, multicollinearity among the IVs does not exist. For all three Regressions, the
tolerances for the IVs and the covariates were all greater than 0.8 indicating that
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multicollinearity does not exist among the IVs and the covariates. Because the tolerance
results were so high they were used as the test for the existence of multicollinearity.
Table 13
Tolerance to Test for Multicollinearity of the IVs for Research Questions 7 - 9
RQ
Severitya
BMIa
Ageb
Familyb
Workb
7c

.979

.979

8c

.979

.987

9d

.903

.969

.999
.968

.879

Note. A Tolerance greater than 0.1 indicates multicollinearity does not exist
a
Independent variable
b
Covariate
c
n= 80
d
n= 77
Multiple Regressions Assumptions Continued Research Questions 10-12
The assumptions for linear regression also apply to multiple regressions and were
tested as indicated previously. The assumptions of multiple regressions were tested to
assess the ability of the model to see if there is a relationship of symptom severity and
HRQOL total score with general health perception in research question 10. The
assumptions of multiple regressions were tested to assess the ability of the model to see if
there is a relationship of symptom severity and HRQOL total score with general health
perception, along with three covariates (age, family history of uterine fibroids, and
employment history of missed work due to uterine fibroids) in research questions 11-12.
The four assumptions of multiple regressions that were addressed were linearity,
homoscedasticity, independence of errors, and normality.
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Linearity. The assumption of linearity was assessed by examining scatter plots. The
correlations of the perception of general health (DV) with the IV (symptom severity,
HRQOL total score) and covariates (age, family history, & employment history) are
displayed in Table 14. This method was also used to identify if the association between
general health perception, symptoms severity, HRQOL total score and the three
covariates were statistically significant. Statistical significance were identified when the
p- value for the association between variables was < 0.05. Bivariate correlations showed
only the IV HRQOL total score was significantly correlated with the DV (perception of
general health) indicating HRQOL has a linear relationship with the DV (r = -.254, p =
.023). The negative correlation indicates that as the HRQOL score (higher score indicates
higher impact of uterine fibroids with the respondent’s health related quality of life)
increased, the rating for general health (higher rating indicates higher perception of
general health) decreased. Severity of symptoms was not significantly correlated with the
DV (perception of general health) indicating that the IV (symptom severity) does not
have a linear relationship with the DV (r = -.191, p = .090). Therefore the assumption of
an association between the IVs and DV was supported for HRQOL total score, but not for
symptom severity. None of the covariates had a significant correlation with the DV
(perception of general health).
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Table 14
Correlations of Perception of General Health with Symptom Severity,
HRQOL Total Score, and Demographics (n=80)
Variable
Severity Symptoms
HRQOL Total
Age

General Health
-.191
-.254*
.015

Employment History
Family History

-.090
-.061

* p < .05

Homoscedasticity. The assumption of homoscedasticity (the errors have the same
variance) was tested by examining the plots of the standardized residuals against the
predicted values. The plots of the standardized residuals against the predicted values were
constructed (see Appendix H, Figures 10 - 12). If the plots are approximately rectangle
around the middle y = 0 line, the assumption of homoscedasticity is supported. The plots
in Appendix H, Figures 10-12 were approximately rectangular around the middle y = 0.
Therefore the assumption of homoscedasticity of variance is supported.
Independence of errors. The assumption of independence of error was assessed
with Durbin- Watson statistic. The Durban -Watson statistic was used to test for
independence. The acceptable range for the Durban-Watson statistic is between 1.50 and
2.50 (Leech, Barrett, & Morgan, 2005). The Durban-Watson statistics for all of the
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hypotheses tests were within this range. Therefore the assumption that the errors are
independent was supported (see Table 15).
Table 15
Summary of Assumptions Support for Research Question 10 - Research Question 12
RQ
Relationa
Homoscedasticityb Residuals Independentc Residuals Normald
10

Mixed

Yes

1.85

.942 (.001)

11

Mixed

Yes

1.83

.944 (.002)

12

Mixed

Yes

1.88

.942 (002)

a

refer to correlations in Table 14
refer to the scatterplots in Appendix H, Figures 10 - 12
c
Durban-Watson statistic - an acceptable range is 1.50 - 2.50
d
Shapiro-Wilk statistic - .sss(.ppp) .sss = Shapiro-Wilk statistic, .ppp = probability or pvalue, a p-value > .05 indicates the residuals are distributed normally
b

Errors of Normality. The assumption of normality was assessed by using the
Shapiro-Wilk test of studentized residuals. The Shapiro-Wilk statistic was used to test for
normality of the residuals. If the p is greater than .05 the assumption that the distribution
for the residuals is normal is supported. For all three hypotheses p < .05 indicating the
residual distributions were not normal (see Table 15). For these tests the assumption of
normality of the residuals was not supported. If the histogram is approximately unimodal
and symmetric the condition that the distribution is nearly normal is supported (Bock,
2014). As the assumption of normality was not supported by Shapiro-Wilk, an
examination of the histograms for the residuals was carried out to see if the histograms
were approximately unimodal and symmetric (see Figures 8 – 10). All three of the
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distributions are unimodal and approximately symmetric. Therefore the condition of
normality is supported for research questions 10-12.

Figure 8. Histogram of RQ10 standardized residuals.

Figure 9. Histogram of RQ11 standardized residuals.
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Figure 10. Histogram of RQ12 standardized residuals.
Correlation Matrix. The correlation matrix was constructed in order to examine
the correlations of the IVs to the DV and the inter-correlations among the IVs (see Table
16). An outcome of high correlations between the DV and each IV and low intercorrelations among the IVs indicates that multicollinearity does not exist. The correlation
of the DV (perception of general health) and the IV (total HRQOL) was significant. The
correlation of the DV (perception of general health) and the IV (symptom severity) was
not significant. The correlations between the IVs (symptom severity and total HRQOL
score) were significant. There were significant inter-correlations among the IVs and
covariates (symptom severity and employment history, total HRQOL and employment
history, age and family history). The correlations were small; therefore, the tolerance
results were examined as a test for multicollinearity
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Table 16
Intercorrelations of Perception of General Health and the IVs
Variable
1
2
3
4

5

6

1. Perception of general
-.191

health
2. Severity Symptoms
3. Total HRQOL
4. Age
5. Employment History

-.254*

.015

-.090

-.061

.627**

.019

.283*

-.039

.109

.392**

-.056

.061

-.251*
-.171

6. Family History
* p < .05

Tolerance. In Table 17 the calculations for the Tolerance are listed research
questions 10-12. A Tolerance close to 0 indicates multicollinearity. The cut-off used was
0. If the Tolerance is more than 0.1, multicollinearity among the IVs does not exist. For
all three Regressions, the tolerances for the IVs and the covariates were all greater than
0.55 indicating that multicollinearity does not exist among the independent variables and
the covariates. Because the tolerance results were so high they were used as the test for
the existence of multicollinearity.
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Table 17
Tolerance to Test for Multicollinearity of the IVs for Research Questions 10 - 12
RQ
Severitya
HRQOL Totala
Ageb
Familyb
Workb
10c

.607

.607

11c

.598

.605

12d

.598

.553

.984
.970

.819

Note. A Tolerance greater than 0.1 indicates multicollinearity does not exist
a
Independent variable
b
Covariate
c
n = 80
d
n = 77

Test of Hypotheses and Results of Data Analyses
Linear Regression Analyses Research Questions 1-6
To test the first six hypotheses, linear regression analysis was used. In the linear
regression analysis symptom severity was used as IV and the six HRQOL subscale
variables (concern, activities, energy/mood, control, self- consciousness, sexual function),
as measured by the UFS-QOL were used as the DV (See Table 18). The objective of the
first six research questions was to examine the association between symptom severity and
the six HRQOL subscale variables (concern, activities, energy/mood, control, selfconsciousness, sexual function), as measured by the UFS-QOL.
Variables
The independent variable for all six regressions used in questions 1 – 6 was
symptom severity. The symptom severity score was obtained based on the total sum
response of questions 1-8 as measured by the UFS-QOL instrument. The dependent
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variables for questions 1- 6 were the individual summed scores for each of the 6 subscale
variables. Concern was the DV in question 1, control was the DV in question 2, activities
was the DV for question 3, energy/mood was the DV for question 4, sexual function was
the DV for question 5, and self-consciousness was the DV for question 6. The 6 subscale
variables were measured by the UFS-QOL instrument.
Table 18
Simple Linear Regression Results for HRQOL Scales Regressed on Symptom Severity
Scale
B
SE B
β
F
p
Adj aR2
Concern

.849

.137

.576

38.72

.000

.323

Activities

.721

.114

.581

39.78

.000

.329

Energy/mood

.645

.094

.614

47.19

.000

.369

Control

.596

.092

.590

41.71

.000

.340

Self-consciousness

.610

.118

.505

26.71

.000

.246

Sexual function

.563

.129

.443

19.03

.000

.186

a

Same size for all regressions n=80

Test of Hypotheses Research Questions 1-6
The specific goal of the first six research questions was to examine the association
between symptom severity and the six HRQOL subscale variables (concern, activities,
energy/mood, control, self- consciousness, sexual function), as measured by the UFSQOL.
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Research Question 1: What is the association between symptom severity, as measured by
the UFS-QOL instrument, and concern (a dimension of HRQOL) among African
American women age 30 to 45 years diagnosed with UF?
Results
The null hypothesis was not retained, F (1, 78) = 38.72, p < .001. There is a
significant association between concern and severity of symptoms. The coefficient (B =
.849) is positive, indicating that as the severity of symptoms increases, concern about the
adverse impact of their uterine fibroid symptoms on their life also increases. Adj. R2 =
.323 indicating that severity of symptoms accounts for 32.3% of the variability in concern
about soiling.
Research Question 2: What is the association between symptom severity, as measured by
the UFS-QOL instrument, and activities (a dimension of HRQOL) among African
American women age 30 to 45 years diagnosed with UF?
Results
The null hypothesis was not retained, F (1, 78) = 39.78, p < .001. There is a
significant association between activities and severity of symptoms. The coefficient (B =
.721) is positive, indicating that as the severity of symptoms increases, the negative
impact on their activities due to their uterine fibroid symptoms also increases. Thereby
suggesting that participants in this study are likely to decrease their activities as their
severity of symptoms increases. Adj. R2 = .329 indicating that severity of symptoms
accounts for 32.9% of the variability in the impact on activities.
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Research Question 3: What is the association between symptom severity, as measured by
the UFS-QOL instrument, and energy/mood (a dimension of HRQOL) among African
American women age 30 to 45 years diagnosed with UF?
Results
The null hypothesis was not retained, F (1, 78) = 47.19, p < .001. There is a
significant association between energy/mood and severity of symptoms. The coefficient
(B = .645) is positive, indicating that as the severity of symptoms increases, the negative
impact on the respondent’s energy/mood also increases. Adj. R2 = .369 indicating that
severity of symptoms accounts for 36.9% of the variability in impact on the respondent’s
energy/mood.
Research Question 4: What is the association between symptom severity, as measured by
the UFS-QOL instrument, and control (a dimension of HRQOL) among African
American women age 30 to 45 years diagnosed with UF?
Results
The null hypothesis was not retained, F (1, 78) = 41.71, p < .001. There is a
significant association between control and severity of symptoms. The coefficient (B =
.596) is positive, indicating that as the severity of symptoms increases, the negative
impact on the respondent’s feeling of control of their life also increases. Adj. R2 = .340
indicating that severity of symptoms accounts for 34.0% of the variability in the impact
on their control of their life.
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Research Question 5: What is the association between symptom severity, as measured by
the UFS-QOL instrument, and self-consciousness (a dimension of HRQOL) among
African American women age 30 to 45 years diagnosed with UF?
Results
The null hypothesis was not retained, F (1, 78) = 26.71, p < .001. There is a
significant association between self-consciousness and severity of symptoms. The
coefficient (B = .610) is positive, indicating that as the severity of symptoms increases,
their negative feelings of self-conscious relating to their uterine fibroid symptoms also
increases. R2 = .246 indicating that severity of symptoms accounts for 24.6% of the
variability in their feeling of self-conscious relating to their uterine fibroid symptoms.
Research Question 6: What is the association between symptom severity, as measured by
the UFS-QOL instrument, and sexual function (a dimension of HRQOL) among African
American women age 30 to 45 years diagnosed with UF?
Results
The null hypothesis was not retained, F (1, 78) = 19.03, p < .001. There is a
significant association between sexual function and severity of symptoms. The
coefficient (B = .563) is positive, indicating that as the severity of symptoms increases,
the negative impact on their sexual function due to their uterine fibroid symptoms also
increases. R2 = .186 indicating that severity of symptoms accounts for 18.6% of the
variability in the impact on their sexual function due to their uterine fibroid symptoms.
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Hierarchical Multiple Regression Analyses Research Questions 7-9
The objective of the second set of research questions (7-9) was to examine the
association between the total HRQOL summed score as measured by the UFS-QOL with
symptom severity and BMI when controlling for age, employment, and family history.
Hierarchical multiple regression analysis was used on questions 8 and 9 to determine if
there is a relationship between symptom severity, BMI, and HRQOL, when controlling
for three covariates (age, family history of uterine fibroids, and employment) (See Table
18). The dependent variable was the total HRQOL summed score for all three research
questions. The independent and control variables were added to the model in steps. In
order to determine what the control variables, then symptom severity, and lastly BMI
each contributed to the model, they were added in the following three steps:
1) In step one, the covariate, characteristics of the individual (RQ 8 - age), and
characteristics of the environment (RQ9 - family history of UF diagnosis, and
employment history of missed work due to uterine fibroids) were added to the
model and the change in R2 was examined.
2) In step two, the variable symptom severity was added to the model and the change
in R2 was examined to determine whether or not symptom severity significantly
increased R2.
3) In step three, the variable BMI was added to the model and the change in R2 was
examined to determine whether or not BMI significantly increased R2.
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Variables
Dependent = Total HRQOL summed score as measured by the UFS- QOL instrument.
Independent (all three hierarchical regressions) = Symptom Severity and BMI
The three covariates were:
1) Age (characteristics of the individual). This co variant was used in RQ8.
2) Family History of uterine fibroid diagnosis (this co variant was used in RQ9). For
regression analysis, family history was coded as 1 = yes and 0 = no, missing or
don’t know.
3) Employment (this co variant was used in RQ9). For regression analysis,
employment history was coded as 1 = yes and 0 = no, did not miss work.
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Table 19
Hierarchical Regression Results for HRQOL Scales Regressed on Demographics,
Symptom Severity, and BMI
Scale
B
SE B
β
F
R2

ΔR2

a. Research Question #7 (n=80)
Step 1 Symptom
Severity
Step 2 Symptom
Severity
BMI

.664**

.093

.627

50.47**

.393

.644**

.094

.608

26.71**

.410

.019

.013

.131

.017

b. Research Question #8 (n=80)
Step 1 – Age

.029

.030

.109

.93

.012

Step 2 – Age

.026

.023

.097

25.91**

.402

.390*
*

.662**

.092

.625

.027

.023

.101

18.33**

.420

.018

.642**

.094

.606

.019

.013

.134

6.76**

.154

19.68**

.447

Symptom Severity
Step 3 - Age
Symptom Severity
BMI

c. Research Question #9 (n=77)
Step 1 – Employ.
history
Family history

.835**

.229

.396

.045

.239

.020

Step 2 – Employ.
history
Family history

.483**

.195

.229

.031

.195

.014

.599**

.096

.566

Symptom Severity

.293*
*

Table 19 Continues
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Step 3 – Employ.
history
Family history
Symptom Severity
BMI

.460*

.195

.218

.020

.195

.009

.587**

.097

.557

.015

.013

.101

15.15***

.457

.010

* p < .05 ** p < .01

Test of Hypotheses Research Questions 7-9
The specific goal of question 7 was to examine the associations between symptom
severity, body mass index (BMI), and overall HRQOL. The specific goals of research
questions 8 and 9 were to examine the associations between symptom severity, body
mass index (BMI), and overall HRQOL, controlling for the three co-variables (age,
family hx of UF, and employment).
Research Question 7: What is the association between symptom severity as measured by
the UFS-QOL instrument, BMI, and HRQOL total score as measured by the UFS-QOL
instrument among African American women ages 30 to 45 years diagnosed with UF?
Variables
Dependent = total summed HRQOL score
Independent = Symptom Severity and BMI
Results
In step 1 with the IV symptom severity being added, the model was significant, F
(1, 78) = 50.47, p < .001. R2 = .393. Specifically, symptom severity does contribute to the
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prediction of total HRQOL summed score. In step 2 with the addition of BMI the model
remained significant F (2, 77) = 26.71, p < .001. R2 = .410 with the change in R2 =.017 (p
= .144) which was not significant. The non-significant change in R2 indicates that the
addition of BMI does not increase explanation of the variability in total HRQOL. BMI
does not contribute to the prediction of total HRQOL. The coefficient for symptom
severity (B = .644) was significant and positive, indicating that as the severity of
symptoms increases, the negative impact on total HRQOL also increases.
Research Question 8: When controlling for characteristics of the individual (age) what is
the association between symptom severity as measured by the UFS-QOL instrument,
BMI, and HRQOL total score as measured by the UFS-QOL instrument among African
American women age 30 to 45 years diagnosed with UF?
Variables
Dependent = Total HRQOL summed score
Independent = Symptom Severity and BMI
Co-variable
Characteristics of the Individual or age (the only co variable in this category).
Results
In step 1 with the addition of age, the model was not significant, F (1, 78) = .93, p
= .337. Age does not contribute to the prediction of total HRQOL summed score. In step
2 with addition of symptom severity, the model was significant, F (2, 77) = 25.91, p <
.001. R2 = .402 with the change in R2 = .390, p < .001. The significant change in R2
indicates that the addition of symptom severity significantly increases the explanation of
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the amount of variability in total HRQOL. In step 3 with the addition for BMI, the model
was still significant F (3, 76) = 18.33, p < .001. R2 = .420 with the change in R2 =.018 (p
= .134) which was not significant. The non-significant change in R2 indicates that the
addition of BMI does not increase explanation of the variability in total HRQOL. Neither
age nor BMI were found to have a significant association with total HRQOL summed
score. Only symptom severity significantly added to the model. The coefficient for
symptom severity (B = .642) was significant. It is positive, indicating that as the severity
of symptoms increases, the negative impact on total HRQOL increases (indicated by
higher total HRQOL summed score).
Research Question 9: When controlling for characteristics of the environment (family
history of UF diagnosis and employment history of missed work due to uterine fibroids)
what is the association between symptom severity as measured by the UFS- QOL
instrument, BMI, and HRQOL total score as measured by the UFS-QOL instrument
among African American women age 30 to 45 years diagnosed with UF?
Variables
Dependent = Total HRQOL summed score.
Independent = Symptom Severity and BMI
Co- variables
Characteristics of the Environment
Family history of UF diagnosis. For regression analysis, family history was coded
as 1 = yes and 0 = no, missing or don’t know. Two of the participants did not respond to
this question.
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Employment history of missed work due to uterine fibroids. For regression
analysis, employment history was coded as 1 = yes and 0 = no, did not miss work. One of
the participants did not respond. Because a total of 3 participants did not respond to these
questions, the sample size for this regression was n=77 instead of n=80.
Results
In step 1 with the addition of employment and family history, the model was
significant, F (2, 74) = 6.76, p = .002. It is important to note that while the overall model
was significant when the control variables were added, the coefficient for family history
(B = .045, p = .852) was not significant. Family history did not contribute to the
prediction of total HRQOL score. However, the coefficient for employment (B = .835, p
< .001) was significant indicating that employment history was related to total HRQOL
summed score. Employment history was coded 1 = yes – missed work, and 0 = no – did
not miss work. For employment “yes” indicates the participant has missed work because
of uterine fibroid symptoms. The positive coefficient indicates that as employment
history or days missed from work increases (moves from 0 to 1) the total HRQOL
summed score also increases. The positive relationship between the total HRQOL
summed score and employment indicates that the participants who missed work due to
uterine fibroid symptoms experienced an increased negative impact on their total
HRQOL (indicated by a higher total HRQOL summed scores). In step 2 with the addition
of symptom severity the model was significant, F (3, 73) = 19.68, p < .001. R2 = .447
with the change in R2 = .293, p < .001. The significant change in R2 indicates that the
addition of symptom severity significantly increases the explanation amount of variability
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in total HRQOL. In step 3 with addition for BMI, the model was still significant F (4, 72)
= 15.15, p < .001. R2 = .457 with the change in R2 =.010 (p = .254) which was not
significant. The non-significant change in R2 indicates that the addition of BMI does not
increase explanation of the variability in total HRQOL summed score. Only employment
history and symptom severity significantly contributed to total HRQOL. The coefficient
for symptom severity (B = .587) was significant. The association is positive, indicating
that as the severity of symptoms increases, the negative impact on total HRQOL also
increases (indicated by a higher total HRQOL summed score).
Hierarchical Regression Analyses continued: Research questions 10-12
The objective of the third set of research questions (10-12) was to examine the
association between general health perception with symptom severity and total HRQOL
score as measured by the UFQOL when controlling for demographics (age, family
history, employment history) (see Table 20). Hierarchical multiple regression analysis
was also used in research questions 11-12, to determine if there was a relationship of
symptom severity and HRQOL total score with general health perception, controlling for
three covariates (age, family history of uterine fibroids, and employment history of
missed work due to uterine fibroids). The dependent variable was general health
perception for all three research questions. In order to determine what the control
variables, then symptom severity, and lastly total HRQOL contributed to the model, the
variables were added to the model in the following three steps:

138
1) In step one, for RQ11 only the control variable age, and for RQ12 only the
two control variables family history and employment history were added to
the model and the change in R2 was examined.
2) In step two the variable symptom severity was added to the model and the
change in R2 was examined to determine whether or not symptom severity
significantly increased R2.
3) In step three the variable total HRQOL summed score was added to the model
and the change in R2 was examined to determine whether or not HRQOL
significantly increased R2.
Variables
Dependent variable = General health perception
Independent variables (all three hierarchical regressions) = Symptom severity and Total
HRQOL summed score.
The three covariates were:
1) Age (this co variant was used in RQ11).
2) Family History of uterine fibroid diagnosis (co variant was used in RQ12). For
regression analysis, family history was coded as 1 = yes and 0 = no, missing or don’t
know.
3) Employment (this co variant was used in RQ12). For regression analysis,
employment history was coded as 1 = yes and 0 = no, did not miss work.
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Table 20
Hierarchical Regression Results for Perception of General Health Regressed on
Demographics, Symptom Severity, and Total HRQOL Score
B
SE B
β
F
R2
Scale

ΔR2

a. Research Question #10 (n=80)
Step 1 Symptom Severity

-.311

.181

-.191

2.94

.036

Step 2 Symptom Severity

-.085

.231

-.052

2.72

.066

Total HRQOL Score

-.341

.218

-.221

.030

b. Research Question #11 (n=80)
Step 1 – Age

.006

.046

.015

.018

.000

Step 2 – Age

.008

.045

.019

1.47

.037

.037

-.312

.183

-.191

.017

.045

.041

1.84

.068

.031

Symptom Severity

-.079

.232

-.049

Total HRQOL Score

-.351

.221

-.228

.558

.015

1.06

.042

Symptom Severity
Step 3 - Age

c. Research Question #12 (n=77)
Step 1 – Employ. HistoryFamily history
Step 2 – Employ. History
Family history

-353

.381

-.108

-.263

.398

-.077

-.188

.395

-.058

-.256

.396

-.075

Table 20 Continues
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Symptom Severity

-.280

.196

-.172

-.015

.408

-.004

Family history

-.245

.392

-.072

Symptom Severity

-.065

.240

-.040

Total HRQOL Score

-.359

.236

-.233

Step 3 – Employ. History

1.39

.072

.030

Test of Hypotheses Research Questions 10-12
The specific goal of question 10 was to examine the association between
symptoms severity, HRQOL total score, and general health perception. The specific goals
for research questions 11 and 12 was to examine the association between symptom
severity, total HRQOL summed score, and general health perception, controlling for the
three co variables (age, family history of uterine fibroids, and employment history).
Research Question 10: What is the association between symptom severity as measured by
the UFS-QOL instrument, HRQOL total score as measured by the UFS-QOL instrument
and general health perception among African American women age 30 to 45 years
diagnosed with UF?
Variables
Dependent = General health perception
Independent = Symptom severity and Total HRQOL summed score
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Results
In step 1 with the addition of the IV symptom severity, the model was not
significant, F (1, 78) = 2.94, p = .090. R2 = .036. Specifically symptom severity did not
contribute to the prediction of general health perception. In step 2 with the addition of
total HRQOL summed score, the model remained insignificant F (2, 77) = 2.72, p = .072.
R2 = .066 with the change in R2 =.030 (p = .122) which was not significant. The nonsignificant change in R2 indicates that the addition of total HRQOL summed score does
not increase explanation of the variability in general perception of health.
Research Question 11: When controlling for characteristics of the individual (age) does
symptom severity as measured by the UFS-QOL instrument, and HRQOL total score as
measured by the UFS-QOL instrument have an association with general health perception
among African American women age 30 to 45 years diagnosed with UF?
Variables
Dependent = General health perception
Independent = Symptom severity and Total HRQOL summed score
Co-variable
Characteristics of the Individual or age (the only co variable in this category).
Results
In step 1 with the addition of age, the model was not significant, F (1, 78) = .02, p
= .892. The non-significant change indicates that age does not contribute to the prediction
of general health perception. In step 2 with the addition of symptom severity the model
was significant, F (2, 77) = 1.47, p = .237. R2 = .037 with the change in R2 = .037, p =
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.092. The insignificant change in R2 indicates that the addition of symptom severity does
not significantly increase the explanation of the amount of variability in general health
perception. In step 3 with the addition of total HRQOL summed score, the model was
insignificant F (3, 76) = 1.84, p = .147. R2 = .068 with the change in R2 =.031 (p = .116)
which was not significant. The non-significant change in R2 indicates that the addition of
total HRQOL summed score does not increase explanation of the variability in general
health perception.
Research Question 12: When controlling for characteristics of the environment (family
history of UF diagnosis and employment history) does symptom severity as measured by
the UFS-QOL instrument, and HRQOL total score as measured by the UFS-QOL
instrument have an association with general health perception among African American
women age 30 to 45 years diagnosed with UF?
Variables
Dependent = General health perception
Independent = Symptom severity and Total HRQOL summed score
Co-variants-Characteristics of the Environment
Family history of UF diagnosis. For regression analysis, family history was coded
as 1 = yes and 0 = no, missing or don’t know. Two of the participants did not respond to
this question.
Employment history of missed work due to uterine fibroids. For regression
analysis, employment history was coded as 1 = yes and 0 = no, did not miss work. One of
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the participants did not respond. Because a total of 3 participants did not respond to these
questions, the sample size for this regression was n=77 instead of n=80.
Results
In step 1 with the addition of employment and family history, the model was not
significant, F (2, 74) = .56, p = .575. Specifically employment nor family history were
found to be a predictor of general health perception. In step 2 with the addition of
symptom severity, the model was significant, F (3, 73) = 1.06, p = .371. R2 = .042 with
the change in R2 = .027, p = .156. The insignificant change in R2 indicates that the
addition of symptom severity does not significantly increase the explanation of the
variability in general perception of health. In step 3 with addition of total HRQOL, the
model was remained significant F (4, 72) = 1.39, p = .246. R2 = .072 with the change in
R2 =.030 (p = .132) which was not significant. The non-significant change in R2 indicates
that the addition of total HRQOL summed score does not increase explanation of the
variability in general health perception.
Linear Regression Analyses Research Question 13
To test the last hypotheses/research question 13, linear regression analysis was
used. In the linear regression symptom severity) was used as IV and Overall quality of
life was the DV (see Table 21).
Table 21
Linear Regression Results for Overall quality of Life Regressed on Symptom Severity
Scale
B
SE B
β
F
p
Adj aR2
Symptom severity
a

-.040

Adjusted for sample size, n = 80

.190

-.024

.05

.833

.012
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Test of Hypotheses Research Question 13
The specific goal of RQ13 was to examine the association between symptom
severity and overall quality of life.
Research Question 13: What is the association between symptom severity as measured by
the UFS-QOL instrument and overall quality of life among African American women age
30 to 45 years diagnosed with UF?
Variables
Dependent: Symptom severity
Independent: Overall quality of life
Results
The null hypothesis was retained, F (1, 78) = .05, p = .833. There is no significant
association between overall quality of life and severity of symptoms.
Summary
The purpose of this study was to explore the severity of symptoms associated with
UF and the impact of UF symptoms on HRQOL of African American women ages 30 to
45 diagnosed with UF. A total of thirteen (13) research questions were developed and
used in order to explore the severity of UF symptoms and the impact of UF symptoms on
HRQOL using linear and multiple regression analyses. In this study, the following factors
were investigated: BMI, symptom severity, functional status (concern, activities,
energy/mood, control, self- consciousness, sexual function), overall quality of life,
general health perception, characteristics of the individual (age), and characteristics of the

145
environment (family hx of UF diagnosis and employment) among African American
women age 30 to 45 years with a diagnosis of UF.
The overall goal for research questions 1 – 6 was to determine the association
between symptom severity and the six HRQOL subscale variables (concern, activities,
energy/mood, control, self- consciousness, sexual function) as measured by the UFSQOL. The linear regressions for all the subscale scores indicated there is a significant
association with the severity of symptoms and respondent’s health related quality of life
along the six subscale variables. Bivariate correlations showed a strong positive
correlation between symptom severity and all 6 of the HRQOL subscale variables (see
Table 7). All of the correlations of the IV to the DVs are significant indicating that
symptom severity has a linear relationship with all of the HRQOL sub scale variables.
Therefore, the null hypotheses related to research questions 1-6 were rejected.
The overall goal for research question 7 was to examine the association between
the total HRQOL score as measured by the UFS-QOL with symptom severity and BMI
using multiple hierarchical regression analysis. The overall goal for research questions 8
and 9 was to examine the association between the total HRQOL score as measured by the
UFS-QOL with symptom severity and BMI, when controlling for demographics (age,
family history, employment history) using multiple hierarchical regressions analyses. The
three hierarchical regressions indicated there is a significant association with the severity
of symptoms and employment (missed work due to uterine fibroid symptom). BMI and
age did not significantly contribute to the models. R2 for the final three models ranged
from 41.0% to 45.7%. These relatively high R2 indicate that the severity of symptoms and
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employment have a strong impact on the respondents’ health related quality of life.
Therefore, the null hypotheses related to research questions 7-9 were rejected.
The overall goal for research question 10 was to examine the association between
the general perception of health score with symptom severity and HRQOL total score
using multiple hierarchical regression analysis. The overall goal for research questions 11
and 12 was to examine the association between the general perception of health score
with symptom severity and HRQOL total score, when controlling for demographics (age,
family history, employment history) using multiple hierarchical regressions analyses. The
three hierarchical regressions indicated there was no significant association of general
health perception with the composite of the variables severity of symptoms, HRQOL
total score, and employment history (missed work due to uterine fibroid symptom), and
family history (relative diagnosed as having uterine fibroids. Specifically employment,
nor family history were found to be a predictor of general health perception in questions
11 and 12. In questions 11 with the addition of symptom severity, the model was
significant, F (3, 73) = 1.06, p = .371. R2 = .042 with the change in R2 = .027, p = .156.
The insignificant change in R2 indicates that the addition of symptom severity does not
significantly increase the explanation of the variability in general perception of health. In
question 12 with the addition of total HRQOL, the model was remained significant F (4,
72) = 1.39, p = .246. R2 = .072 with the change in R2 =.030 (p = .132) which was not
significant. There was, however, a significant correlation between general perception of
health and total HRQOL summed score. The correlation was negative, indicating the
respondents felt a greater negative impact on their health related quality of life, as the
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rating of their general health perception decreased. Therefore, the null hypotheses related
to research questions 10-12 were accepted.
The overall goal for research question 13 was to examine the association between
symptom severity and overall quality of life using linear regression analysis. The linear
regressions demonstrated there was not a significant association between the severity of
symptoms and overall quality of life (F (1, 78) = .05, p = .833). Therefore, the null
hypothesis related to research question 13 could not be rejected. In Chapter 5,
interpretation of the findings in the context of the current literature and the overall
summary are provided.
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Chapter 5: Discussion, Conclusion, and Recommendations
This study of health related quality of life (HRQOL) was designed to explore the
relationship between UF symptom severity and the impact of UF symptoms on HRQOL
among 30 to 45 years old African American women diagnosed with UF. This chapter
details the results of the data collected and the interpretations. A description of the
implications of the study results with regard to social change and future research
concludes the chapter.
Overview
The impact of UF symptoms on the HRQOL of women suggests this chronic
condition can lead to a number of challenging social, physical, and emotional health
concerns. Research findings corroborate that a disproportionate number of African
American women are diagnosed with and treated for UF (Davis et al., 2009; ORWH,
2006; NIH, 2011; Wise et al., 2005b). More importantly, there is a disparity in the age at
which African American women are diagnosed, and the symptoms that are experienced
by African American women when compared to their counterparts from other racial
backgrounds (Hartman et al., 2006; NIH, 2011; Wise et al., 2005a; 2005b). There are a
lack of empirical studies exploring the severity of UF symptoms and the impact of UF
symptoms on the HRQOL of African American women age 30 to 45 years.
The purpose of this study was to obtain empirical evidence from an existing
population of African American women ages 30 to 45 years diagnosed with UF regarding
the symptoms associated with UF and the impact of UF symptoms on their HRQOL.
Using an exploratory, non- experimental research design, this study attempted to answer
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thirteen questions regarding the relationship between UF symptom severity and the
impact of UF symptoms on HRQOL among African American women ages 30 to 45
years diagnosed with UF. This approach was suitable for this study because none of the
independent variables (symptom severity, HRQOL, BMI, age, employment, and family
history of UF diagnosis) were able to be logistically or ethically manipulated. The revised
Wilson and Cleary model of HRQOL was used as the foundation for this study to
investigate the following factors: BMI, symptom severity, functional status, overall
quality of life, general health perception, characteristics of the individual, and
characteristics of the environment among African American women age 30 to 45 years
with a diagnosis of UF. The Uterine Fibroid Symptom and Health Related Quality of Life
(UFS-QOL) designed by Spies et al. (2002) was used for this study. The survey is
divided into two sections, with the first eight questions focusing on symptom severity and
the remaining twenty seven questions evaluating the impact of factors associated with
HRQOL.
Linear regression analyses were conducted to test hypotheses 1-6 and 13.
Hierarchical multiple regressions analyses were conducted to test hypotheses 7-12.
Assumptions of normality were applied. However, findings could not be generalized due
to sampling limitations and a smaller than estimated sample size. Given the results of the
analyses, 9 of the 13 null hypotheses were rejected. Following is an interpretation of
findings within the context of this study project.
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Interpretation of Findings
Uterine fibroid research has demonstrated that African American women are at a
greater risk for diagnosis of UF when compared to their Caucasian and Asian
counterparts. UF tumors cause an array of burdensome health problems which can
negatively impact HRQOL. Multiple researchers have identified a number of symptoms
and stressors among African American women with UF (Cabness, 2010; Lerner et al.,
2008; Popovic et al., 2009). Some of these symptoms and stressors include but are not
limited to increased fatigue, depressive symptoms, difficulty concentrating, negative
impact on sexual life, and decreased performance at work (Cabness, 2010; Lerner et al.,
2008; Popovic et al., 2009; Zimmerman et al., 2012). Researchers have found that more
women with UF are actively seeking out information related to management of UF
symptoms, less invasive surgical treatment options, and ways to preserve their fertility
status in order to minimize the impact of UF on their lives (Khan, Shehmar, & Gupta,
2014). The physical and emotional burdens found to be associated with the presence of
symptomatic UF among African American women ages 30 to 45 years can lead to
undesirable effects on HRQOL.
Theoretical Framework Variables
This study sought to determine if there was a relationship between specific
factors that influence HRQOL among women who have been diagnosed with UF. It also
sought to offer a personalized perspective on how the lives of African American women
ages 30 to 45 years are being impacted by UF symptoms. In the next section,
interpretations of the study’s findings within the conceptual framework that was used to

151
investigate the following factors: symptoms, functional status, BMI, general health
perception, characteristics of the individual (age), characteristics of the environment
(family hx of UF and employment) and overall quality of life among African American
women age 30 to 45 years with a diagnosis of UF (see Table 1) are addressed. This
framework was the basis for exploring seven distinct UF condition categories: symptom
severity, concern, activities, energy/mood, control, self-conscious, and sexual function,
based on the UFS-QOL instrument (see Table 1).
Symptoms. The focus of these 8 questions was to determine how distressed the
respondents were by the physical symptoms (e.g. heavy bleeding, fatigue, passing blood
clots, frequent urination, changes in duration and length of monthly cycle) associated
with UF. This measure was then used to help establish a basis for determining if
symptom severity had an association with the respondents’ functional status as measured
by the six (6) HRQOL subscale variables in the first six research questions. When
assessing the association of functional status, total HRQOL and employment history
(missed time from work), there was a positive association with symptom severity.
Research has found that symptoms such as pain and multiple bleeding episodes were
found to have a negative impact on women’s life (Zimmerman et al., 2012). Researchers
Brito et al. (2014) also found in their study that symptomatic UF or the symptoms
associated with UF (e.g. bleeding and pelvic pain) had a negative impact on the HRQOL
for women in their study. The significance of symptom severity and its impact on total
HRQOL in this study supports current research findings. While the results of these 8
questions alone was not specifically investigated for this project it was important to
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measure how the participants rated their personal experience with the symptoms
associated with UF and if they believed those symptoms to be impactful to their lives.
Functional Status. Functional status was measured using the six HRQOL
subscale variables (concern, activities, energy/mood, control, self- consciousness, sexual
function) as measured by the UFS-QOL. The linear regressions for all the subscale scores
indicated there is a significant association with the severity of symptoms and
respondent’s health related quality of life. Functional status was determined based the
study participants mean score response to questions in each category of the six HRQOL
subscale variables.
In each of the six questions the independent variable, symptom severity remained
the same; however, the dependent variable was different in each question. In Hypothesis
1, the association between symptom severity and concern was examined. In Hypothesis
2, the association between symptom severity and activities was examined. In Hypothesis
3, the association between symptom severity and energy/mood was examined. In
Hypothesis 4, the association between symptom severity and control was examined. In
Hypothesis 5, the association between symptom severity and self-consciousness was
examined. In Hypothesis 6, the association between symptom severity and sexual
function was examined. The null hypotheses for all six questions in this section were
rejected.
These study findings suggest that an association does exist among symptom
severity and all of the health related quality of life subscale variables. However, the
subscale variable Concern was identified as having an increased level of association with
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symptom severity when compared to the other subscale variables in this study. The
concern subscale variable had a total of five questions. These five questions were
designed to address the participants’ feelings or level of concern about issues related to
the symptoms associated with UF. Topics such as anxiety due to unpredictability of onset
or duration of monthly cycles, concern for soiling clothing and bed linens, and being
inconvenienced about having to carry extra feminine products to avoid accidents were
addressed (Spies et al., 2002). Brito et al. (2014) found participants in their study
expressed feelings of concern more specifically “…huge sensations of fear” (p. 3) related
to the unpredictability of symptoms associated with UF. Researcher Cabness (2010) also
found that feelings of increased anxiety related to insecurity and shame of breakthrough
bleeding prevented African American women with UF from attending social events. This
study findings suggest that respondents increased level of concern appear to be consistent
with current research findings related to UF symptom severity.
The subscale HRQOL variables, Self-conscious and Energy/mood both fell
slightly left of the midpoint score for their respective categories. The three questions for
self-conscious were designed to address how participants felt about some of the changes
in their physical appearance or the impact of bulk symptoms on their HRQOL. Topics
such as increase in abdominal girth or bloating, weight gain and having to wear larger
size clothing were the common focus of the questions related to self- conscious (Spies et
al., 2002). Research indicates that women diagnosed with UF are not only impacted by
their experience with the physical symptoms associated with UF, but they also expressed
among other problems, concerns related to body image, problems with sexual function,
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and relationships (Borah et al., 2013). The seven questions related to energy and mood
addressed the emotional and physical barriers that women with UF often encounter. For
example at least two of the three questions related to self- conscious inquired about
bodily or physical changes that occur (e.g. weight gain, size and appearance of stomach).
The difference between the two variables in this study though slight may reflect more on
the participants’ state of mind and the impact of UF symptoms on their outward
appearance. More importantly it suggests there is a possible dissatisfaction participants
may feel related to those negative physical changes that occur in their outward
appearance.
Spies et al. (2002) found that women with UF who were unhappy about the
physical appearance were also impacted in their sexual lives. However, researchers
Ertunc, Uzan, Tok, Doruk, & Dilek (2009) study findings suggest that the pain and
bleeding symptoms associated with UF may have more of a negative impact on the
sexual life of women in their study. Participants in this study did indicate they felt an
impact on their sexual function due to their uterine fibroid symptoms a little of the time to
some of the time. This study findings appear to correlate with researchers Voogt et al.
(2009) who found that premenopausal women with symptomatic UF expressed increased
problems with sexual functioning (i.e. lubrication, orgasm and pain during intercourse)
prior to having the UAE procedure for treatment of UF. Zimmerman et al. (2012) also
found that 42.9% of the women in their study with UF expressed problems with sexual
intercourse and that their sexual life was negatively affected. The researchers concluded
that UF did have a negative influence on the participants’ sexual life among other areas.
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The findings of this study show that sexual life is somewhat impacted in a negative way
by UF symptoms; however, this remains an area that requires further research.
The two subscale variables activities and control appear to also have a statistically
significant association with symptom severity. The control subscale variable seeks to
examine how participants feel about their ability to control their health, life, and future
(Spies et al., 2002). In particular it addresses how the effects of UF symptoms “…could
immediately alter all plans for travel, social engagements, or physical activities.” (Spies
et al., 2002, p 295). The researchers found that control was reported as one of the most
areas affected the symptoms of UF in the lives of women diagnosed. Zimmerman et al.
(2012) found that women in their study reported a mild to severe negative impact of UF
symptoms on ability to perform various activities (e.g. housekeeping, sports, performance
at work) in their life. In another study Brito et al. (2014) indicated that participants of
their study had to change or limit their domestic and social activities as a result of the
symptoms associated with UF. The results of the Brito et al. (2014) and Zimmerman et al.
(2012) studies demonstrate the lack of ability to control UF symptoms can negatively
influence the active and social of lives of women impacted by UF. Participants in this
study indicated they felt the least impact in the subscale variable of control. These
findings related to the subscale variable control are an interesting discovery given current
research suggests that control is generally rated higher as an area of interest. However, in
spite of its ranking the control sub variable is statistically significant in this study and
indicates this is an area where respondents experience some level of negative impact in
their HRQOL. This finding remains consistent with current literature.
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Biological function. Body Mass Index (BMI) was the biological factor selected
for this study. BMI did not significantly contribute to the regression model; however, it
did have a significant correlation to total HRQOL (see Table 10). Specifically, the
findings of the study suggest that even when controlling for the study covariate factors,
age, family history of UF diagnosis, and employment, BMI continues to not have an
association to the participant’s HRQOL. The finding that BMI was not a significant
contributor to the model was an interesting outcome of this study. To date, there are no
published study findings that have found an association specifically between BMI and
total HRQOL among women with UF, although researchers Trivedi and Abreo (2009)
suggest that a relationship exists between UF diagnosis and higher BMI among women.
Other researchers have also found an elevated BMI along with some other biological
factors place African American women at an increased risk for developing UF (Faerstein,
Szklo, & Rosenshein, 2001; Flake, Andersen, & Dixon, 2003; Wise et al., 2005).
According to the CDC (2013) a normal BMI range is 18.5 to 24.9, 25 to 29.9 being
classified as overweight and 30 or more being classified as obese. It is important to note
the range of BMI for participants in this study was 19 to 51, with a mean of 30.8, with
46.25% of the participants falling into the obese category. Interestingly, the BMI findings
of this study suggest most of the participants were African American women who meet
the criteria for being classified as overweight or obese.
Characteristics of the individual. One characteristic of the individual was
selected for inclusion in the study, age. The covariate age was not significant in any of
the regression models. Research by the National Institute of Environmental Health
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Sciences indicates that by the age of 50 years more than 80% of African American
women and about 70% of Caucasian women in the United States would be affected by
UF (Baird et al., 2003). Research findings from Davis et al. (2009) and Wise et al. (2005)
have revealed that African American women between the ages of 25 to 45 years have a
statistically significant (p > 0.001) greater risk of diagnosis of UF when compared to
Caucasian women. Study inclusion criteria required that participants must be between the
ages 30 to 45 years. The mean age for participants in this study was 39.2 years. Even
though age did not significantly contribute to the model, it is important to note that this
study participants mean average age is consistent with the age range (35 to 45 years) for
African American women with the highest percentage of UF diagnosis (Davis et al.,
2009; Peddada et al., 2008; Wise et al., 2005).
Characteristics of the environment. There were two characteristics of the
environment selected for inclusion in the study: (a) family hx of UF diagnosis and (b)
employment history. At least one characteristic of the environment did significantly
contribute to the model.
Family history of UF diagnosis. In this study family history did not contribute to
any of the regression models, suggesting that family history of UF diagnosis did not
impact HRQOL among the participants of this study. Over two thirds (67.8%) of the
respondents in this study stated they had an immediate relative that had been diagnosed
with uterine fibroids. Fifty percent of the participants identified their mother as the most
common relative diagnosed with UF. Approximately 18.7% indicated they had a sister
who had uterine fibroids. However, this percentage should be interpreted with care as all
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of the respondents did not report whether or not they had a sister. Researchers have found
women who have a relative with a diagnosis of UF are at increased risk for UF
development (Hyuck et al., 2008; Peddada et al., 2008; Scwhartz et al., 2000). Family
history of UF diagnosis did not significantly contribute to any of the regression models.
Therefore suggesting that family history of UF among African American women age 30
to 45 years and UF diagnosis in this study may not be related. It is important to note that
research in this area is very limited and further research is required.
Employment history. In this study employment history did contribute to the
regression models. More specifically, there was a significant association with the severity
of symptoms and employment (missed work due to uterine fibroid symptom) and total
HRQOL. In this study more than one in three of the respondents indicated they had
missed work as a direct result of UF symptoms. The significance of employment history
being impacted by symptoms associated with UF is an important finding. This study
finding is similar to current research findings which have shown that decreased work
productivity and work loss are common among women diagnosed with UF when
compared to women without UF (Downes et al., 2010; Lerner et al., 2008; Pron et al.,
2003). Brito et al. (2014) reported findings that the women in their study felt their
professional activities were negatively impacted by the symptom associated with UF.
Zimmerman et al. (2012) reported that performance at work was rated the second highest
area that was negatively impacted by women with UF in their study. In their study,
researchers Lerner et al. (2008) found among African American women with UF, reports
of more difficulty managing physical and interpersonal job tasks, increased at- work
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productivity loss, increased fatigue, and difficulty concentrating were consistently higher
when compared to Caucasian women in their study. When trying to evaluate health
related quality of life among women with UF, results from the current study indicate it
may be essential to understand the burden of UF on the livelihood and job performance
of women diagnosed.
General health perceptions. General health perceptions was measured with one
single global question which measured perception of health on a scale from 1= poor, to
10 = excellent. There was no significant association of general health perceptions with
severity of symptoms, total HRQOL summed score, and employment history (missed
work due to uterine fibroid symptom), and family history (relative diagnosed as having
uterine fibroids). General health perceptions are described as the individuals’ overall
evaluation of the various aspects of their health and are highly personable (Wilson &
Cleary, 1995). For this reason, general health perceptions were examined with multiple
variables to determine how it may be impacted by various life factors. The insignificance
of general health perceptions in this study is a surprising find, given that all six of the
HRQOL subscale variables were significantly associated with symptom severity.
Although general health perceptions did not contribute to total HRQOL summed score in
this study, there was a significant correlation between general health perceptions and total
HRQOL summed score. The correlation was negative, indicating that as the respondents
felt a greater impact of uterine fibroids on their health related quality of life, their general
health perceptions decreased.
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Overall quality of life. For this study overall quality of life was measured using
one question, “How satisfied are you with your overall life in general on a scale of 1 to
10 (with 1 = poorly satisfied and 10 = very satisfied)”. Though similar to general health
perceptions given that both are individualized and subjective, the two concepts overall
quality of life and general health perceptions do differ. The major difference is that
overall quality of life is based on how happy or satisfied individuals may be with their
life in total (Ferrans et al., 2005; Wilson & Cleary, 1995); whereas general health
perception, is the individuals’ view on various aspects of their health. The literature
reviewed suggests that quality of life for women diagnosed with UF can be negatively
impacted by the symptoms associated (Spies et al., 2002; Williams et al., 2006).
Cambridge and Sealy, (2012) suggest that African American women with symptomatic
UF are often challenged with constant pain, embarrassment, and in some cases limited
support systems which can negatively affect their life and sense of well-being. However,
in this study the linear regressions indicated there was not a significant association
between the severity of symptoms and overall quality of life. The findings for this study
do not support current research findings as it relates to the impact of severity of UF
symptoms and overall quality of life. Given the significant association between symptom
severity and the six subscale HRQOL variables in this study, the findings may suggest
that African American women ages 30 to 45 years with UF may place greater importance
on how specific areas of their life are being impacted rather than on their overall quality
of life in general.
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Health related quality of life. Respondent’s perspective on HRQOL was
specifically captured in hypotheses 7-12. The findings in this study, suggest that the
respondents felt a negative impact on their health related quality of life due to their
uterine fibroid symptoms a little of the time to some of the time. In research questions 7 –
9 there was a significant association with total HRQOL and symptom severity and
employment history. The relationship is positive, indicating that as the severity of
symptoms increases, the negative impact on HRQOL also increases. Therefore, the null
hypotheses for questions 7-9 were rejected. This study finding supports current research
which implies the greater the severity of symptoms experienced by women with UF, the
more their total HRQOL will be negatively impacted (Borah et al., 2013; Spies et al.,
2002; Vines, Ta, & Esserman, 2010). Given the significant association between symptom
severity and the six subscale variables of HRQOL examined in this study the findings
that respondents felt their HRQOL was impacted in some way appears to be consistent
with current research findings. Researchers Brito et al. (2014) and Zimmeran et al. (2012)
both found that women with UF reported their HRQOL to have been impacted negatively
in multiple areas. It is important to note that this study findings suggest that African
American women age 30 to 45 years with UF experience at least some significant
negative influence on their health related quality of life based on the severity of UF
symptoms and these findings remain consistent with current research literature.
The R2 for the three models in research questions 7 – 9 ranged from 41.0% to
45.7%. The high R2 indicate severity of symptoms and employment have a strong impact
on the respondents’ health related quality of life. Current research also suggests that days
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missed at work and decreased work productively is higher among women with UF
(Zimmerman et al., 2012). Cote, Jacobs, and Cummings (2002) estimated that costs
associated with work loss from symptoms associated with UF are around $1,692 annually
per woman. Downes et al. (2010) study findings demonstrated a loss in work productivity
by 36% and 37.9% noted particularly in the general activity level for women with UF
compared to women without UF in their study population. The results of this study
indirectly lends support to the adaptation that non health factors among women with UF
such as employment and the role it has on HRQOL is related. More importantly, the
findings in this particular study suggest that more investigation as to the direct and in
direct impact of work loss on HRQOL among women with UF should be further
explored.
BMI and age did not significantly contribute to the models, suggesting that age
nor BMI have a significant association with total HRQOL. However, this study did find a
significant correlation of total HRQOL and symptom severity and BMI. The correlations
of the total HRQOL summed score (DV) with symptom severity (IV), BMI (IV) and the
covariates (age, relative, missed work) are displayed in Table 10. All the correlations of
the IVs to the DV are significant indicating that symptom severity and BMI have a linear
relationship with total HRQOL summed score. The literature reviewed found estrogen
levels and elevated BMI among African American women, place them at increased risk
for developing UF (Faerstein, Szklo, & Rosenshein, 2001; Flake, Andersen, & Dixon,
2003). The correlation of BMI, symptom severity and total HRQOL in this study
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provides support for the role that BMI may have in the increased development among
African American women should be further examined.
For research questions 10 -12, there was no significant association of general
health perception and HRQOL total score. Therefore, this study failed to reject the null
hypotheses for questions 10 -12. Given the significant association between symptom
severity and total HRQOL for this study, the findings general health perceptions and total
HRQOL are not associated in this study is an interesting find. Since general health
perceptions largely examines the respondents’ view of their total health and is not
specific to UF symptoms alone, it may suggest that general health perceptions is not a
significant predictor for examining HRQOL among African American women with UF.
While total HRQOL summed score was not significantly associated with general health
perceptions, the two variables were significantly correlated in this study. General health
perceptions (r = -.254, p = .023) as the DV and total HRQOL summed score as the IV has
a linear relationship in this study (see Table 14). The negative correlation indicates higher
total HRQOL summed score suggest an increased negative impact of uterine fibroids on
the respondent’s health related quality of life occurs as general health perceptions
decreases. If a correlation between these two variables exists as suggested by this study
findings, the connection can be vital for the research community and more investigation
is warranted.
The literature reviewed for this study lacked empirical studies that examined all of
the predictors of HRQOL in the manner that was attempted in this study. This study
attempted toaddress that gap in the literature; some reliable measures of HRQOL were
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obtained in spite of the sampling’s limitations. The findings in the current study
demonstrate that symptom severity has a significant association with functional status
and total HRQOL. More specifically, the findings of this study aided in determining how
various elements in the participants’ life (concern, energy/mood, activities, sexual
function, self- conscious, concern, and employment history) were significantly associated
with symptom severity. Conversely, in this study the following variables, symptom
severity and total HRQOL are not significantly associated with general health perception,
or overall quality of life even when controlling for covariates such as BMI, family hx of
UF diagnosis, and age. Therefore, other variables that could be used to explore factors
associated with HRQOL among African American women age 30 to 45 years with UF
should be further explored.
Limitations of the Study
This was an exploratory non- experimental quantitative study design utilizing a
survey instrument. The data were collected electronically. The population was identified
because of their increased risk for UF development. The researcher attempted to broaden
the sample by using three organizations (RGR, MRACDST, and SMLACDST) with a
wide-ranging base of African American women. Several limitations were identified that
could limit the generalizability of the findings. Overall, the limitations involve
respondents characteristics/demographics, sample size, survey administration, and selfreporting of information.
The first limitation involved use of a convenience sample which included only
African American women ages 30 to 45 years. The age inclusion for this study was
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specific to women who were ages 30 to 45 years because research has demonstrated this
age range among African American women are at an increased risk for UF development.
The average age was 39.2 years for the respondents of this study. Research has indicated
that African American women are diagnosed at a higher rate and suffer more from UF
when compared to women from other racial and ethnic backgrounds (Davis et al., 2009;
ORWH, 2006; NIH, 2011; Wise et al., 2005b). Therefore, this study only included
women who self-identified their race as being black or African American. According
toTaran, Brown, & Stewart (2010) there has been limited reporting of the participants
race and ethnicity within the studies associated with UF. Racial diversity in the sample
population was lacking in that this researcher only sought to explore HRQOL factors
among African American women only between the ages of 30 to 45 years to help fill that
gap in literature. However, only having African American women between the ages of 30
to 45 years limited generalizability of this study findings to women from other racial and
ethnic backgrounds and those outside of the specified age range.
The second limitation of the study was the small sample size. A total of 103
surveys were received. Twenty three were excluded from the study leaving a total of 80
who were included in the study. While the actual study sample size obtained for the study
was sufficient enough to be adequately power the study, a larger sample size may have
produced stronger statistically reliable results.
The third limitation of the study was that the survey was based online and only
administered electronically. While electronic administration of the survey was more
feasible and allowed participants to support this research anonymously, it also meant that
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only women who had access to a computer and the internet could respond to the survey.
Therefore, economically or educationally advantaged African American women are more
likely to have responded to the survey. Subsequently, the experiences of African
American women with UF from lower socio-economic communities may be
underrepresented in the study findings.
The fourth limitation was that participants self-reported personal health data such
as history of UF diagnosis and no history of treatment for UF. In order to increase the
likelihood of participants having a diagnosis of UF, they were asked if they had been
informed by a health practitioner that they had a diagnosis of UF. Additionally,
participants were asked to self-report information such as height, weight, race, and if they
had received medical treatment for UF. There was lack of access to participants’ medical
records by the researcher in order to confirm height, weight, race, and treatment history
of UF by the participants. Therefore, it is likely that some women with UF were excluded
from the study because they have yet to seek medical attention or receive a preliminary
diagnosis from a health practitioner which could have potentially increased the number of
women eligible to participate in the study. In addition, the study findings are limited to
those women with a first time diagnosis because a sub section of women with a second
diagnosis of UF were excluded because they may have received treatment in the past but
their UF have returned.
Recommendations
There is limited documentation on symptoms associated with UF and the impact
of UF symptoms on HRQOL African American women ages 30 to 45 years. The results
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from this study added important information to the current knowledge base in this area.
In addition, the results from this study provides valuable information on the symptoms
and specific functional elements (concern, activities, energy/mood, self- conscious,
sexual function, and control) that influence HRQOL among African American women
ages 30 to 45 years that have been diagnosed with UF. More importantly, the findings
from this study help promote the need for continued research that is patient centered and
focused on African American women whose lives are more likely to be impacted
negatively by UF.
The revised Wilson and Cleary revised model of HRQOL has been reviewed in
depth in previous sections of this paper. No previous studies were found that used this
conceptual framework to investigate the impact of symptom severity on HRQOL among
African American women ages 30 to 45 years with UF. While this model was found to be
effective in this study in exploring multiple factors that can influence HRQOL among
women diagnosed with UF, each component of the model needs continued research to
determine which factors can best influence HRQOL. The present study used the revised
Wilson and Cleary model of HRQOL as the foundation to investigate the following
factors: BMI, symptoms, functional status, overall quality of life, general health
perception, characteristics of the individual, and characteristics of the environment
among African American women age 30 to 45 years with a diagnosis of UF. Functional
status, symptoms (severity), and employment history one of the characteristics of the
environment were important and significant determinants of HRQOL. Because only these
three model components were significant in the overall model, other variables which
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might explain HRQOL among women with UF need to be reviewed and examined.
Subsequently, further studies using this model examining factors associated with UF and
HRQOL are needed.
Employment history, as one of the two variables selected for characteristics of
the environment in this study was found to have a significant association with HRQOL.
Based on this finding, the impact UF symptoms has on job performance and potential
work loss specifically among African American women with UF should continue to be
examined. Age, as the only characteristics of the individual and BMI one of the two
characteristics of the environment selected for this study were insignificant. The
association of age and BMI with HRQOL among African American women with UF
remains unclear. However, BMI was found to have a significant correlation with total
HRQOL score. The finding that BMI is significantly correlated to the total HRQOL score
suggests that additional investigation is warranted to determine a more specific
correlation between BMI and health related quality of life among women with UF.
The convenience sample in this study was different from most of the literature in
that it only included African American women ages 30 to 45 years, thus limiting the
generalizability. African American women are likely to be diagnosed up to three times
more when compared to their Euro American, Asian, and Hispanic counterparts
(Moorehead and Conrad, 2001; NIH, 2011). Therefore, it was important to focus this
research on the community of women likely to be impacted by UF at an increased rate
when compared to their racial counterparts. Stakeholders may benefit from this study by
understanding and identifying the specific areas in health and the daily lives of African
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American women ages 30 to 45 years that are most affected by UF. More specifically,
Women’s health care professionals could more routinely incorporate communications
related to the particular areas of HRQOL that may be impacted and identify some of the
barriers to care that exist among African American women with UF. Additionally public
health professionals could help with development of educational materials; thereby,
playing a vital role towards ensuring current and relevant information is available to
support delivery of sensitive and thoughtful care related to treatment of UF.
Implications for Social Change
Significant association between some of the predictor variables and symptom
severity and total HRQOL was found in this study. Data on HRQOL associated with UF
show that women with UF have significantly lower HRQOL scores when compared to
those women without this condition (Pron et al., 2003; Spies et al., 2002). In order to
provide sensitive patient centered care women’s health care professionals need to have an
understanding about the specific distresses that are experienced by women diagnosed
with and suffering from UF. Researchers Harding et al. (2008) implied that more research
that focuses on patient-reported outcomes about the problems and issues associated with
UF symptoms are needed for the development of patient centered care options and to
potentially improve patient outcomes. The rate at which African American women are
diagnosed, the negative impact UF symptoms can have on HRQOL, and the burden of
increased usage on healthcare systems for treatment of UF make this chronic and
progressive health condition a growing public health concern (ORWH, 2006; NIH, 2011).
This study’s social change implication involves providing information that can stimulate
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health care providers in the development of health maintenance programs that are
sensitive to the needs of African American women diagnosed with UF. Research suggests
that African American women with UF are actively seeking out information related to UF
symptoms and ways they can minimize those symptoms from impacting their lives
(Ankem, 2007). Another social change implication for this study is that public health
professionals and American medical organizations also can be motivated to increase the
availability of information related to UF symptoms and the impact of UF symptoms on
HRQOL. Thereby, supporting increased education and awareness about a chronic health
condition that is likely to impact at least 1 in 3 African American women in their lifetime.
These combined efforts can positively support the continued well-being of African
American women diagnosed with UF and encourage more dialogue to help minimize the
current culture of suffering in silence (Cambridge & Sealy, 2012) noted among African
American women diagnosed.
Summary
Uterine fibroids are a medical condition with wide spread symptoms that occur
among women of all races. According to the Office of Research on Women’s Health
(2006) approximately one quarter of all women in the United States of reproductive age
have symptomatic UF. African American women however, are diagnosed up to three to
nine times more often when compared to Caucasian women (NIH, 2011). In addition,
there is a higher prevalence among African American women of child bearing age
compared with women of other races (Davis et al., 2009; Wise et al., 2005b). Research
has identified that UF symptoms and the problems associated with UF symptoms can
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affect the HRQOL among women diagnosed. Often times women who are diagnosed
with UF that experience prominent symptoms seek treatment because of the difficulty
they encounter with managing the symptoms effectively and the negative burden UF
symptoms can have on HRQOL.
Currently, much of the research related to UF is centered on identifying the most
efficacious medical treatment options for removal of UF that would decrease the
extended time of recovery and still allow women of childbearing age the option to keep
their uterus intact supporting improved quality of life. This study attempted to obtain
empirical evidence from an existing population of African American women ages 30 to
45 diagnosed with UF regarding the symptoms associated with UF and the impact of UF
symptoms on their HRQOL. Participants reported a significant association with symptom
severity and total health related quality of life and symptom severity and all of the health
related quality of life subscale variables or functional status. More specifically
participants noted at least some to a little distress in the areas of concern, activities,
energy/mood, self- conscious, sexual function, and control as it’s related to the symptoms
associated with UF. Participants also reported that symptom severity did negatively
impact their employment leading to days missed from work. General health perception,
overall quality of life, BMI, age, nor family hx of UF diagnosis did not show a significant
relationship with HRQOL.
Uterine fibroids is a chronic condition, which can be debilitating to the health and
lives of women who experience severe symptoms. African American women who have
been diagnosed with UF face a myriad of issues related symptom management, treatment
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options, increased financial burden, and interruption in their daily lives. Aiding African
American women and health professionals understanding of the problems associated with
UF symptoms and how they influence HRQOL can impact decisions related to treatment
options and how to better manage symptom. For that reason, continued exploration into
the personal health factors associated with UF and their specific impact on HRQOL is
warranted to further highlight factors that can influence HRQOL. Therefore, future
research particularly on the effects of factors that are related to UF symptoms impact on
HRQOL is recommended to support an enhanced personal sense of well-being for
African American women diagnosed.
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Appendix A: Consent Form
You are invited to participate in a research study of health related quality of life in
African American women. You have been selected as a possible participant because you
identify yourself as African American, female, current diagnosis of UF and between the
ages of 30-45 years. Please read this form. This form is part of a process called “informed
consent” to allow you to understand this study before deciding whether to take part.
This study is being conducted by: Ilisher Ford, doctoral candidate at Walden University.
Background Information:
The purpose of this study is to explore symptom severity associated with uterine fibroids
and the impact of UF symptoms on health related quality of life. Participants in this study
will represent African American women ranging in age from 30-45 with a current
diagnosis of UF and have not received any surgical treatment for uterine fibroids. The
participants in this study will be members of a community service organization and a
running group for women. The findings of this study will assist the Public Health
community in effectively exploring the factors that are associated with uterine fibroids
among African American women.
Procedures:
If you agree to participate in this study, you will be asked to do the following things:
Review this consent form, complete a 37 item questionnaire, and complete a form with
background information about you.
Voluntary Nature of the Study:
PLEASE NOTE: You have the freedom to decide not to participate in this study. Your
participation in this study is strictly voluntary. Your decision whether or not to participate
will not affect your current or future relations with the researcher or your organizational
affiliation. If you initially decide to participate, you are still free to withdraw at any time
later, without affecting those relationships.
Risks and Benefits of Participation:
Being in this type of study involves some risk of the minor discomforts that can be
encountered in daily life, such as fatigue, stress or becoming upset. Being in this study
would not pose risk to your safety or wellbeing.

PLEASE NOTE: in the event you experience stress or anxiety during your participation
in the study, you may terminate your participation at any time. You may refuse to answer
any questions you consider invasive or stressful. You may also seek additional counsel
with Cobb and Douglas Community Services Boards, call ________ or Dekalb
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Community Services Board, call __________, should you feel any anxiety or stress as
a result of your participation in this study.
Compensation:
There is no compensation to be gained from participation in this study.
Confidentiality:
The records of this study will be kept private. In any report of this study that might be
published, the researcher will not include any information that will make it possible to
identify you as a participant. Research records will be kept in a locked file; only the
researcher will have access to the records.
Contacts and Questions:
The researcher conducting this study is Ilisher Ford. The researcher’s adviser is Dr.
Precilla L. Belin, PhD, MA, CHES. You may ask any questions you have now. If you
have questions later, you may contact her at ____________. The Research Participant
Advocate at Walden University is __________; you may contact her at ___________, if
you have questions about your participation in this study. Walden University’s approval
number for this study is ________ and it expires on ___________.

Thank you for participating! Please print or save this consent form for your records.
Statement of Consent:
I have read the above information and I feel I understand the study well enough to make a
decision about my involvement. By clicking the identified link, I understand that I am
agreeing to the terms described above.
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Appendix B: Screening Information

Instructions: PLEASE READ CAREFULLY
This section asks four questions that may or may not describe some general
characteristics about you. The information obtained from this form will be kept private
and confidential. PLEASE DO NOT LIST ANY NAMES OR INCLUDE ANY
PERSONAL IDENTIFYING INFORMATION WHEN COMPLETING THIS FORM.
Direction: Please select the one response that best fits your current status.
1. Do you identify yourself as Black/African American? YES or NO
2. Have you ever been informed by a medical healthcare practitioner (Medical
Doctor, Nurse Practitioner, Physician Assistant) that you have a diagnosis of
Uterine Fibroids? YES or NO
3. Are you currently between the age of 30 to 45 years? YES or NO
If you responded NO, to any one of the three questions above, please STOP here and do
not proceed forth with completion of the survey.
If you responded YES to all three of the questions above please proceed forth to the next
question.
4. Have you ever received medical treatment in the form of Uterine Fibroid
Embolization, Myomectomy, or Hysterectomy for your Uterine Fibroids? YES or
NO
If you responded YES to the question above, please STOP here and do not proceed forth
with completion of the survey. If you responded NO, to the question above, please
proceed forth to the next section.
Thank you for your time and willingness to support this research project.
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Appendix C: Demographic Information Form

Instructions: PLEASE READ CAREFULLY
This section asks questions that describe some general characteristics about you and your
family. This information helps us to understand general characteristics of the people who
have completed this survey. The information obtained from this form will be kept private
and confidential. PLEASE DO NOT LIST ANY NAMES OR INCLUDE ANY
PERSONAL IDENTIFYING INFORMATION WHEN COMPLETING THIS FORM.
Direction: Please fill in the blank or select the response that best fits your current status
1) How old are you?
Age: __________ in years
2) What is your current height? ________ Feet ______ Inch(es)
3) What is your current weight? ______lbs
4) Have you ever missed days or time off work as a direct result of the symptoms you
have experienced from Uterine Fibroids?
Yes _____
No _____
I do not know ______
5) Has anyone in your immediate (e.g. mother, sister, grandmother, aunt) family ever
been diagnosed with UTERINE FIBROIDS?
Yes _____
No ______
I do not know ______

6) If your response to question five (5) is YES, please select all that apply.
Mother _____
Aunt _______
Grandmother ______
Sister _______
I do not know ______
Not Applicable ______
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7) How would you rate your current health on a scale from 1 to 10 (with 1= poor and 10
= excellent)? ________
8) How satisfied are you with your overall life in general on a scale from 1 to 10 (with 1
= poorly satisfied and 10 = very satisfied)? __________
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Appendix D: Survey Instrument

Please do not include your name or
any personal identifiers on this form.
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Appendix E: Research Survey Instrument Permission Document
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Appendix F: Homogeneity of Variance Assumption Tests, Research Questions 1 Through
6
Figures used to test the homogeneity of variance assumption.
Research Question 1 through Research Question 6.

Figure F1. RQ1 - concern

Figure F2. RQ2 activities

Figure F3. RQ3 - energy/mood

Figure F4. RQ4 control
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Figure F5. RQ5 - self-consciousness

Figure F6. RQ6 sexual function
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Appendix G: Homogeneity of Variance Assumption Tests, Research Questions 7
Through 9
Figures used to test the homogeneity of variance assumption.
Research Question 7 through Research Question 9

Figure G7. RQ7 - IVs = severity, BMI

Figure G8. RQ8 - IVs = severity, BMI, age

Figure G9. RQ9 - IVs = severity, BMI, employment history, family history
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Appendix H: Homogeneity of Variance Assumption Tests, Research Questions 10
Through 12
Figures used to test the homogeneity of variance assumption.
Research Question 10 through Research Question 13.

Figure H10. RQ11 - IVs = severity, HRQOL
total score

Figure H12. RQ12 - IVs = severity,
HRQOL total score, employment history,
family history

Figure H11. RQ11 - IVs = severity,
HRQOL total score, age

Figure I13. Scatterplot to test homogeneity
of variance for RQ13.
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